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Detection of Pathogenic Bacteria and Fecal Enterococci in
Recreational Water With an Evanescent Wave Fiber Optic Biosensor
Maria Theresa Trindade
ABSTRACT
Development of a rapid method for the detection of fecal enterococci and
pathogenic microorganisms in beach water was attempted utilizing an evanescent wave
fiber optic biosensor. Various assay formats including a sandwich immunoassay were
tested in the development of a rapid assay. Fluorophore labeled antibodies were used for
specific detection of bacteria captured or adsorbed directly to the surface of a polystyrene
fiber optic waveguide. Binding of the fluorescent labeled antibody to its specific target
or binding of a fluorescent labeled anti-IgG within 100-1000 nm of the waveguide
surface caused excitation of the fluorescent conjugate resulting in a quantifiable signal.
Enterococcus faecalis, Staphylococcus aureus, Escherichia coli O157:H7, and Vibrio
cholerae were used as model organisms for biosensor detection in phosphate buffered
saline and seawater. Seawater samples were selectively enriched for the presence of
these model organisms, which were later detected on the biosensor. The sensitivity and
specificity of the biosensor was examined by testing various assay formats, sample
preparations, and molecules for capture and detection. Finally, an enrichment protocol
combined with filter concentration was utilized to enhance detection of low levels of
enterococci.
ix

The fiber optic biosensor has the potential to be a sensitive and specific system for the
detection of fecal enterococci. The lower limit of detection in seawater and phosphate
buffered saline was 2.8 x 106 CFU/ml. As few as 6 CFU/100ml (0.06CFU/ml) could be
detected in seawater following a 14-24 hour enrichment and concentration step. Vibrio
alginolyticus was found to grow under the same enrichment conditions as the
enterococci. V. alginolyticus crossreacted with the polyclonal anti-Strep group D
antibody used in the immunoassay at high cell concentrations. Staphylococcus aureus
was the only other organism which showed significant cross-reactivity with this antibody.
The biosensor was also able to detect other bacterial pathogens in PBS and seawater.
The lower limit for detection of E. coli O157:H7 was 3.6 x 105 CFU/ml. The lower limit
for detection of Vibrio cholerae O1 was 1.3 x 108 CFU/ml. The antibodies used in these
assays were found to crossreact with other gram negative microorganisms. The biosensor
was not able to detect Staphylococcus aureus.

x

INTRODUCTION
Biosensors
Background. A biosensor is an analytical detection system that exploits the specific
nature of a biological recognition element for its target analyte. This definition is broad
and encompasses the most basic systems such as over the counter home pregnancy tests
and sophisticated platforms to detect bioterrorist agents in complex matrices. The
coupling of a specific biological recognition element with its specific ligand can take
many forms in biology including antibody-antigen binding, enzyme-substrate reactions,
and receptor-ligand binding. These dynamic interactions have all been incorporated into
biosensor technology for the specific detection of a number of biological agents including
bacteria, viruses, and toxin molecules (63, 69,159). The technology has also been
developed for the monitoring of basic elements like oxygen (biological oxygen demand;
BOD) or phosphate concentrations (44, 78).
Biosensors work on the principle that through specific receptor-ligand interactions, a
signal will be generated that is proportional to the number of interactions between the
recognition element and the target (Figure 1). A transducer ultimately receives that
signal and produces an electronic signal that can be recorded. The coupling mechanisms
between the recognition element and the transducer vary. The biological recognition
molecules can be covalently attached to the surface of the transducer, passively adsorbed
to the transducer surface through hyrdrophobic interactions, linked to each other through
1

molecules such as avidin and biotin, or a prosthetic group attached to the transducer
surface can be arranged to bind an apoenzyme (280).
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Electric
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Conversion

FIGURE 1. Biosensor principles as described by Nakamura et al. (185).

Many different biological recognition elements have been tested for use in biosensor
experimentation which exploit the specific binding relationships between a receptor and a
ligand. These molecules include low molecular weight carbohydrates and peptides,
synthetic polymers, enzymes, receptors, cells, bacteria, and antibodies. They have been
incorporated into a variety of different types of biosensors for the specific capture and
detection of several target pathogens (viral or bacterial), toxins, and chemicals like
pesticides or herbicides (280). The biosensor field has expanded to include an array of
instruments incorporating intricate technologies such as fiber optic biosensors, surface
2

plasmon resonance sensors, piezoelectric immunosensors, and colorimetric biosensors
(280).
Biosensor technology has been in development for over 30 years, and the field has
seen many changes during this period. The most common sensors have been those used
to detect glucose. This was the first type of sensor developed by Clark and Lyons in
1962 (48). This sensor technology has brought much commercial success to the
biosensor field with the invention of portable glucose monitors which measure blood
sugar concentration. The success of this technology sparked research efforts toward
making these instruments diverse, versatile, and widely applicable (260). The use of this
technology in other fields of science is expanding. One such application is the
monitoring of bacterial contamination in food and water. Developing sensitive assays is
very difficult for many bacterial pathogens such as E. coli O157:H7 because the
infectious dose of this organism is very low (23). This is true for immunoassays where
high affinity antibody can make the difference between a sensitive assay and an assay
which does not work at all. Detection can also be difficult because of the limitations on
biomolecules used to detect these pathogens. Antibodies, for example, can be very
crossreactive with other similar targets and this can hinder the development of a specific
assay. A complex matrix such as seawater or food can further impair assay performance
due to inhibitors and debris that inhibit ligand-target interaction. Many systems are still
in development to overcome these obstacles, but biosensors show promise in this field.
This is evident as biosensors are now being used to detect biological warfare agents in
substances such as talc-based powders and cornstarch (256).
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Biosensor instruments have evolved from large bulky machines feasible only for
laboratory use to small, portable, automated machines that can fit in one’s pocket and
give rapid results (135). There are still many obstacles facing the further evolution of
biosensor technologies, such as cost reduction and development of systems sensitive
enough to detect low levels of agents without enrichment or concentration (135).
Piezoelectric biosensors. Piezoelectric biosensors (PZ) were first described by Shons
and Najarian who reported a sensor based on a quartz crystal microbalance (229). A
quartz crystal microbalance (QCM) is made up of a thin quartz disc with electrodes
plated on its surface. The QCM is piezoelectric so an oscillating field applied to the
balance induces an acoustic wave that is propagated throughout the crystal. The
frequency of this wave fluctuates in response to material deposited on the surface of the
crystal. Changes in the resonant frequency are related to the mass built up on the crystal
surface. Antibodies can be immobilized on the surface of the crystal and with increased
binding of the target, the resonant frequency decreases. Piezoelectric biosensors have
been used to detect several viral agents such as herpes virus and hepatitis C virus as well
as bacteria such as E. coli O157:H7 and byproducts of bacteria like staphylococcal
enterotoxin B (141, 159, 240, 248). Piezoelectric biosensors have been used for
environmental monitoring by immobilizing protein on the crystal surface. One such
protein, formaldehyde dehydrogenase, has been used to successfully assay for
formaldehyde without interference from other air pollutants. The bioterrorist agent, ricin
and herbicides like atrazine have also been assayed with PZ biosensors (32, 101, 181).
There are several commercial piezoelectric biosensors available from companies such as
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Elchema (Potsdam, NY) and Maxtek (Torrance, CA) which have been used to test for
substances like estrogen and organophosphates (29, 102).
While PZ biosensors are promising, several issues still must be addressed for this type
of sensor to have a wider applicability. Reproducible immobilization of protein on the
crystal surface must be achieved as well as elimination of non-specific binding of other
proteins to the crystal surface. The issue of reuse of the quartz crystal needs to be
addressed as well (193).
Surface plasmon resonance biosensors. Surface plasmon resonance (SPR) biosensors
are real-time, label-free, optical detection systems for examining the interactions of
soluble analyte with immobilized ligand. They are some of the most successful
biosensors on the market. SPR occurs when light is reflected off thin metal films placed
between a medium of high refractive index and a medium of low refractive index. A
fraction of the light energy incident at a sharply defined angle can interact with the
delocalized electrons in the metal film and reduces the reflected light intensity (94). The
precise angle of incidence at which this occurs is determined by several factors, like the
refractive index on the backside of the metal film where target molecules can be
immobilized and bind ligands in the mobile phase. An electromagnetic field called an
evanescent wave is formed which extends into the lower refractive media on the other
side of the metal. The propagation of the evanescent wave depends on the refractive
index of the thin layer adjacent to the light interface. The evanescent wave decays
exponentially with increased distance from the reaction interface. If binding of the target
occurs, the refractive index changes. The result is a change in SPR angle which can be
monitored in real-time by detecting changes in the intensity of the reflected light and will
5

produce a sensorgram. Theoretically, the size of the change in SPR signals is directly
proportional to the immobilized mass and this change can be used to calculate the
concentration of analyte being assayed. The rate of change of the SPR signal can also be
tracked to rate constants for the association and disassociation of a receptor for its target.
SPR has been used in many fields of science including medicine and biotechnology. This
technology has given much insight into kinetic rate constants for analyte-ligand
relationships as well as aiding in the characterization of the mechanism of certain
biomolecular interactions (94).
Colorimetric biosensors. Colorimetric biosensors rely on an obvious color change to
distinguish a positive from a negative result. Modern colorimetric instruments do not
rely on the addition of a chromogenic substrate to provide that color change. Novel
polymers called polydiacetylenes (PDAs) have unique color properties which are
dependent on several factors including the exposure of the material to environmental
conditions such as heat, mechanical stress, or solvents. Substituted PDAs undergo
dramatic color changes from blue to red. Biosensors have been designed to induce the
PDA blue to red conversion by specific binding of the biological target (e.g. antigen) and
the molecular recognition element which is directly linked to the transducer (PDA). An
example of such a biosensor is a system to detect influenza A virus by the binding of its
viral hemagglutinin to sialic acid residues incorporated into the PDA resulting in a color
change to red (42, 43). Another colorimetric biosensor has been developed based on the
red color of gold nanoparticles for the detection of lead. DNA-functionalized gold
nanoparticles are incubated with complementary strands labeled with a specific enzyme
(DNAzyme). When complementary sequences come together, they form aggregations
6

that cause a chromogenic change from red to blue. This aggregation is reversible. When
the aggregates are in the presence of lead, the enzyme on the DNAzyme catalyzes the
cleavage of the complementary strand leading to disruption of the nanoparticle assembly
and a color change to red (162).
Molecular recognition elements used in biosensor development. The list of biological
molecules that have been used in biosensor assay development is extensive. It is the
recognition element which is the heart of the system and makes a useful biosensor. There
are two categories of molecular recognition elements, catalytic (enzymes or bacteria) and
affinity-based (antibodies or receptors). More recently, synthetic recognition elements
such as peptide nucleic acids (PNA) have been developed for biosensor use as well (21).
Whole living cells of yeast, bacteria, and fungi have been manipulated for several
different detection needs, especially in the environmental and clinical fields (241).
Biological oxygen demand (BOD) sensing yeast have been genetically engineered for
luminous BOD sensing in environmental biosensor experiments. Thiobacillus
ferrooxidans has been used as a novel microbial sensor for detecting sulfate in rainwater.
This bacterium is known to oxidize Fe (II) in the presence of sulfate and the decrease in
current at the microbial electrode of the sensor correlates to the sulfate concentration
(221). A similar approach has also been done by using recombinant luminescent
bacteria. These bacteria were patterned onto a slide and exposed to toxic compounds.
When the target compound is present, a cascade is set off within the cell that ultimately
results in bioluminescence which can be recorded (147, 196).
Enzymes have been used for years to detect metabolites such as lactate, urea and
creatinine (268). Enzymatic biosensors have been developed mainly for the detection of
7

pesticides, clinical testing of metabolites such as glucose, and detection of
organophosphates in foods and environmental samples (268). The most common
enzymes used in biosensor detection are acetylcholinesterase (AChE),
butyrilcholinesterase, horse radish peroxidase, tyrosinase, and urease (168). These
enzymes cleave their particular substrate and the end result is a product which shows an
obvious color change or is fluorescent and can be detected. Once isolated and purified,
enzymes can be manipulated genetically for specific detection purposes. Pyruvate
oxidase from Pediococcus sp. has been isolated and used to detect phosphate in river
water (145). The enzyme cyanidase has been purified and genetically modified to
increase its binding affinity for cyanide, which can be a dangerous contaminant of river
water (116, 269).
Affinity molecules such as antibodies have been very useful for development of
detection assays. They are probably the most popular biological recognition elements in
use today because of their great specificity and ease of use. Antibodies, both polyclonal
and monoclonal, have been a huge asset to the field of immunoassays and rapid detection.
They are stable when stored under the proper concentrations and conditions and are easy
to use.
Antibodies are a group of glycoproteins present in the serum and tissue fluids of all
mammals. They are produced by the B cells of the mammalian immune system in
response to exposure to foreign antigen. IgG molecules commonly used in
immunoassays have an approximate molecular weight of 150,000 -160,000 (152). The
complex and efficient nature of the immune system causes the body to react to the
presence of a foreign antigen with the production of many different antibody species
8

which are specific for different epitopes on a particular target. Several genetic
mechanisms are responsible for the diverse nature of antibodies produced by different B
cells in response to an antigen, including gene recombination and genetic conversion (49,
228). This cocktail of antibodies can be extracted as whole serum from whatever host
(usually rabbit, goat, or donkey) has been exposed to the foreign material and are referred
to as polyclonal antibodies. Polyclonal antibodies are commonly used in the field of
biosensor immunoassays and have been useful in detecting E. coli O157:H7 in ground
beef and Salmonella in sprout wash (63, 142). Monoclonal antibody production,
introduced by Kohler and Milstein in 1975, has been a valuable tool for achieving a large
amount of specific antibody by using hybridoma technology to fuse mouse splenocytes
with a B cell myeloma (140, 215). These immortal clones can be maintained indefinitely
and can produce unlimited quantities of antibody. While adding enhanced specificity to
any immunoassay, this technique could also be limiting by generating a recognition
molecule specific only to one epitope on the antigen. In an assay that is designed to
maximize the chance of detecting a pathogen with several antigenic determinants, there
are advantages to using an antibody mixture which is specific for more than one target on
that cell.
There are ways to make these two types of antibodies work synergistically and to the
advantage of the assay. A polyclonal antibody can be used to capture the target
pathogen, and a monoclonal antibody can be used for detection in a sandwich
immunoassay. Another strategy to increase the efficacy of monoclonal antibodies is to
make several monoclonal antibodies to many antigens on a particular pathogen or target.
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The monoclonal antibody species could then be mixed together to form a “custom
polyclonal” or an antibody cocktail.
In addition to the drawbacks listed above, monoclonal antibodies are very expensive.
Furthermore, the immunogenicity (ability to elicit an immune response) of the antigen
could limit the use of this strategy. This problem was encountered in this study when
monoclonal antibodies were made to teichoic acid from Enterococcus cells. The best
results obtained were of IgM which has high avidity (combined strength of the
interactions between a multivalent antibody and a multivalent antigen), but the affinity
(binding strength between an epitope and an antibody paratope) is not very good.
Nonetheless, since the advent of the technique, numerous monoclonal antibodies have
been developed against an array of different agents including the anthrax lethal toxin, the
envelope glycoprotein of the Ebola virus, and botulinum neurotoxin A (103, 114, 167,
203).
The last decade has seen the development of recombinant antibodies using phage
display, which shows great promise for improving specificity for detection of biological
agents. Phage display uses bacteria and bacteriophage to produce and select synthetic
antibodies that have all the target recognition attributes of natural antibodies (202).
These synthetic antibodies are made by the same genes that encode for the variable
region (antigen recognition region) of natural antibodies in mammalian systems (202). In
phage display, a library of variant DNA sequences (derived from mammalian B cells)
encoding antibody fragments is created and cloned into phage as a fusion to a viral coat
protein (274). This phage library displaying antibody fragments is exposed to the target
antigen. Any unbound phage are washed away. Bound phage are eluted and used to
10

infect a bacterial host to amplify the phage population (274). The phage display
technique is especially advantageous for the production of antibodies to antigens which it
has previously been very difficult to raise antibodies against (77, 174). Phage display is
advantageous because antibody production no longer relies upon the immune response of
a mammalian host. Phage libraries can contain up to a billion different antibodies (202).
Phage display has been utilized to generate target specific antibodies in many fields of
science. The technique has been used in clinical applications to identify epitopes which
are produced in the early onset of infection with the hepatitis C virus in an effort to
develop tests for early diagnosis (124). Another clinical application has been the
development of recombinant antibodies against thyroid stimulating hormone (TSH) for
the diagnosis of thyroid diseases (144).
Certain ligands have native receptors through which they exert their effects, and
receptor-ligand relationships can be effective recognition strategies for biosensor assays.
For example, cholera toxin binds to the ganglioside receptor GM1 on the surface of
human intestinal cells (236). Receptor-ligand binding has also been utilized for hormone
detection (241). The estrogen receptor can identify ligands which can act as estrogen-like
compounds in humans (60). This research has been conducted to develop drugs which
provide the benefits of estrogen and less of the detrimental effects of the hormone (60).
Receptor-ligand pairs have the potential to be diversified into detection systems for other
molecules like bacterial toxins (236).
Some of the most recent advances in recognition elements have been on the
molecular level, with the incorporation of nucleic acids as detection molecules. One such
group of molecules are peptide nucleic acids (PNA) invented by Peter Nielsen (189).
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Peptide nucleic acid oligomers are synthetic DNA analogs with an amide backbone.
PNAs have several advantageous features; eg, they are stable under acidic conditions and
are resistant to nucleases and proteases (20, 189). Their neutrally charged backbones
increase their binding strength when bound to complementary DNA sequences, and also
enable the probe sequences to enter whole cells if necessary (20). PNAs are also stable
across a wide range of temperatures and pHs; however they are expensive. Nonetheless,
PNA is an alternative to less specific and less stable recognition elements available, and
has been used to detect E. coli, Salmonella, and S. aureus (21, 246).
Aptamers are another nucleic acid alternative. They are DNA sequences (less than
100 nucleotides in length) designed to bind proteins much as an antibody would bind its
target. Their binding affinity is similar to that of antibodies. Anti-lysosyme and antiricin aptamers have already been created for use on detection systems such as the
electronic tongue sensor array (134). Aptamers display high affinity and specificity for
target molecules, but they can be unstable and vulnerable to degredation by nucleases.
Lectins are a group of plant proteins with the ability to agglutinate cells and
precipitate carbohydrates. They interact with bacterial cell surface structures including
teichoic acid, teichuronic acids, peptidoglycan, lipopolysaccharide, glycoprotein, group
specific polysaccharides, and capsular polysaccharides (70). Lectin-based technologies
have numerous applications, including the ability to distinguish bacteria from each other.
For example, Bacillus anthracis can be distinguished from other bacilli by growth at
37°C and aggregation with the glycine max (soybean) lectin (50). Lectins can also be
used to type blood groups, purify teichoic acids, and to investigate microbial
ultrastructure (70, 277).

The most widely characterized lectins are wheat germ
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agglutinin (WGA) and concanavalin A (conA). ConA binds to α-D-glucopyranosyl or αD-mannopyranosyl groups on the cell surface of gram positive bacteria and WGA binds
the teichoic acid of gram positive bacteria (10). Enzyme linked lectinsorbent assay
(ELLA) has been used to detect and characterize extracellular polysaccharides and
bacteria (99, 151). Biosensors are now being developed to exploit the specific binding
properties of lectins. A nano-gold plasmon resonance biosensor utilizing gold labeled
conA has been developed for the detection of blood glucose levels (11, 172). The current
study utilized conA and WGA for the detection of enterococci in a sandwich assay format
on a fiber optic biosensor because of their ability to bind carbohydrate groups on the
surface of these cells.(27). The applicability of lectins is expanding and there are obvious
advantages to their use. Lectin agglutination assays are rapid, inexpensive, and
reproducible. Lectins are also stable, easy to store, readily available from commercial
suppliers and reactive at low concentrations (70).
Evanescent wave fiber optic biosensors, immunoassays, and their applications.
Immunosensors have been developed using the principles of well established
immunoassay techniques as models (197). The effectiveness of an immunoassay relies
on the following elements: i) the antigen to be detected, ii) the antibody or antiserum used
to detect the target, iii) the method to separate bound antigen antibody complexes from
free reactants, and iv) the mechanism of signal generation (8). Immunoassays date back
as far as 1959 when Yalow and Berson introduced the radioimmunoassay (RIA) for
insulin detection (279). The techniques of the immunoassay using labeled molecules,
specifically antibodies, to detect antigens or vice versa are economical. They can also be
sensitive depending on the target molecule. Solid phase assays employing ligands
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labeled with radioisotopes or enzymes (enzyme-linked immunosorbent assay) are the
most widely used immunoassays because of the large sample throughput that can be
attained. Radioisotopes and enzyme labels are now being replaced by fluorophores and
chemiluminescent markers to further increase sensitivity and shelf life of these assays.
Two typical immunoassay formats are depicted in Figure 2a and 2 b, a sandwich
immunoassay and an indirect immunoassay.
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FIGURE 2 a.) Sandwich immunoassay and b.) Indirect immunoassay.

Immunosensors allow for the real time measurement of interactions between antibodies
and antigens, receptors and ligands, and membrane reactions between cells. Optical
biosensors have made it possible to measure the kinetics of such biomolecular reactions
in a rapid and simple fashion (215).
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Evanescent wave, fiber optic biosensors combine fiber-optic technology with the
many facets of biology and physics. The instrumentation for this type of biosensor is
composed of three parts: i) the optics, which includes the platform or waveguide used to
collect emitted fluorescence, the light source for excitation, and the detector; ii) the
fluidics for delivering solutions; and iii) electronics and a computer system to convert the
signally electronically and record it numerically (216). Evanescent wave excitation for
use in fluorescent immunoassays was first reported by Kronick and Little in 1975 (143).
Evanescent waves work on the principle that light launched into a waveguide placed into
a fluid medium will be reflected internally. Consequently, an electromagnetic field or
evanescent wave is generated extending from the waveguide surface into the surrounding
medium and any fluorescent molecule within that evanescent wave is excited.
Evanescent wave sensors must satisfy several criteria, beginning with a platform that is
transparent to the wavelength used. The platform used must also be as free from
impurities as possible so as not to scatter the laser light or cause shifts in the refractive
index (216). This type of biosensor has been used to detect viral agents and toxins such
botulinum toxin A and staphylococcal enterotoxin B with much success (69, 194, 237,
251). The Analyte 2000 (Research International; Monroe, WA) biosensor used in this
study uses polystyrene fibers as waveguides to collect fluorescence emitted perpendicular
to the waveguide (216).
The Analyte 2000 biosensor used in this study has been developed to exploit the
sensitive and specific nature of antibody-antigen interactions in a sandwich immunoassay
format (157, 230). This biosensor platform is multi-functional and has the unique
capability of detecting pollutants and pesticides in the environment, monitoring food15

borne pathogens in the food supply, and detecting biological warfare agents (158, 260).
Evanescent wave fiber-optic biosensors are very well suited for the sandwich
immunofluorescence assay. Biotinylated capture antibodies can be affixed on the
surface of the waveguide by biotin-avidin binding where they can bind target molecules
of interest. The sample is incubated with a detection antibody conjugated to a fluorescent
molecule. If this fluorophore conjugated antibody is within the evanescent wave, the
fluorescent molecule is excited creating a detectable signal (157). This sandwich
immunoassay has been used to detect pathogenic bacteria and viruses on the Analyte
2000 biosensor including vaccinia virus, E. coli O157:H7, Listeria monocytogenes, and
Salmonella (63, 64, 91, 142,157). The sandwich immunoassay is not the only assay
format that can be adapted to this instrument for pathogen detection. An indirect
immunoassay format (Figure 2b) has been adapted to the Analyte 2000 biosensor in this
study for the detection of fecal enterococci in beach water.
The Analyte 2000 biosensor has the ability to detect pathogens in a complex matrix.
This is a desirable characteristic for treating recreational water samples that can be laden
with particulate matter and debris. High sensitivity is great importance in waterborne
pathogen detection because some bacteria such as E.coli O157:H7 have a low infectious
dose (157, 254). The Analyte 2000 biosensor has been used to detect E. coli O157:H7 in
a homogenate of ground beef and in apple cider at low levels. The overall assay time is
20 minutes (63, 64). These results are encouraging for applying this instrument to
detection of pathogens in water, especially considering the diverse matrix of beach water.
The future of biosensor technology. Biosensors are a cutting edge technology with
universal appeal across many fields of science. Over the past decade, there has been
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increased interest in biosensors for use in environmental, medical, toxicological, and
defense applications (197). They are being developed as instruments for the rapid
detection of possible bioterrorism agents such as ricin, botulinum toxin, and anthrax
spores (32, 194, 256). Biosensors like glucose monitors have been used as efficient tools
for tracking blood sugar level fluctuations observed in diseases like diabetes (18).
Research is ongoing to adapt these instruments and concepts to other areas of science
such as drug discovery and pharmaceuticals. Newly designed biosensors are smaller and
more versatile than their predecessors. They are being assembled with miniature
components that will enable them to one day be assembled into small multi analyte
detection chips (175). A single biosensor could theoretically serve as a chip array with
multiple detection capabilities in various simple and complex matrices (175). Biosensors
such as the fiber optic evanescent wave Analyte 2000 biosensor have been developed as
reusable instruments thereby reducing cost. Continued research and advancements in the
fields of biochemistry, fiber optics, engineering, proteomics, and genomics will continue
to drive further developments of rapid detection methods using biosensor instrumentation
(216).
Indicators of Fecal Contamination
Starting with the first documented case of waterborne illness in 1854, a cholera
outbreak in England (243), waterborne disease has been a public concern. A major focus
of public health programs has been to prevent waterborne disease outbreaks from
occurring. This is especially important during times of crisis, such as the events
associated with recent hurricane Katrina, which left the city of New Orleans vulnerable to
the dissemination of pathogenic bacteria and disease. Documented illness stemming
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from V. vulnificus infections did indeed occur (34). For over 100 years, U.S. public
health officials have relied on indicator organisms to assess the microbiological quality of
water (188). Directly assaying for specific pathogens is not easy and can be expensive.
Fecal indicator bacteria provide an estimate of the amount of feces and, indirectly, the
presence and quantity of fecal pathogens in water (261). Initially, indicators were applied
to asses the quality of drinking water and, over time, indicator measurements combined
with chlorination drastically reduced the incidence of disease associated with drinking
water like cholera and typhoid (188). Presently, indicator levels are a standard guideline
by which the extent of fecal contamination of all types of water are assessed (261, 262).
Over the long history of indicators, assays for their detection have been standardized and
made relatively easy to use for the enumeration of these organisms in water, with the
drawback that results still take 24-48 hours (71, 179).
The study of waterborne illness began with an outbreak of cholera in England in 1854
(243) which was studied by John Snow. A prominent physician, Snow conducted an
epidemiological study showing that drinking water from a contaminated well caused the
outbreak (243). In 1885, Theodor Escherich showed the frequency of coliform bacteria,
specifically E.coli, in human fecal matter. The term “indicator” was coined in the 19th
century by Klein and Houston who also reported findings on the prevalence of coliform
bacteria in sewage contaminated water in (137). Based on the findings of Escherich,
Theobold Smith, an employee of the State of New York Department of Health, developed
a presumptive test for the presence of E. coli based on its ability to ferment lactose in
contaminated samples. This test later became known as the coliform test (242). In 1932,
Scott proposed using coliform concentrations as a guideline to indicate sewage
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contamination in coastal beaches in Connecticut (223). It was later discovered, however,
that some of the bacteria that tested positive in the coliform test were not always of fecal
origin. Tests based on higher incubation temperatures (44.5 °C) and detection of βglucoronidase activity in fecal coliforms, a subset of the coliform group, were then
developed. This method is still used today to enumerate fecal coliforms in contaminated
waters. One such method is the Colilert system (54) developed by Idexx Laboratories
(Westbrook, ME).
The contamination of recreational bodies of water has become an escalating problem
along the coastal United States. There are five commonly-recognized elements involved
in the transmission of disease through water: i) the source of the infectious agent, ii)
specific mode of water related transmission, iii) characteristics of the organism that allow
it to survive and perhaps multiply and move into and within the environment, iv) the
infectious dose and virulence of the pathogen, and v) host susceptibility (19). Waterrelated diseases were described by Bradley and have provided a framework for the
classification of waterborne illness (19). In this scheme, water related infections are
divided into four groups i) waterborne infections ii) water-washed infections, iii) waterbased infections, and iv) infections with water related insect vectors.
The present study focused on the rapid detection of indicator organisms as a means of
assessing the extent of fecal contamination in beach water to prevent the incidence of
waterborne infectious disease. Along with detection of these organisms comes the
sometimes difficult issue of pinpointing the source of that contaminant. Point source
discharge of waste from wastewater treatment plants into coastal waters has necessitated
the implementation of precise environmental regulations for treatment and disposal of
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such waste (80). A bigger problem than point source discharge such as sewage and
industrial waste is nonpoint source contamination. Nonpoint source pollution such as
urban and agricultural runoff and overflowing storm drains has generally not been
regulated and, therefore, this type of pollution in the past has gone untreated and persists
in the environment (41, 93). Human and animal feces contribute to nonpoint source
contamination and are one of the most hazardous forms of pollution. Animals and
humans can harbor highly pathogenic organisms such as E.coli O157:H7 or hepatitis
virus. The result is contaminated coastal beaches, which are unsuitable for the swimming
public. Tainted beaches can cause economic impacts due to lagging tourism but, most
importantly, the health of the public suffers (90).
In response to disease acquired from recreational water use, many programs have
been implemented to monitor coastal water pollution and establish water quality
standards. In 1972, Congress passed the Clean Water Act and established the U.S.
Environmental Protection Agency (EPA). National regulations for water quality were
established based on coliform densities, and research began to find other indicators which
could be more accurate for assessing water contamination. In that same year, the EPA
launched a series of epidemiological studies to test the correlation between indicator
organisms and recreational water illness. Discriminant comparisons between fecal
indicators and disease incidence revealed that elevated levels of enterococci strongly
correlated with disease in freshwater and marine waters (25, 26). In 1986, the EPA
released Ambient Water Quality Criteria for Bacteria revealing the results of those
studies and new guidelines for indicator levels in freshwater and marine water beaches
(261). E. coli (a member of the fecal coliform group) was found to correlate positively
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with gastroenteritis in freshwaters. Total coliforms and fecal coliform counts, which
were routinely monitored at that time, only weakly correlated with disease (25). It was at
this time that well defined criteria for enterococci and coliforms as indicators were
developed. In freshwater, levels of E.coli should not exceed 126 CFU/100 ml and levels
of enterococci should not exceed a geometric mean of 33 CFU/100ml (261). In marine
waters, levels of enterococci should not exceed a geometric mean of 35 CFU/100 ml
(261). There is still no single indicator which can be used to assess contamination of all
types of water. The specific criteria for an ideal indicator organism as well as for the
methods required to detect each indicator are listed in Table 1.
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TABLE 1. Criteria for ideal indicator organisms and methods for their detection
(90, 188).

Criteria for an ideal indicator of fecal contamination
•
•
•
•
•
•
•
•

Correlates to health risks
Found consistently in the feces
at higher concentrations than
other fecal pathogen s
Should not multiply outside the
human intestinal tract
As resistant to disinfection
as other pathogens
Should correlate to the presence
of fecal pathogens
Persists in the environment
as long as other fecal pathogens
Should be a simple, easy and
reliable test to assay for the organism
Specific to a fecal source or identifiable as
to source of origin

Criteria for ideal methods to detect indicator organisms
•
•
•
•
•
•
•
•

Specific for the target organism
Broad applicability
Precision
Appropriate sensitivity
Quick results
Allows for enumeration
Can measure viability or infectivity
Logistically feasible

E.coli is considered to be a good indicator of freshwater fecal contamination. The
contamination source is presumed to be warm-blooded animals. Fecal coliforms are not
good indicators for beach water. The presence of fecal coliforms does not directly
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correlate to the increased incidence of gastrointestinal disease among swimmers (261).
E. coli has been isolated from freshwater collected from leaf axilae of bromeliads in a
tropical rainforest suggesting that E.coli is indigenous to the water environment (213).
Clostridium perfringens, Staphylococcus aureus, phages of Bacteroides fragilis have
been mentioned as possible indicators of fecal contamination (90). The saturated sterol
coprostanol has also been as an indicator because it is specific to higher mammals (117).
The EPA recommends enterococci as the most reliable indicator of fecal contamination in
marine waters because it positively correlates with human illness (261).
Enterococci-Indicators of Fecal Contamination
Biochemical properties and characterization. The enterococci are Gram positive
organisms that occur singly, in pairs or in short chains. These microorganisms are
characterized by their ability to grow at 10°C and 45°C, in the presence of high sodium
chloride (NaCl) concentrations, and broad pH ranges. They are capable of survival at
60°C for 30 minutes. Enterococci are aerotolerant fermentative organisms which grow
optimally at 35°C and hydrolyze esculin in the presence of 40% bile salts.
Some species of enterococci can be motile and most hydrolyze pyrrolidonyl-βnaphthylamide (PYR). All strains produce leucine aminopeptidase. Most strains are
homofermentative, producing lactic acid without gas from glucose. The enterococci are
biochemically distinct from streptococci and have been placed in a unique genus,
(Enterococcus). Enterococci are found in the gastrointestinal tract of warm-blooded
mammals. These bacteria can be shed through fecal matter into soil, water, and food. As
of 2002, 23 distinct species of Enterococcus were recognized (Table 2).
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TABLE 2. Species included in the genus Enterococcus (81).
Ent. faecalis
Ent. faecium
Ent. avium
Ent. casseliflavus
Ent. durans
Ent. gallinarum
Ent. malodoratus
Ent. hirae
Ent. mundtii

Ent. raffinosus
Ent. pseudoavium
Ent. cecorum
Ent. columbae
Ent. saccharolyticus
Ent. dispar
Ent. sulfurous
Ent. asini
Ent. villorum

Ent. haemoperoxidus
Ent. moraviensis
Ent. ratti
Ent. pallens
Ent. gilvus

Many methods have been developed for the biochemical identification of
Enterococcus species. The API 20S (BioMerieux; Hazelwood, MO), the API Rapid ID
32 (BioMerieux; Hazelwood, MO), and the Vitek Gram-Positive Identification Card
(BioMerieux; Hazelwood, MO) are examples of miniaturized biochemical test kits.
These rapid tests often result in inaccurate identifications, particularly for Ent. gallinarum
and Ent. casseliflavus isolates. Molecular techniques have offered a promising tool for
the rapid and accurate identification of Ent. faecalis and Ent. faecium. Examples are
PCR amplification of the Enterococcus protein A genes efaAfs from Ent. faecalis and
efaAfm from Ent. faecium and amplification of the Ent. faecalis ace (adhesion for
collagen) gene (239). Biochemical tests, although more time consuming, are considered
by some to be cost effective and user friendly than these molecular methods (81).
Reservoirs of enterococci; human and non human. As described previously, the
enterococci (previously grouped as streptococci) are native inhabitants of the mammalian
and avian gastrointestinal tract and comprise approximately 1% of the overall microflora
(105 to 107 organims/gram) in the feces (105, 224). They have also been isolated from
reptiles and insects on occasion (62). With the emergence of antibiotic resistance within
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the genus, there has been increasing interest in identifying the reservoirs of these
organisms and their antibiotic resistance genes. There is a concern that the use of
antimicrobial compounds on food animals that has created a large reservoir of
antimicrobial resistant enterococci which have the potential to be passed onto human
hosts (2, 13).
Enterococci have been isolated from plants, soil, and water as fecal contaminants. In
water, the predominating species are Ent. faecalis and Ent. faecium. Other species have
been associated with a particular environment or animal host. Examples of host specific
species include Ent. assini found in donkeys and Ent. columbae, which is specific to
pigeons (61, 67). Ent. faecalis and Ent. faecium have a broad distribution in the
environment. Methods have been developed (microbial source tracking) to divide
Enterococcus species into host-specific ecovars. These methods are based on genotypic
and phenotypic traits that ultimately discern the possible source of contamination. For
example, Ent. faecium isolated from poultry retained the ability to ferment raffinose,
whereas strains isolated from other origins did not (66). Pinpointing the source of
contamination, especially in beach water, can benefit the public health. Preventative
measures to stop contamination at the source are more likely to prevent illness altogether
(1).
Group D antigen and lipoteichoic acid. Teichoic acids were discovered in gram
positive bacteria in 1958 by Baddiley and Davison (12). Most gram positive bacteria
produce a cell-wall associated teichoic acid and a membrane associated teichoic acid
(lipoteichoic acid or LTA). Lipoteichoic acids are a class of phosphate-containing
polymers that are covalently linked to membrane glycolipids of the plasma membranes of
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gram positive bacteria (138). They are not synthesized by gram negative bacteria. There
are two types of teichoic acids, glycerol phosphates or ribitol phosphates substituted with
various glycosyl and D-alanyl ester groups (Figure 3) (55, 138, 273). In enterococci, the
LTA is referred to as the group D antigen (74-76, 272).

FIGURE 3. Structure of ribitol and glycerol teichoic acids (55).

The group D antigen is located below the Enterococcus cell wall and constitutes
approximately 1-2% of the bacterial mass (12, 125,126). This location contributes to the
difficulty of raising a good immune response against LTA, which is evident in studies
dating back to the Lancefield classification schemes (146, 170). Watson et al. discovered
that a good immune response to LTA in group D streptococci could be obtained only
when the cells were enzymatically digested with lysozyme to reveal the LTA under the
bacterial cell wall (270). The limited availability of LTA on the cell surface of intact
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cells deters the formation of an antibody response against this antigen. Knox and Wicken
also noted this difficulty in raising antiserum to LTA using whole cells, but were able to
prepare cell fractions which produced a strong antibody response (138). The cell wall
structure of a typical Ent. faecalis cell is shown in Figure 4.

Type specific capsular
polysaccharide
E. faecalis species antigen
(rhamnopolysaccharide)

Teichoic acid

GNAc

MNAc

MNAc

Lipoteichoic Acid
(group D Antigen)

MNAc

GNAc

GNAc

GNAc

MNAc

MNAc
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MNAc

GNAc

GNAc
GNAc
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Cytoplasmic
membrane

FIGURE 4. Structure of the Enterococcus cell wall (55). Enterococci have cell wallassociated teichoic acid and membrane-associated lipoteichoic acid (group D antigen).
The group D antigen is located beneath the cell surface.
Several methods have been used to extract LTA from gram positive bacteria. These
methods vary from the preparation of a crude extract using enzymes like DNase and
lysozyme to the more complicated hot or cold phenol extraction method (127). Ideally,
for a good immune response against teichoic acid, LTA must be extracted/separated from
protein or extracted with some protein. A single extraction technique does not work for
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all bacteria especially when bacteria contain LTA and cell wall-associated teichoic acid
(138).
LTA is a complex and important antigenic structure in gram positive bacteria.
Comparisons have been made between the LTA of gram positive bacteria and the LPS of
gram negative bacteria. The teichoic acid portion is thought to be analogous to the core
polysaccharide of gram negative cells. While previously thought to be poorly
immunogenic, LTA’s location within the bacterial cell prevented the generation of
antibodies when whole cells were used as the immunogen. To date, however, several
monoclonal antibodies have been successfully made against LTA (104, 119). This study
will show that disruption of Enterococcus cells leads to a good immune response in
rabbits against these bacteria.
LTA biosynthesis has been extensively studied. LTA is continually synthesized even
when bacterial cells are under starvation conditions. Growth conditions also have a large
effect on the extent of LTA synthesis. Synthesis of the group D antigen is dependent on
the glucose concentration and final pH of the bacterial growth medium. Glucose
concentration increases the sugar group substitution of the LTA. Antibodies are typically
formed against these carbohydrate components of the LTA. Other studies have also
shown that production of LTA is greatest during exponential phase of growth (86).
Public health significance of enterococci and use as an indicator of fecal pollution.
Fecal enterococci were first discovered in the late 1880s as commensals of the
gastrointestinal tract of humans and animals. They have been useful in monitoring the
water quality of bathing beaches due to their abundance in human feces. Ent. faecalis
was initially named Micrococcus ovalis by Escherich, and later renamed by Andrewes
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and Horder in 1906 (9). Ent. faecium was first identified in 1899 (195). These two
species stand out because they were the main species isolated from sewage-contaminated
waters. By 1900, enterococci were recognized as being of fecal origin and were proposed
as potentially useful indicators. The genus name Enterococcus was first used by
Thiercelin and Jouhaud in 1903 (253). Controversy has followed the classification of the
enterococci since the turn of the century. Dible in 1921 proposed that Ent. faecalis be
renamed Streptococcus faecalis (68) and Sherman in 1931 proposed that the bacteria
known as enterococci be reclassified as Streptococcus (226). Sherman coined the term
fecal streptococci instead of fecal enterococci for these indicators. This group of bacteria
was characterized as gram positive catalase negative non sporeforming facultative
anaerobes which belonged to the Lancefield group D streptococci. In 1984, based on
immunological and molecular methods, the fecal Streptococcus group was reclassified as
Enterococcus once again. Only a few group D streptococci remained as Streptococcus
including Streptococcus bovis and Streptococcus equinus. Beginning in the 1940s and
1950s, the development of a method to enumerate fecal enterococci began. Cabelli at the
EPA developed a reliable membrane filtration technique for detecting enterococci in
water in 1970 (25). The experiments were conducted as prospective epidemiologicmicrobiological studies to compare rates of gastrointestinal illness in swimmers and nonswimmers at freshwater and marine water beaches. As a result, the presence of fecal
enterococci in marine water has been considered indicative of fecal contamination. The
presence of fecal enterococci can also be correlated to the incidence of gastrointestinal
illness in swimmers (26, 72, 95, 259, 265, 283). Mean Enterococcus densities were
designated as a result of these studies. Enterococci were not to exceed a geometric mean
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value (over at least 5 samples) of 35 CFU per 100 ml and no one sample should carry
greater than 104 CFU of enterococci per 100 ml (261). As previously mentioned, 1986
was marked as the year when strict guidelines for water quality were established and the
EPA recommended that Enterococcus counts be used to monitor water quality for marine
and coastal areas (261).
Coastal states across the U.S. have implemented EPA guidelines for the routine
monitoring of recreational bodies of water using coliform or Enterococcus counts or
both. The State of Hawaii added a third indicator, Clostridium perfringens, that is
routinely monitored, (89). Since the 1986 guidelines were published, several countries
have sponsored studies for the further assessment of the relationship between indicator
organism densities and disease incidence (45, 53, 83). Some results support the 1986
findings of the EPA, that enterococci should be used to monitor marine waters (261).
Noble et al. found that a more integrated approach for monitoring these organisms should
be used (190) where more than one organism is assayed to monitor marine water in order
to obtain additional information on the overall quality of the water (259). The State of
Florida monitors fecal coliforms and enterococci in marine water (87). Regardless, the
enterococci have been found to be reliable and to retain attributes that other indicators
have not. Enterococci are not as ubiquitous as coliforms, are always present in the feces
of humans and animals, are unable to multiply in contaminated waters, die off less
rapidly than coliforms in water, and persist in the water as long as specific pathogens
(258). There are disadvantages to using enterococci including their ability to become
viable but non culturable, to survive associated with zooplankton, and to survive in
sediments and sand resulting in resuspension of the organisms at high tide (6). All
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factors need to be considered when developing rapid methods for the detection of fecal
enterococci.
Methods for the detection of fecal enterococci. Improved methods for the detection
of enterococci have been developed that are rapid and simple. Table 3 shows a
comparison of the most recent methods developed to detect bacteria by desirable
characteristics.
TABLE 3. Comparison of common methods to detect bacteria by desirable attributes
(188). The three types of detection methods were rated from low to high for each
criterion listed.
Method attributes

Culture

Specificity to desired
target

Low to Moderate

High

High

Broad applicability

High

High

High

Repeatability

Moderate

Low-High

High

Sensitivity

Moderate/High

Low-High

High

Speed of results

Low/Moderate

Moderate/Fast

Moderate/Fast

Quantifiable

Moderate

Low

Low/Moderate

Measures viability or
infectivity

Yes

No

No/ Is possible

Low/High

Moderate

Low/High

Moderate/High

Low/High
Low/High

Moderate
Low

Feasibility
Training and personnel
requirements
Can be used in the
field
Cost
Volume requirements

Immunological
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Nucleic acid

Moderate
Moderate/High
Moderate
Low

The easiest, less labor intensive, most reliable, and most feasible method for the detection
of fecal enterococci today are still culture methods. Enrichment culture methods
combined with filtration permit bacteria from contaminated samples to be enumerated.
Selective plate media and broth cultures can be used to enrich for specific enzymatic
activity in enterococci. In both cases, the medium has been created to target growth of
desired bacteria by adding selective agents that will repress the growth and proliferation
of the undesired background flora. The medium also contains components that cause the
growth of the target bacteria to appear unique and distinguishable from non-targets. The
most common method to date has been the use of membrane filtration of beach water.
The filter is then placed on selective and differential agar and enterococci are
enumerated. This is the standard method used today by local, county, and state public
health agencies across the United States (263).
Levin et al. described a two-step membrane filtration (MF) method for the
enumeration of enterococci from beach water (153). This method involved the filtration
of a sample of water through a 0.45µm filter. The filter was placed onto primary
selective isolation medium (mE) containing nalidixic acid (NA), cycloheximide, and
triphenyltetrazolium chloride (TTC). The NA inhibited the presence of gram negative
organisms; the TTC permitted for the differentiation of enterococci from other organisms
and cyclohexamide inhibited fungi. The medium was then incubated at 41°C. Following
primary isolation, the filter was transferred to EIA media (esculin-iron media). Pink to
red colonies on mE would produce a brown-black precipitate on EIA if they were
enterococci due to the hydrolysis of esculin by the enzyme β-glucosidase. While this
medium was convenient at the time, it took 48 hours to obtain a result.
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Years later, the two-step MF technique developed by Levin was modified by the EPA
(263). Building on the foundation of the two step method, the process was made easier
and more rapid by addition of the chromogenic substrate indoxyl β-D-glucoside (0.75 g/l)
to the primary isolation media and reducing the concentration of TTC (from 0.15 g/l to
0.02 g/l). The addition of indoxyl β-D-glucoside to the medium resulted in β-glucosidase
positive colonies of enterococci. The β-glucosidase produced an indigo blue complex
which diffused into the surrounding agar forming a blue halo around the colony. The
modified medium was termed mEI and was referred to by the EPA as Method 1600 (179,
263). All colonies regardless of color were counted as enterococci if they had a blue halo
surrounding them. This method offered several advantages including reduction of overall
assay time from 48 hours to 24 hours, and elimination of the need to prepare a secondary
medium (EIA) for identification of enterococci, using the existing mE base which was
commercially available. Colonies were smaller and more distinct making them more
easily counted, and the specificity was better than the two step method (only 6% false
positive rate compared to 10% with the two step method) (179). Both the two-step
method (using mE and EIA agars) and the modified method (using mEI) are listed in the
Method 1600 Manual published by the EPA (263). Unfortunately, the indoxyl β-Dglucoside substrate is expensive so that the 2-step method is still used by some
laboratories.
Enterolert developed by Idexx Laboratories is a semi-automated most probable
number (MPN) technique that can enumerate enterococci. It is intended to be less labor
intensive, requires fewer confirmatory tests, less skilled labor, and provides results in 24
hours. The test is based on the activity of the Enterococcus β-glucosidase enzyme. The
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Enterolert medium contains the substrate 4-methylumbelliferone-β-D-glucoside which is
cleaved by β-glucosidase to the fluorescent product 4-methylumbelliferylone. 4methylumbelliferylone can be seen when exposed to long wave UV light of 365 nm.
Enterolert is used to test for the presence of enterococci in freshwater and marine waters.
This method has been found to be just as effective as membrane filtration techniques, less
labor intensive requiring shorter incubation time for results (24, 71, 191, 192). However,
because samples need to be diluted, this method is incapable of detecting very low levels
of enterococci (71).
Newer Molecular methods are now available that do not have the limitations of
culture methods, specifically, the sensitivity and the time it takes for results. Polymerase
chain reaction (PCR) to amplify specific DNA sequences from enterococci has been used
to overcome the limitations of traditional current methods (57, 220). This method uses
DNA polymerase to make thousands of copies of a particular gene sequence from a
bacterial genome. The product is then assayed by common laboratory techniques such as
gel electrophoresis. Realtime PCR, which uses fluorescent dyes that can intercalate into
double stranded DNA, is a variation of PCR and is quantitative. Several PCR assays
have been developed for the detection of enterococci. Danbing et al. developed a novel
procedure by amplifying the tuf gene in enterococci which encodes for an elongation
factor; however, this procedure has been used for clinical applications only (57). Most
procedures are developed to amplify conserved sequences such as the 16S or the 23S
rRNA sequences from enterococci (111). A procedure developed by Santo-Domingo et
al. showed the potential for using PCR for detecting enterococci in environmental water
samples by amplifying a segment of the 16S rRNA region (220). This procedure was
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successful for detecting levels of enterococci greater than 600 CFU/100ml, but was not
able detect lower concentrations directly from water. In addition; enterococci could not
be detected in samples with heavy fecal contamination because of inhibitory materials.
Nonetheless, detection of clean samples took only about three hours, and therefore, this
procedure has potential for further development (220). A comparative study has been
done between PCR, specifically quantitative PCR (QPCR), and the membrane filtration
methods and a positive correlation has been observed (110). Whether this technique
could potentially replace MF is yet to be seen because epidemiological studies need to be
performed.
Emerging and Reemerging Waterborne Pathogens
Indicator organisms have long been used as a standard in water quality testing.
Ideally, an integrated method for the universal detection of pathogens, known and
reemerging, needs to be developed to prevent waterborne disease, especially in those
third world countries where disease is prevalent due to poverty (247). Cholera in Asia,
Africa and now South America remains a concern and has been a constant problem in
these areas for years. Other waterborne pathogens including E. coli O157:H7,
Cryptosporidium parvum, and microsporidia are also a health concern (Table 4) (225,
252).
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TABLE 4. Emerging and reemerging waterborne pathogens (188, 247).
Group

Pathogen (Source)

Diseases

Viruses

Enteroviruses (polio, Coxsackie)
(human feces)
Hepatitis A and E
(human feces)
Human Caliciviruses
(human feces)
Norwalk viruses
Rotavirus

Bacteria

diarrhea, gastroenteritis
diarrhea, gastroenteritis

Salmonella
(human and animal feces)
Shigella
(human feces)
Campylobacter
(human and animal feces)
Yersinia enterocolitica
(animal feces and urine)
E.coli O157:H7
(human and animal feces)
Legionella pneumophila
(freshwater and soil)

Protozoa

Cyanobacteria

meningitis, paralysis
rash, fever, respiratory
disease, diarrhea
infectious Hepatitis,
jaundice, fatigue

Naegleria
(freshwater in warm temps.
Entamoeba hystolitica
(human feces)
Giardia lamblia
(human and animal feces)
Cryptosporidium parvum
(human and animal feces)
Microsporidia
(feces)

Microcystis
(cyanobacterial blooms)
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typhoid, gastroenteritis
diarrhea
diarrhea
diarrhea
diarrhea, can lead to
hemolytic uremic
syndrome in children
respiratory pneumonia
meningoencephalitis
amoebic dysentery
chronic diarrhea
acute diarrhea
diarrhea in
immunocompromised
and immunocompetent
travelers
diarrhea from toxins
produced

Vibrio cholerae
Vibrio cholerae, the etiological agent of cholera, is a facultatively anaerobic, motile,
curved or straight, gram negative rod that is 1-3 mm in length. A minimum of 5 mM
sodium chloride (NaCl) is required for optimum growth; however, the bacterium can
grow without NaCl and in alkaline conditions up to pH 10 (204). Recent and ongoing
research indicates that this organism is a native member of the aquatic microbial
community (129). V. cholerae has caused numerous epidemics in the past and more
recently in South America (35). Approximately 200 serovars of V. cholerae have been
reported; however, only two serovars, O1 and O139, have been associated with major
epidemics. There are two biotypes of V. cholerae O1, classical and El Tor. V. cholerae
O1 is classified into two serotypes, Inaba and Ogawa, based on agglutination in
antiserum (218). A third serotype, Hikojima, has been described, but has rarely been
encountered (218). Isolates of V.cholerae O1 and O139 which produce cholera toxin
(CT) are considered virulent and capable of causing epidemic cholera. Some isolates of
V. cholerae O1 have been found that do not produce CT and do not cause epidemic
cholera. These nontoxigenic isolates are implicated in sporadic diarrheal disease (51).
Epidemic and non-epidemic strains of V. cholerae are compared in Table 5.
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TABLE 5. Comparison of epidemic and non-epidemic strains of V. cholerae (131).
Typing Systems
Serogroups
Biotypes for V. cholerae O1
Serotypes for serogroup O1

CTa production
a

Epidemic-associated
O1, O139
Classical and El Tor
(does not apply to
O139)
Inaba, Ogawa, and
Hikojima
(does not apply to
O139)
Produce cholera toxin

Non-epidemic associated
Non-O1 (>150)
Biotypes do not apply to
non-O1 V. cholerae
Serotypes do not apply
to non-O1 V. cholerae
Typically not CT producers
may produce other toxins

Cholera toxin

Historical background. The Ganges Delta in the Indian subcontinent is considered to
be the source of cholera disease (14). Pandemics of cholera spread through the world in
the nineteenth century. The massive epidemic in Southeast Asia in 1961 was the
beginning of the seventh cholera pandemic. The biotype responsible for this pandemic
was V. cholerae O1, El Tor, which spread rapidly through south Asia, the Middle East,
and southeastern Europe, eventually reaching Africa in 1970 (35, 97, 275). Epidemic
cholera reappeared in 1991, but this time in South America, specifically, the coastal cities
of Peru (35). V. cholerae O1 El Tor serotype Inaba was found to be responsible for this
epidemic. It spread swiftly and by 1996, the disease had spread to 21 countries in Latin
America. Over one million cases were reported and close to 12,000 deaths resulted
(210). In recent times, an increase in cholera cases has been reported from western
Africa and Asia. Cholera in the United States dates back to 1832 in New York (14).
Disease spread rapidly and intermittent illness was reported between 1832 and 1875.
Cholera then disappeared. No notable cases were reported until 1941 from a New
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Orleans longshoreman and then in 1973 from a shrimp fisherman in Texas (98, 271).
Later findings revealed that V. cholerae is indigenous to the U.S. Gulf of Mexico coast
and in waters of other countries (129, 200). The majority of isolates from the U.S. Gulf of
Mexico coast have been non-O1, but, on occasion, toxigenic V. cholerae has been
isolated (65, 155).
V. cholerae O139. Prior to the seventh pandemic, outbreaks of cholera were traced
back to the classical biotype. By 1961, El Tor strains had replaced the classical biotype
and this strain was determined to be responsible for epidemic cholera which appeared in
Peru beginning in 1991 (30). Today, the El Tor biotype is responsible for virtually all of
the cholera cases throughout the world. Classical isolates are not found outside of
Bangladesh. V. cholerae O139 first emerged in 1992 in southeastern India and the Bay
of Bengal (209). This serotype appears to have arisen from genetic exchange with V.
cholerae O1 El Tor (209). Prior to the seventh pandemic, V. cholerae O139 and nonagglutinating strains of V. cholerae were considered to be a different species of Vibrio.
Biochemical and molecular analysis studies have shown that these strains were all of V.
cholerae. The only distinguishing factor between V. cholerae O1 and V. cholerae O139
is that V. cholerae O139 will not agglutinate with O1 antiserum. O139 antiserum is
necessary for identification of this organism. Eleven countries reported cases of O139
cholera to the World Health Organization through 1998 (276). While V. cholerae O139
seems to be confined to Asia, imported cases have been reported in the United States as
well as other countries (51).
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Ecology. The ecology of Vibrio cholerae appears to be complex and depends on
several different environmental factors. This is especially true since V. cholerae is now
known to be indigenous in some aquatic environments. Cholera displays a distinct
seasonal pattern, especially in those areas where it is endemic (51). The patterns are
related to the ecology of V.cholerae. Higher cell numbers are seen when water is warmer
and when there is an increase in zooplankton blooms (51, 115). Plankton blooms
influence the bacterium’s attachment, growth, and multiplication in the aquatic
environment, particularly when associated with copepods (121). The physical factors
that affect the proliferation of V. cholerae in the environment include warmer
temperatures and salinity combined with elevated pH. The incidence of V. cholerae in
the environment is thought to follow a predictive pattern that can be monitored in order to
predict outbreaks before they occur (165). Those methods include remote sensing to
monitor sea surface temperature, sea surface height, and plankton blooms (165).
Monitoring would at least serve as a preventative measure when the potential for
outbreaks is high.
The mechanisms of survival utilized by endemic V.cholerae are being further
characterized. The survival of V. cholerae in the environment is enhanced by their close
association with zooplankton and, in particular, copepods whose chitin provides a good
source of nutrients for the growth or regrowth of V.cholerae (115). Viable but nonculturable (VBNC) phenomenon in V. cholerae is also a survival mechanism (37, 267).
V. cholerae O1 and O139 cells have been found to retain viability and pathogenicity for
up to one year in the VBNC state (37).
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Virulence genes and pathogenesis. Virulence of V. cholerae is due to the production
of a heat labile enterotoxin (CT). V. cholerae has two chromosomes, large and a small,
and the genes encoding CT are located on the large chromosome (51). Most
environmental strains lack the genes necessary to produce toxin. Virulence genes are
distributed among strains of V. cholerae (51). There is the potential of acquiring those
genes from these and other pathogenic bacteria, allowing for the emergence of new
toxigenic strains of V. cholerae. In fact, the V. cholerae O139 serovar acquired novel
DNA from the environment (82). Bacterial viruses also play a role in development of
new toxigenic variants and in imparting antibiotic resistance (51, 160).
The primary site of infection is the small intestine. Cholera toxin causes an
electrolyte imbalance resulting in profuse watery diarrhea (154). Pathogenicity of
toxigenic V. cholerae depends on several factors, including the presence of a colonization
factor (TcpA), production of CT, and the presence of associated outer membrane proteins
(199, 250). After colonization in the body, production of CT activates adenylate cyclase
elevating the levels of cyclic AMP in the body and ultimately leading to extreme
diarrhea. A distinctive symptom of cholera is rice water stool (210). The resultant sideeffects of the massive diarrhea include loss of circulation and blood volume, metabolic
acidosis, potassium depletion, and finally vascular collapse and death (210). After onset
of disease, death can result from extreme dehydration due to lack of fluids and
electrolytes (16, 36). In severe cases, the severe diarrhea results in the loss of up to 10%
of human body weight, leading to hypovolemic shock and death. Infection with V
cholerae can vary depending on the amount of exposure. Lower infecting doses may
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cause, at most, mild illness and discomfort. Only 2% of patients who are infected with
V.cholerae see a progression of the disease to a life-threatening condition (36).
Research has shown that strains of non-O1 V. cholerae (NT V. cholerae) are capable
of causing disease. Some studies describe pathogenenesis from NT V. cholerae strains
that produce a novel toxin that is not CT (238). Sporadic cases of disease from non-O1
V. cholerae have been reported to the CDC. Symptoms ranged from fever, nausea, and
cramps to mild diarrhea (3, 56). None of the cases from NT V. cholerae have been
considered life-threatening (17).
Public health significance and epidemiology. Transmission of V. cholerae occurs as
a result of poor sanitation in highly populated areas where the organism is endemic. The
vehicles of transmission are contaminated water and undercooked food (180, 207).
Water contaminated with free living V. cholerae cells is the main origin of epidemics,
followed by the food-borne ingestion of shellfish. The infectious dose of V. cholerae is
high and varies between 104 and 1011 CFU, depending on the matrix (33). Cases of
cholera in the U.S. have been sporadic since the epidemic of 1832 in N.Y. (14). More
recently, cases of cholera that have emerged in the southern U.S. have been near the Gulf
of Mexico, where V. cholerae appears to be endemic (155). These cases have been few
and have not resulted in epidemics, and some have been reported to be caused by nonO1 V.cholerae (184). Non-O1 V.cholerae has been found to be native to the Gulf of
Mexico.
Two of the survival mechanisms in V. cholerae that are being further investigated are
the VBNC phenomenon and their close association with copepods in the environment.
These mechanisms combined with environmental conditions that allow for the
42

proliferation of this bacterium are factors that need further study. It is still unknown how
an epidemic begins in the absence of any clinical cases of cholera. A summary of the
factors influencing the survival of V. cholerae in the environment are listed in Table 6. A
sensitive and rapid method is necessary to monitor V.cholerae concentrations in water so
that the public can be warned when cell numbers begin to increase. Such a method
would be an important tool to prevent the spread of cholera.
TABLE 6. Factors affecting the survival and growth of V. cholerae in the
environment (133).
Factor
Temp
pH
Water activity (aw)
NaCl content
Degree of contamination
Exposure to sunlight
Presence of organic matter
Osmotic pressure
Carbohydrate content
Other microflora
Humidity

Effects
Refrigeration extends survival; growth occurs above 10°C
Optimum 7.0-8.5; survives at 6-10
>.93
Best survival, .25-3%; optimum 2%; requires Na+
Longer survival with more contamination
Survival is reduced
Survival is prolonged
Survival is unfavorable at high pressure
Survival is reduced when high concentrations present
Survival and growth suppressed by competitors
Survival is longer in high moisture environment

Detection Methods. Detection methods for Vibrio cholerae in water are largely
culture based (132). A sample first has to be enriched in liquid alkaline peptone medium
with 1% sodium chloride. Incubation at 37°C is followed by subculture onto selective
plating medium. For over twenty years, the medium of choice has been ThiosulfateCitrate-Bile salt-Sucrose Agar (TCBS) (73, 201). TCBS distinguishes sucrose
fermenting V. cholerae from other non-sucrose fermenting vibrios. This medium is
commonly used because it is commercially available, easy to make, and needs no
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autoclaving. Enumeration of V. cholerae in water requires a most probable number
method (MPN) for selection because of the large number of vibrios in environmental
water samples. Following isolation on TCBS agar, the bacteria are inoculated into nonselective media for further biochemical and serological testing. Those tests include the
oxidase test, the string test (to differentiate vibrios from non-vibrios), and triple sugar
iron test. Serological identification is performed by testing the isolate for agglutination
with V. cholerae O1 or O139 antiserum (131, 132). Unfortunately, VBNC V. cholerae
cannot be detected by such methods.
E. coli O157:H7
E. coli O157:H7 is a foodborne and waterborne pathogen, whose main reservoir is
cattle; however, the bacterium can be passed by human fecal matter. It was first
recognized as a human pathogen following two outbreaks in 1982 in Oregon and
Michigan (212). These outbreaks were traced back to ground beef tainted with feces.
Transmission of this pathogen occurs from food or water contaminated with animal and
human feces or sewage. E.coli O157:H7 produces a vero-cytotoxin, that causes
haemorrhagic colitis (HC) (123). HC manifests as severe abdominal pain, diarrhea and
bloody stools. Progression of the disease to hemolytic uremic syndrome could lead to
kidney failure and death (187). Of particular importance to public health officials is the
infectious dose which has been reported to be lower than 50 CFU (254).
While E.coli O157:H7 typically is transmitted via undercooked meat or raw milk,
waterborne cases have been reported and are a concern. The first case of waterborne
E. coli O157:H7 was reported in 1986 in Philadelphia (176). The bacterium was isolated
from a reservoir outside the city and was presumed to have a non-human origin. The
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majority of waterborne infections are from tainted lake or municipal water (38).
Beaches with higher bather densities and especially those close to sewage treatment
plants present a high threat of infection with E.coli O157: H7, especially since this
pathogen is capable of entering a viable but non-culturable state in the water prolonging
its survival (106). E.coli O157:H7 can also survive in saltwater for up to 15 days (182).
Methods for the detection of E. coli O157:H7 include PCR assays to detect the
presence of genes encoding shiga-like toxins, or by coupling molecular techniques with
culture methods. Culture methods involve direct plating on sorbitol MacConkey agar
supplemented with cefixime and tellurite (CT-SMAC) followed by serotyping (112). E.
coli O157:H7 is unable to ferment sorbitol, resulting in colorless colonies on CT-SMAC
agar. Some laboratories test E. coli O157:H7 strains for the enzyme β- glucuronidase
using a broth or agar medium containing the substrate 4-methylumbelliferyl-β-Dglucuronide (MUG) (84). Cleavage of MUG produces a fluorescent product is produced.
E. coli O157:H7 strains are MUG negative. Immunomagnetic separation (IMS) is also
an isolation technique developed to detect E. coli O157:H7 in food and stool samples
(130). IMS uses magnetic beads with covalently attached antibodies specific for E. coli
O157:H7. E. coli O157:H7 cells in a a sample bind to the antibodies. The antibody
coated beads can then be isolated from the rest of the sample using a magnet. This
strategy was used in this study for the isolation of E. coli O157:H7 from beach water. E.
coli O157:H7 has been successfully detected at low levels in apple juice and ground beef
using a sandwich immunoassay format with an evanescent wave fiber optic biosensor
(63, 64). The same instrument was used in this study for the detection of E. coli
O157:H7 in sea water.
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Staphylococcus aureus
Staphylococcus aureus is a gram positive pathogen which has been considered for use
as a parameter for assessing the water quality of recreational waters (72, 90). It is a
normal inhabitant of the human flora being present in the nose, hands, and respiratory
tract. Its overabundance on the body allows it to be easily shed into recreational water.
Once in water, this bacterium can infect cuts or abrasions on the skin or mucous
membranes of the nose and eyes. Such infections can result in skin rashes, boils and eye
infections and other forms of disease. The increase in resistance of Staphylococcus
aureus to methicillin makes infection even more life-threatening. A rapid method for
detection is therefore imperative (39).
Summary
A rapid method for detection and enumeration of indicator bacteria and microbial
pathogens in water is desirable and necessary. In 1997, the EPA launched the Beaches
Environmental Assessment Closure and Health program (BEACH) to further improve the
quality of the nation’s beaches (262). In 1999, broad goals for the BEACH program were
established. These goals included development of methods to detect water pollution
within a few hours so that swimmers can be warned of a contamination event before they
are exposed (262). Public policy and water quality research is now directed towards
preventing the incidence of water-borne disease.
Biosensor immunoassays that can be highly specific and sensitive are an attractive
approach for detecting pathogens and indicators in mixed samples. If a high affinity
antibody is available, a rapid, near real-time assay can be developed for the analysis of
contaminated water. The purpose of this study is to use the biosensor to detect the
46

presence of these pathogens and/or indicators in beach water samples from Clearwater,
FL. and St. Petersburg, FL. and to provide a quantitative assessment of water quality.
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MATERIALS AND METHODS
Bacterial Strains
Enterococcus faecalis (ATCC 19433) was used as a model organism in all
experiments in seawater and in phosphate-buffered saline pH 7.4 (PBS) to detect fecal
enterococci. Additional strains used in this study are listed in Table 7.
TABLE 7. Bacteria used in Enterococcus assay development.
Microorganism

Strain

Aerococcus viridans…………………………………………………….ATCC 700406
Aeromonas hydrophila ………………………………………………………..USF 530
Enterococcus casseliflavus……………………………………………………USF 691
Enterococcus casseliflavus……………………………………………………USF 707
Enterococcus casseliflavus……………………………………………………USF 740
Enterococcus casseliflavus……………………………………………………USF 703
Enterococcus durans………………………………………………………….USF 694
Enterococcus durans………………………………………………………….USF 699
Enterococcus durans……………… …………………………………………USF 732
Enterococcus faecalis…………………………………………………….ATCC 19433
Enterococcus faecalis…………………………………………………………USF 693
Enterococcus faecalis…………………………………………………………USF 696
Enterococcus faecalis…………………………………………………………USF 700
Enterococcus faecalis ………………………………………………………...USF 708
Enterococcus faecalis…………………………………………………………USF 709
Enterococcus faecalis…………………………………………………………USF 710
Enterococcus faecalis ………………………………………………………...USF 711
Enterococcus faecalis…………………………………………………………USF 713
Enterococcus faecalis ………………………………………………………...USF 715
Enterococcus faecalis…………………………………………………………USF 719
Enterococcus faecalis ………………………………………………………...USF 720
Enterococcus faecalis ………………………………………………………..USF 721
Enterococcus faecalis ………………………………………………………...USF 723
Enterococcus faecalis ………………………………………………………...USF 724
Enterococcus faecalis ………………………………………………………...USF 726
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Enterococcus faecalis ………………………………………………………...USF 727
Enterococcus faecalis ………………………………………………………...USF 730
Enterococcus faecalis ………………………………………………………...USF 734
Enterococcus faecalis ………………………………………………………...USF 741
Enterococcus faecalis ………………………………………………………...USF 747
Enterococcus faecalis ………………………………………………………...USF 751
Enterococcus faecalis ………………………………………………………...USF 764
Enterococcus faecalis ………………………………………………………...USF 769
Enterococcus faecalis ………………………………………………………..USF 807
Enterococcus faecium ……………………………………………………ATCC 19434
Enterococcus faecium ………………………………………………………..USF 691
Enterococcus faecium ………………………………………………………..USF 692
Enterococcus faecium ………………………………………………………..USF 725
Enterococcus faecium ………………………………………………………..USF 730
Enterococcus faecium ………………………………………………………...USF 746
Enterococcus faecium ………………………………………………………...USF 753
Enterococcus faecium ………………………………………………………..USF 754
Enterococcus faecium ………………………………………………………..USF 759
Enterococcus faecium ………………………………………………………..USF 763
Enterococcus faecium ………………………………………………………..USF 768
Enterococcus gallinarum …………………………………………………….USF 767
Escherichia coli …………………………………………………………ATCC 29417
Escherichia coli O157:H7 ……………………………………………………USF 640
Group A Streptococcus ………………………………………………….8-R291 TGH
Group B Streptococcus ………………………………………………1215-RNSJ183V
Lactobaccillus arabinosa …………………………………………………….USF 541
Lactococcus lactis ……………………………………………………….ATCC 11454
Leuconcostoc …………………………………………………………………USF 706
Non Protein A Staphylococcus aureus ………………………………….ATCC 10832
Pediococcus dextrinicus …………………………………………………ATCC 33087
Providencia rettgeri ………………………………………………………….USF 517
Staphylococcus aureus ………………………………………………………USF 645
Staphylococcus aureus Cowan I ……………………………………………..USF 613
Streptococcus bovis ……………………………………………………...ATCC 15351
Streptococcus bovis ……………………………………………………..ATCC 49133
Vibrio alginolyticus …………………………………………………………..USF 516
Weissella confusa ………………………………………………………..ATCC 14434
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All Enterococcus strains without ATCC numbers were environmental isolates obtained
from the following sources: Tumblin Creek, Gainesville, FL; Tampa Palms sewer station
(Tampa, FL); sewage from California; and beach water from Pinellas County beaches.
These isolates were provided by the laboratory of Dr. Valerie J. Harwood (University of
South Florida, Tampa, FL) and identified as isolates from various hosts including cows,
humans, seagulls and dogs. Another sample of Enterococcus faecalis (ATCC 19433) and
one of Enterococcus faecium (ATCC 19434) was obtained from Dr. Al Dufour (U.S.
Environmental Protection Agency, Cincinnati, OH). The remaining isolates were clinical
and environmental isolates obtained from USF freezer stocks. The Aeromonas
hydrophila strain was isolated from Naples Bay (Naples, FL). The Vibrio alginolyticus
strain was a seawater isolate obtained from Courtney Campbell Causeway beach
(Clearwater, FL).
Escherichia coli O157:H7 (USF 640) isolated from hamburger meat from a taco stand
in Massachusetts following an outbreak was used to develop biosensor assays for E.coli
O157:H7 in seawater. Staphylococcus aureus USF 645 and Vibrio cholerae biotype O1
El Tor serotype Inaba (CDC E5906-1018) were used as model organisms to develop
biosensor assays. All other bacterial strains used in experiments for Vibrio cholerae are
listed in Table 8.
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TABLE 8. Bacteria used in V. cholerae assay development.
Microorganism

Strains

Aeromonas hydrophila ………………………………………………………USF 530
Escherichia coli …………………………………………………………ATCC 29417
Pseudomonas aeruginosa ……………………………………………….ATCC 15442
Pseudomonas aeruginosa ……………………………………………………USF 620
Salmonella typhimurium ………………………………………………...ATCC 23564
Salmonella typhimurium ……………………………………………………..USF 515
Vibrio alginolyticus ………………………………………………………….USF 516
Vibrio cholerae O1 …………………………………………………………..USF 646
Vibrio cholerae biotype O1 El Tor Inaba cholera toxin (+) ………..CDC E5906-1018
Vibrio cholerae biotype O1 El Tor Ogawa cholera toxin (-) ……..CDC1074-78-1019
Vibrio cholerae O139 ………………………………………………………..USF 647
V. cholerae O139 ……………………………………………………….CDC 2412-93
All Vibrio cholerae isolates were clinical isolates obtained from either the Centers for
Disease Control and Prevention (CDC) (Atlanta, GA) or from Dr. Mark Tamplin (United
States Department of Agriculture; Wyndmor, PA) who was at the University of Florida,
Gainesville, FL when these cultures were donated. All other isolates without ATCC
numbers are environmental isolates. The Aeromonas hydrophila and the Vibrio
alginolyticus strain were the same as those used in the Enterococcus experiments.
Media, Culture Conditions, and Sample Collection
Stock cultures. Cultures of all isolates were obtained from stock cultures maintained
at -80° C. The cultures were grown on trypticase soy agar (TSA) (BD, Sparks, MD) or in
trypticase soy broth (TSB) (BD) for 18-24 hours at 36°C. This working stock was
maintained at 4°C for up to 1 month. Once grown, the cells were resuspended in one of
three solutions: 0.01M phosphate buffered saline, pH 7.4 (PBS); 0.1M carbonatebicarbonate buffer, pH 9.3; or seawater. This culture procedure was standard in all assays
and viable counts unless otherwise indicated.
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Enrichment and recovery media for enterococci. Azide dextrose broth and ToddHewitt broth were prepared in single strength concentrations according to the recipes in
Standard Methods for the Examination of Water and Wastewater for the growth of
Enterococcus faecalis (ATCC 19433) in teichoic acid extraction experiments (4). Bile
esculin azide broth (4), mE broth, mEI broth (263), brain heart infusion broth (BD), and
brain heart infusion broth (BD) with 6.5% NaCl were evaluated for rapid and selective
growth of enterococci by Dr. Allyson Bissing, a postdoctoral fellow formerly associated
with our laboratory. Based on her findings, the fastest growth rate for enterococci
occurred in bile esculin broth (personal communication). Due to its lack of selectivity,
this medium was replaced with mE broth. Modified mE broth was prepared in 0.1 M
carbonate-bicarbonate buffer, pH 9.3 instead of deionized water (DI H2O). All
enrichments were performed at 37° C in a shaking water bath.
mE agar (BD) supplemented with nalidixic acid (0.24 g/l) and triphenyltetrazolium
chloride (TTC) (0.02 g/l) was used to prepare the standard mEI medium as suggested by
the EPA Method 1600 (263). Indoxyl β-D glucoside was added at .75 g/L. mEI agar was
used for the recovery of enterococci in all seawater samples analyzed. Environmental
water samples were enriched in mE broth at 37°C before biosensor analysis. These
samples were serially diluted in PBS and plated onto mEI agar and assayed on the
biosensor. These plates were incubated in a 36° C incubator and allowed to grow for 1824 hours. Initial counts of environmental water samples were obtained from filtering 50
and 100 ml samples of seawater through a 0.45µm filter (Milipore, Bedford, PA) and this
filter was placed on mEI agar to grow at 41°C for 18-24 hours. Alternatively, counts
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were obtained from David Wingfield at the Florida Department of Health Tampa Branch
Laboratory.
Water samples. One liter volumes of seawater were obtained biweekly from the
Florida Department of Health Tampa Branch Laboratory. These samples were collected
according to standard practices in Standard Methods for the Examination of Water and
Wastewater (4). Seawater samples were collected from two beaches: North Shore beach
(St. Petersburg, FL) and Courtney Campbell Causeway beach (Clearwater, FL). These
two beaches were the sources of seawater samples in all experiments where bacteria were
enriched and recovered in this study. Figure 5 shows the locations of these beaches on
the Florida Coast.
FIGURE 5. Map showing Tampa Bay beaches where seawater samples were
collected. Diamond ( ) – Courtney Campbell Beach; Star ( )- North Shore Beach
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Enrichment and recovery methods for E. coli O157:H7 in seawater. Seawater
samples were analyzed for E. coli O157:H7 by filtering a volume of seawater (100-300
ml) first through a Whatman #5 filter and then through a 0.45 µm filter using a vacuum
pump model number 5KH33DN16AX (General Electric; Ft. Wayne Indiana). The filters
were placed onto selective media for growth which included mFC agar (BD) and eosin
methylene blue agar (EMB) (BD). The plates were grown at 36°C and at 44.5°C for 24
hours to evaluate which temperature showed greater recovery. Any suspect E. coli
O157:H7 isolates (green sheen colonies on EMB or blue colonies on m FC agar) were
streaked on Sorbitol MacConkey agar (Remel; Lenexa, KS) supplemented with 0.05
mg/ml Cefixime and 2.5 mg/ml Potassium tellurite (CT, Dynal; Oslo, Norway) (CTSMAC). Any colorless colonies were tested for agglutination with anti-E. coli O157:H7
polyclonal antibody (Kirkegaard and Perry (KPL); Gaithersburg, MD).
Later experiments to recover E. coli O157:H7 were performed using
immunomagnetic separation with Dynabeads (Dynal Inc.,Oslo, Norway) conjugated to
anti-E.coli O157:H7 according to manufacturer’s instructions and as reported by Liu and
Li and LeJeune et al. (149, 163). The day before the assay, one liter of seawater was
filtered through a 0.45 µm filter. This filter was placed in 90 ml of TSB modified with
20 mg/ml novobiocin to inhibit gram positive organisms. The sample was incubated at
36°C for 6-18 hours. The following day, 20 µl of resuspended Dynabeads conjugated to
anti-E.coli O157:H7 polyclonal antibody was added to 1 ml of the pre-enriched sample.
The studies were done in triplicate. These tubes were mounted onto the Dynal magnetic
particle concentrator rack. The rack was placed on a rotator at 24°C and allowed to rock
for 10 minutes with continuous agitation to prevent the beads from settling. A strip
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magnet was inserted into the back of the rack and the rack was placed on a rotator to
concentrate the beads into a pellet on the side of the tube. This was done at 24° C for 3
minutes to allow for proper recovery. The supernatant fluid was discarded and the
magnetic plate was removed. The beads were washed with 1 ml PBST. The strip magnet
was reinserted into the rack and the suspension was rotated again for 3 minutes. The
supernatant fluid was discarded and the beads were washed twice more by the same
method. Following the washes, 100 µl of PBST was used to resuspend the beads and
50 µl of this solution was plated onto CT-SMAC agar. Any col orless colonies on CTSMAC were further tested by slide agglutination with anti-E. coli O157:H7 polyclonal
antibody and then identified through API (BioMerieux; Hazelwood, MO).
Enrichment and recovery methods for V. cholerae in seawater. Seawater samples
were analyzed in 100 ml volumes. The seawater was filtered initially through a sterile
Whatman #5 filter to remove any large debris in the water. Samples were analyzed
undiluted and diluted 10-fold and 100-fold. Seawater samples were processed by
filtering through a 0.45 µm filter using a vacuum pump (General Electric). The filter was
removed from the filtration manifold with sterile forceps and placed onto Thiosulfate
citrate bile salts (TCBS) agar (BD) (244). Plates were grown at 36° C and at a more
selective temperature, 42°C for 18-24 h. All samples were filtered in duplicate. The
following day any yellow colonies that were 2-3 mm in diameter were removed from the
filter with a sterile toothpick and inoculated on TSA and allowed to grow for 18-24 h at
36°C. These isolates were further characterized.
Characterization of V. cholerae isolates: API identification and PCR amplification.
All isolates that appeared yellow on TCBS agar and were 2-3 mm in diameter were
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identified. A gram stain and an oxidase test were performed on all suspect isolates. If
the oxidase test was positive and the cells were gram negative rods, the arginine
dihydrolase test and iron esculin hydrolysis test were performed to presumptively identify
any suspect isolates according to the two-test method (46). If the arginine dihydrolase
test and the iron esculin hydrolysis were both negative, these isolates were identified
using the API 20 E biochemical test strip (BioMerieux). Any putative V. cholerae
isolates were tested for O1 somatic antigen (Inaba or Ogawa) by agglutination with
polyclonal antiserum to V.cholerae O1 (Difco Laboratories; Franklin Lakes, NJ). All
isolates identified as Vibrio cholerae through API were further identified using
polymerase chain reaction (PCR) (47). Figure 6 outlines the identification process
followed.
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FIGURE 6. Identification scheme for V. cholerae isolates.
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Primers (IDT; Coralville,IA) ) targeted to a 300 base pair region of the 16S-23S rRNA
intergenic spacer (ITS) region of Vibrio cholerae (47, 161) were used for PCR. Both the
forward and reverse primers were diluted to a 20 µM stock concentration. For each PCR,
2-4 µl of whole Vibrio cholerae cells suspended in sterile H2O was added to a 96-98 µl
master mix prepared for each sample by using a TaKaRa TaqTM PCR kit from TaKaRa
Biomedicals (Shiga, Japan). All reaction mixtures included 10 µl of 10X PCR buffer,
2.5 mM (each) deoxynucleoside triphosphates (dNTP), 0.2 µM (each) forward and
reverse primers, TaKaRa Taq DNA polymerase (5 units/ µl) (TaKaRa Biomedicals), and
sterile H2O to raise the total volume to 100 µl. The primer sequences are listed in Table
9. All PCR reactions were performed on the Bio-Rad I Cycler (Bio-Rad Laboratories;
Hercules, CA). The PCR protocol to identify isolates of V. cholerae is outlined in Table
10.

TABLE 9. PCR primers for the identification of V. cholerae isolates (161).
Target

Vibrio cholerae ITS F
R

Sequence

5´TTA AGC STT TTC RCT GAG AAT G 3´
5´AGT CAC TTA ACC ATA CAA CCC G 3´
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Length

~ 300 bp

TABLE 10. PCR protocol for V. cholerae isolatesa.
Segment
1
2

Number of Cycles

Temperature

Duration

1
30

95° C
2 mins
95° C
1 mins
58° C
1 mins
72° C
2 mins
3
1
72° C
10 mins
Holding mode
4°C
∞
a
PCR was performed using 100 µl volumes in the I Cycler thermocycler (Bio-Rad
Laboratories). Primers to the 16S-23S rRNA ITS region of V.cholerae were amplified to
identify environmental isolates.

Four microliters of the PCR product was combined with 1 µl of the gel loading dye (BioRad Laboratories). Five microliter samples were loaded into a 1% agarose gel and run in
TBE electrophoresis buffer (1X working solution: 89 mM Tris base, 89 mM boric acid, 2
mM EDTA) at 100 volts. The marker used was a 1 KB benchtop PCR marker (Promega;
Madison, WI).
Enrichment and recovery methods for S. aureus. Vogel Johnson agar (BD) and Baird
Parker agar (BD) were tested for recovery efficiency. These culture media were found to
be successful in isolation of S. aureus in swimming pool water (136). Baird Parker agar
was chosen as the recovery medium because of its better recovery of S. aureus from
seawater when compared to Vogel Johnson agar in preliminary experiments. Seawater
samples were analyzed in 100 ml volumes. The seawater was pre-filtered through a
sterile Whatman #5 filter to remove any large debris in the water. Samples were
analyzed undiluted and diluted 10-fold and 100-fold. Seawater samples were processed
by filtering through a 0.45 µm filter using a vacuum pump (General Electric). The filter
was removed from the filtration manifold with sterile forceps and placed onto Baird
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Parker agar. These plates were placed in a 36°C incubator and allowed to grow for 48
hours.
Characterization of S. aureus isolates. Any black colonies with surrounding clear
halo area were removed from the culture plate with a sterile toothpick and restreaked on
TSA. These isolates were grown for 18-24 hours in a 36°C incubator. A gram stain and
a catalase test were performed on all suspect isolates. Any catalase positive isolates were
streaked on Mannitol Salt Agar (MSA) (Difco Laboratories). Any isolates which tested
positive for mannitol fermentation were tested for coagulase and DNase activity.
Citrated rabbit plasma (Remel; Lenexa KS) was rehydrated according to manufacturer’s
instructions. A heavy inoculation of the suspect isolate was made in 0.5 ml fractions of
citrated rabbit plasma. These tubes were incubated for up to 4 hours in a 36°C water
bath. Visible clotting of the plasma was considered a positive result. DNase test agar
(Difco Laboratories) was made according to manufacturer’s instructions. Suspect
isolates and a positive control were streaked onto the agar. After 18-24 h of growth, the
agar was flooded with hydrochloric acid. Any visible clearing of the agar around the
growth was considered a positive result. Any isolates which were positive for one or
both coagulase and DNase were frozen down in tubes of TSB and glycerol. They were
stored in a -80°C freezer. The identification scheme for S. aureus is outlined in Figure 7.
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FIGURE 7. Identification scheme for S. aureus isolates.
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Negative

Antibodies
Sources. Antibodies were purchased from the following companies: rabbit polyclonal
anti-Strep Group D antibody, American Research Products (ARP) (Belmont, MA); rabbit
polyclonal anti-Enterococcus antibody, Virostat (Portland, ME); rabbit polyclonal Group
D antiserum, Lee Laboratories (Franklin Lakes, NJ); affinity purified polyclonal antiE.coli O157:H7, Kirkegaard and Perry (KPL) (Gaithersburg, MD); rabbit polyclonal
anti-Vibrio cholerae O1 serotypes Inaba, Ogawa, Hikojima, Difco Laboratories (Detroit
MI); rabbit polyclonal anti-Vibrio cholerae O1, Murex (Lenexa, KS); rabbit polyclonal
anti-Vibrio cholerae serotypes Ogawa, Inaba, Denka Seiken (Tokyo, Japan); monoclonal
anti-Vibrio cholerae O1, AUSTRAL Biologicals (San Ramon, CA); monoclonal antiVibrio cholerae O1, New Horizons Diagnostics Inc.(Columbia, MD); polyclonal rabbitanti-S. aureus antibody Maine Biotechnology Services Inc. (Portland, ME); goat antirabbit IgG labeled with Cy5 (Jackson Immunoresearch; West Grove, PA)and
monoclonal anti-peptidoglycan, Chemicon International (Temecula, CA). Antibodies
used in development of assays for S. aureus were screened through ELISA by Dr.
Marianne Kramer, University of South Florida, Tampa, FL. All commercial antibodies
were screened by enzyme linked immunosorbent assay (ELISA).
Custom prepared antibodies were also tested. A rabbit polyclonal antibody was made
by Strategic Biosolutions (SBS) (Newark, DE). Two rabbits were injected with 2.0 x 109
CFU/ml of heat-killed Enterococccus faecalis, ATCC 19433. Cells were serially diluted
in PBS and a viable count was performed. All cell preparations were heat killed by
boiling for 20 minutes before being sent for injection. Test bleeds and final
exsanguination samples were screened through ELISA. Any antibodies which showed
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high binding affinity for the target antigen were purified and used to develop the
biosensor immunoassay.
A monoclonal antibody to the immunodeterminants of Ent. faecalis and Ent. faecium
was made by the Hybridoma Core Laboratory at the University of Florida, Gainesville,
FL. Six mice were injected with heat-killed cell preparations of Ent. faecalis and Ent.
faecium. Two of the mice were injected with 3.5 x 108 CFU/ml of Ent. faecium (ATCC
19434) cells, two were injected with 1.2 x 109 CFU/ml of Ent. faecalis (ATCC 19433)
cells and two were injected with a mixture of both types of bacteria. The cells were heatkilled by boiling for 20 minutes before injection. IgM from Clone HL 1869 was screened
through ELISA for assay development. A second set of six mice was immunized after
the first monoclonal antibody project was finished. Three mice were immunized with 5.0
x 108 CFU/ml of Ent. faecalis cells (ATCC 19433) cells. Two mice were immunized
with 1.0 x 108 CFU/ml of Ent. faecium (ATCC 19434) cells. One mouse was immunized
with 25 µg of a crude extract of teichoic acid prepared from Ent. faecalis (ATCC 19433)
cells. IgG from clone 1H8-3E8 was screened through ELISA for assay development.
Purification methods. Polyclonal anti-E.coli O157:H7 (KPL) was affinity purified by
the manufacturer. The antibody was rehydrated according to manufacturer’s instructions
to a final concentration of 1 mg/ml. IgG purification using a protein A column kit
(Amersham Biosciences; Piscataway, NJ) was utilized to purify whole serum used in this
study. The purification was done according to manufacturer’s instructions. A 1 ml
aliquot of antibody was passed through the IgG column. The column was washed with
10 ml of 0.1 M sodium phosphate buffer (pH 7.0) to remove any unbound antibody. The
IgG was eluted with 6 ml of 0.1 M sodium citrate (pH 3.0) and collected in 0.5 ml
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fractions in microcentrifuge tubes containing 0.5 ml of 0.1M carbonate-bicarbonate
buffer (pH 9.3) to neutralize the eluted samples. A DU-64 spectrophotometer was used
to analyse fractions for protein content. The samples with highest A280 nm readings
were combined for labeling. A buffer exchange was performed using 0.1 M carbonatebicarbonate buffer (pH 8.5) for labeling purposes and to prevent denaturation of the
antibody. The exchange was done in an Amicon Ultra-4 centrifugal filter (Milipore) with
a 30,000 molecular weight cutoff and by centrifugation in an Allegra 6R centrifuge at
4,000 x g for 30 minutes. This exchange was performed three times.
In preliminary experiments, ARP polyclonal antibody was affinity purified through a
procedure developed by Dr. My Lien Dao, University of South Florida, Tampa, FL. A
high concentration of cells (~108 CFU/ml) was passively adsorbed to nitrocellulose paper
by incubating the membrane with the bacterial cells at 24°C for 1 h with continuous
agitation. The membrane was washed with 2 ml of 0.01 M phosphate-buffered saline
0.1% Tween 20 (PBST). Two hundred microliters of antibody was incubated with the
nitrocellulose membrane at 24°C for 1 h with continuous agitation. The antibody was
aspirated and the filter was washed with 2 ml of PBST. The antibody was eluted with
0.1 M glycine for 10 minutes. Protein concentration was calculated by measurement of
A280 on a DU-64 spectrophotometer. A buffer exchange was performed as described
previously.
A Carbo-Link affinity column kit from Pierce Biotechnology (Rockford, IL) was
tested for its effectiveness in affinity purification of the ARP antibody. A sample of
lipoteichoic acid was prepared for conjugation to the gel column. Two methods were
attempted to obtain a crude extract of teichoic acid for attachement to the Carbo-Link
64

affinity column. The first method was one used for serological identification of group D
Streptococci in Standard Methods for the Examination of Water and Wastewater (4).
Cells of Ent. faecalis were grown in Todd-Hewitt broth and concentrated by
centrifugation in an Allegra 6R centrifuge at 3,000 x g for 5 minutes. Cells were
resuspended in 0.5 ml saline and autoclaved for 15 minutes at 121 °C. The bacteria were
centrifuged again as described above and the supernatant fluid was screened by ELISA
for teichoic acid. Another method of extracting teichoic acid was performed by taking a
heavy suspension of Ent. faecalis cells in 10 ml PBS and adding a pinch of lysozyme,
DNase and RNase to the suspension and allowing the sample to sit at 24°C for 24-48
hours. Ethanol was added at two and a half times greater volume than the original
volume. The entire sample was then centrifuged in an Allegra 6R centrifuge at 4,000 x g
for 1 minute. The supernatant fluid was decanted and 1 ml of water was added to the
pellet. The sample was centrifuged once more at 1,500 x g for 30 seconds to remove all
insoluble debris (76). The concentration of the sample was calculated by extrapolation
from a calibration curve (Figure 8). This calibration curve was created by analyzing
known glucose concentrations on a DU-64 spectrophotometer after reacting the glucose
with phenol and sulfuric acid (58).
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Standard Curve: Glucose

Absorbance (488 nm)

0.7
0.6
0.5
0.4

Glucose

0.3
0.2
0.1
0
0

10

25

50

75

Glucose (ug/ml)

FIGURE 8. Standard curve of glucose. The phenol and sulfuric acid reaction with
different glucose concentrations was monitored by DU-64 spectrophotometer at 488 nm
and the readings were used to create a standard curve (58). A concentration between 0.510 mg of carbohydrate was needed to attach to the affinity column.
The crude extract was conjugated to the carbo-link column according to
manufacturer’s instructions. The teichoic acid sample was oxidized using sodium-metaperiodate provided in the kit. The sample was allowed to react at 24°C for 30 minutes.
The oxidized sample was then applied to a desalting column and three 2 ml fractions
were collected. These fractions were analyzed on a spectrophotometer DU-64
spectrophotometer at 488 nm. The fraction with the highest absorbance contained the
oxidized carbohydrate. A carbo-link gel column was equilibrated with 6 ml of PBS. A
porous polyethylene disc was used to pack the column and the Carbo-link gel slurry was
added to the column (~4 ml slurry containing 2 ml gel). The liquid from the column was
drained and the oxidized sample was applied to the gel matrix. The column was gently
rotated end-over-end for 6-24 h at 24°C. Following incubation, the liquid was drained
from the column. The fractions were analyzed by a DU-64 spectrophotometer at 488 nm
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and based on those reading, the coupling efficiency was calculated. After conjugation,
the column was stored in PBS 0.02% sodium azide. Antibody was purified according to
manufacturer’s instructions. The column was equilibrated with 6 ml of column buffer
(0.01M PBS, pH 7.4). One and a half milliliters of the antiserum was applied to the
column and allowed to enter the gel bed and react with the affinity column for 1 h at
24°C. After incubation, the column was washed with 12 ml of column buffer. The
bound antibody was eluted with 100 mM glycine buffer (pH 3.0). One milliliter fractions
were collected in 1.5 ml microcentrifuge tubes containing 0.1 M carbonate-bicarbonate
buffer (pH 9.3) to neutralize the fractions. The fractions were analyzed using a DU-64
spectrophotometer at 280 nm. The fractions of interest were pooled and a buffer
exchange was performed as described previously.
All antibody samples were screened initially as whole serum using ELISA. Those
which showed high affinity to the target cells were purified by one of the methods
mentioned above. Antibodies were then labeled with biotin and or cyanine 5 (Cy5) as
needed. Only those which showed high binding affinity to the target of interest on
ELISA were eventually tested on the fiber optic biosensor.
Labeling. A labeling kit (FluoroLink Cy5 Reactive 5-pack; Amersham Biosciences,
Piscataway, NewJersey) was used for labeling antibodies with cyanine 5 (Cy5) dye
molecules. The labeling was done according to manufacturer’s instructions. A
concentration of at least 1 mg/ml of antibody was necessary to efficiently label.
Following purification, 0.5 ml of antibody diluted with 0.1 M carbonate-bicarbonate
buffer (pH 9.3) was added to a Cy5 reactive dye pack. The dye vial was incubated in the
dark at 24°C for at least 1 h or alternatively, the vial was incubated at 4°C for 18-24 h.
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After incubation, free dye was separated from labeled antibody by separation on a BioGel P-10 (Bio-Rad Laboratories, Hercules,CA) column with an exclusion limit of 1,50020,000 molecular weight. The column was equilibrated with PBS- 0.02% sodium azide.
Labeled antibodies were collected in 0.5 ml fractions and analyzed on a DU-64
spectrophotometer for protein content. Molar concentrations of dye and protein were
calculated and the final dye to protein ratio was also calculated.
At least 1 mg of antibody was necessary for efficient biotin labeling. Biotin labeling
was performed according to manufacturer’s instructions using EZ-Link NHS-LC-LCBiotin (succinimidyl-6-(biotinamido) hexanoate) (Pierce; Rockford , IL). One mg of EZLink NHS-LC-LC-Biotin was dissolved in 1 ml of N,N-dimethylformamide (DMF).
Seventy five microliters of this solution was mixed with 425 µl of antibody (~1mg/ml).
This solution was incubated at 4° C for 18-24 h. Unattached biotin was separated from
the labeled antibody by using gel filtration on a Bio-Gel P10 column equilibrated with
PBS with .02% sodium azide. Labeled antibodies were collected in 0.5 ml fractions and
analyzed on a DU-64 spectrophotometer (Beckman Coulter) for protein content.
Antibody samples whose final concentration was less than 1 mg/ml were stabilized by
adding bovine serum albumin (BSA) to raise the concentration to 1 mg/ml. All labeled
antibodies were stored at 4°C until needed. Whole serum samples that were unpurified
and unlabeled were stored in a -20°C freezer indefinitely.
Screening. All antibodies, commercial and custom made, were screened using
ELISA. Enterococcus faecalis (ATCC 19433) and the other organisms listed in Tables 7
and 8 were serially diluted in PBS and placed in a 96-well ELISA plate (Nunc,
Rochester, NY). The plate was incubated for 18-24 h at 4°C. The following day, the
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plate was washed with PBST. The plate was blocked with PBS containing 2mg/ml
Casein and 2 mg/ml bovine serum albumin (BSA) for 1 h and then washed again with
PBST. Primary antibody specific to the target antigen was diluted in PBS to a
concentration of 10 µg/ml. The antibody was incubated on the plate at 24°C for 1 h and
then the plate was washed again with PBST. A 1 mg/ml solution of anti-rabbit IgG
(Jackson ImmunoResearch, West Grove, PA) conjugated to horse radish peroxidase
(HRP) was diluted to 2 µg/ml in PBS and incubated on the plate at 24°C for 1 h. The
plate was washed again with PBST. A Quanta Blue kit (Pierce; Rockford, IL) provided
the substrate to react with the HRP enzyme. The substrate was mixed together with the
stabilizing solution provided in the kit according to manufacturer’s instructions. The
mixture was a combined 9 parts substrate solution to 1 part stable solution. One hundred
microliters per well of the substrate was incubated on the plate for 25 minutes. After the
incubation period, 100 µl per well of stop solution was added to each well and the plate
was read on a Spectramax Gemini XS microplate reader (Molecular Devices; Sunnyvale,
CA).
Analyte 2000 Biosensor
The Analyte 2000 biosensor (Research International; Monroe, WA) was used to
perform all biosensor experiments in this study (Figure 9).
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FIGURE 9. Analyte 2000 biosensor (Research International; Monroe WA). This
instrument has four channels allowing for four samples to be processed at once.
In this instrument, optical fibers act as waveguides carrying electromagnetic waves. An
evanescent wave sensing scheme is utilized where only fluorophores close to the surface
of the fiber (~100 nm) will generate a signal (157). This is achieved when a 635 nm
diode laser sends light through the proximal end of a polystyrene waveguide propagating
electromagnetic waves within the optical fiber which are reflected off its exposed surface.
An electric field is generated and causes the excitation of fluorescent molecules at a 1001000 nm distance of the wave guide. The emission energy is recoupled through the
waveguide. The emitted light is collected and the photodiode allows for the quantitation
of the emission at wavelengths above 650 nm. The binding event is recorded as a
numerical signal on a computer.
Biosensor Sandwich Immunoassays
Sample preparation. All samples assayed using a sandwich immunoassay format on
the fiber optic biosensor were prepared by taking a sample of the test organism from the
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freezer stock culture and growing the culture on TSA or TSB for 18-24 h at 36°C. After
this growth period, some of the culture was taken directly from the plate using either a
sterile polyester fiber tipped plastic swab or a loop and resuspended in PBS to
approximately 108 CFU /ml. This starter sample was serially diluted 10-fold in PBS and
plated onto TSA to obtain a viable count of cells. Aliquots from this dilution set were
assayed directly on the biosensor from lowest to highest concentration. If TSB was used,
the culture was centrifuged at 4,000 x g in an Allegra 6R centrifuge to pellet the cells.
The supernatant fluid was decanted and the cells were resuspended in PBS. These
samples were assayed directly after serially diluting and plating on TSA for a viable
count.
Preliminary experiments were performed on the biosensor using viable cells.
Different sample preparations were used in an attempt to improve assay sensitivity. In all
experiments, a starter culture tube was made in PBS to 108 CFU/ml and then serially
diluted in PBS. A viable count was performed by plating onto TSA. In heat killed cell
experiments, the tubes to be analyzed were boiled for 20 minutes. After cooling, the
solutions were assayed directly on the biosensor. Cell samples were also treated by
freeze thawing. Dry ice was combined with denatured ethanol in a Styrofoam cooler.
The samples were then placed in the dry ice solution for 1 minute and then allowed to
thaw in a 36°C waterbath. This procedure was repeated three times to disrupt cells as
much as possible. Sonication was also performed as an alternative cell prep to disrupt the
bacterial cells. A 4 ml volume of bacteria resuspended in PBS was placed in a 50 ml
plastic conical tube. The tube was placed in a styrofoam cooler with ice to ensure that the
tube did not become warm and sonicated at setting number 2 on the Dismembrator 100
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(Fisher Scientific) for different time intervals. These different sample preparations were
compared through ELISA and those which gave the highest signals when reacted with the
target specific antibody were assayed on the biosensor.
Waveguide preparation. Polystyrene waveguides (Research International),
approximately 4 cm in length, were cleaned by sonication for 30 seconds in 2isopropanol using an ultrasonic cleaner. The waveguides were rinsed in deionized water
and then black ink was placed on the tip of each waveguide to prevent the escape of laser
light. The waveguides were allowed to air dry completely and were then placed in a
glass capillary tube approximately 4.5 cm in length which served as the reaction
chamber. The capillary was cut to hold approximately 100 µl of solution. A solution of
streptavidin was prepared in PBS (pH 7.4) at a concentration of 100 µg/ml. One hundred
microliters of solution was used to fill the reaction chamber and the waveguides were
incubated for 18-24 hours at 4°C with this solution.
Sensitivity and specificity assays. Following incubation with streptavidin, the
waveguides were placed into the cuvettes made specifically to fit the instrument’s laser
diode manifold. Figure 10 shows the waveguide and the Analyte 2000 cuvette which
holds the fiber during the assay. Waveguides were secured with a cap that fits and
secures the waveguide into the cuvette. Two ports coming out of the cuvette were
connected to lines of tygon tubing. Wash solution and or antibody solutions were
introduced into the cuvette through the proximal inlet. The distal outlet at the top of the
cuvette was connected to a waste line.
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FIGURE 10. Waveguide and cuvette used for biosensor assay. The polystyrene
waveguide used in all biosensor assays was housed in the black cuvette above. This
cuvette was made specifically for the Analyte 2000 biosensor instrument.
The waveguide was then washed with 3 ml of PBST injected into the cuvette using a 1 ml
syringe to rinse out any unbound streptavidin.
Different capture molecules were tested throughout the course of the study.
Concanavalin A (ConA) (Nordic Immunology; Tilburg, The Netherlands) and Wheat
Germ Agglutinnin (WGA) (Vector Laboratories, Burlingham, CA) lectins were tested as
potential capture molecules for the sandwich immunoassay based on their ability to bind
surface carbohydrate groups on Enterococcus cells (27). They were screened using
ELISA as described above. After screening the two lectins, it was observed that
extensive cross-reactivity existed between ConA and the polyclonal anti-Strep Group D
antibody (ARP) so this was not pursued. WGA crossreacted to a lesser degree with the
antibody and was tested on the biosensor. Biotinylated WGA was diluted to10 µg/ml in
PBS and then incubated on the streptavidin coated waveguide at 4°C for 18-24 h.
Polyclonal antibody labeled with biotin specific to the target being tested was
prepared in PBS to a concentration of 100 µg/ml. Other concentrations of capture
antibody were also tested. An initial reading was taken to observe the inherent
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fluorescence of the waveguide. In later experiments to reduce overall assay time, all
antibody preparations were made in blocking buffer (2 mg/ml casein and bovine serum
albumin in 0.01 M PBS (pH 7.4)). One hundred microliters of capture antibody was
allowed to react in the cuvette for 1 h. Following incubation, the waveguide was rinsed
with 1 ml of PBST. In early experiments, a blocking step was included in the assay to
block non-specific binding on the waveguide. The waveguide was incubated with 100 µl
of blocking buffer for 20 minutes. In later experiments this step was removed and all
antibody solutions were prepared in blocking buffer.
Background fluorescence caused by nonspecific binding of Cy5 labeled antibodies
was determined by incubating the Cy5 labeled antibodies (10-20 µg/ml) at 5 minute
intervals on the waveguides 4 times. After each incubation, the waveguide was rinsed
with 2 ml of PBST. The signal recorded after the PBST rinse was considered the
background signals. These readings were analyzed later to determine limits of detection
(LOD). Cells were serially diluted in PBS for use in the assay. One milliliter of each test
sample was allowed to react with the capture antibody for 10 minutes. Uncaptured
bacteria were washed out with 1 ml PBST. Cy5 labeled detection antibody specific for
the target being tested was allowed to react with captured cells for 5 minutes. Any
unbound detection antibody was washed out of the cuvette with 2 ml PBST and a reading
was taken. The assay scheme is illustrated in Figure 11.
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FIGURE 11. Sandwich immunoassay format for evanescent wave biosensor. The
standard assay time is 20 minutes excluding the attachment of capture antibody on the
waveguide (1 h) and sample preparation (10-30 minutes depending on preparation
method).
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Biosensor Indirect Immunoassays for Enterococci
Sample Preparation. The test organism was grown on TSA at 36°C for 18-24 h. A
starter tube was made by taking a sample from the TSA culture plate with a sterile
polyester fiber tipped plastic swab or loop and resuspending the cells in 0.1M carbonatebicarbonate buffer (pH 9.3) to approximately 108 CFU /ml. A 10-fold serial dilution of
this sample was made in bicarbonate-carbonate buffer (pH 9.3). Samples from the
dilution set were plated onto TSA to obtain a viable count of bacteria.
Waveguide preparation. Polystyrene waveguide fibers were cleaned and prepared as
described previously with one exception, after the waveguides were dried from cleaning,
they were placed in a glass capillary tube, but were not incubated with streptavidin.
Bacterial cells resuspended in PBS or 0.1 M carbonate-bicarbonate buffer (pH 9.3) were
used to fill the glass capillary tube. The cells were allowed to passively adsorb to the
waveguide at 36°C for a minimum of 30 minutes. Experiments were performed to test
the time requirements for adsorption of cells to the waveguide so at times, cells were
incubated up to 18-24 hours. A negative control consisting of either 0.1M carbonatebicarbonate buffer or uninoculated enrichment broth was always included in each assay.
Sensitivity and specificity assays. Following incubation with the bacterial cell
suspension, the waveguides were placed in the Analyte 2000 cuvettes as described
previously. The waveguides were rinsed with 2 ml of PBST to wash out any unadsorbed
sample. An initial reading was taken to determine the inherent fluorescence of the
waveguide and of the dirty sample. Background fluorescence of the Cy5 labeled antirabbit IgG was determined by first, allowing a polyclonal antibody non-specific to the
target antigen (polyclonal anti-V. cholerae O1, Difco Laboratories) to react with the
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sample on the waveguide for 5 minutes. The waveguide was rinsed with 2 mls of PBST.
Then a Cy5-labeled anti-IgG was incubated on the waveguide for 5 minutes. Any
unbound antibody was rinsed with 2 ml PBST and then a reading was taken. This
procedure was repeated four times and a limit of detection was calculated based on these
readings. Unlabeled polyclonal anti-Strep group D antibody (ARP) (American Research
Products, Belmont, MA) was diluted as described previously to a concentration of
10 µg/ml. One hundred microliters of antibody was allowed to react with the attached
cells for 5 minutes. Any unbound antibody was rinsed away using 2 ml of PBST. An
anti-rabbit IgG labeled with Cy5 was diluted to1.5 µg/ml in PBS or blocking buffer. One
hundred microliters of the anti-IgG was allowed to react with the primary IgG already
bound to the bacteria on the waveguide for 5 minutes. Any unbound anti-IgG was rinsed
away with 2 ml PBST and a reading was taken. The assay scheme is illustrated in Figure
12.
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FIGURE 12. Indirect immunoassay format for evanescent wave biosensor. The
standard assay time for the indirect immunoassay for the evanescent wave biosensor is 10
minutes excluding the sample preparation step (10 minutes for a pure culture) and
adsorption of the sample to the polystyrene waveguide (at least 30 minutes).

Data Analysis for Biosensor Assays
The data for the waveguides and bacterial concentrations tested were analyzed
differently for the sandwich immunoassays and for the indirect immunoassays. Data
from each waveguide for the sandwich immunoassays were normalized to allow
comparison of independent waveguides (266). Values were normalized by setting the
signals obtained at the highest concentration tested to 100. The normalized values were
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treated as ratios of 100%. An average normalized signal was calculated for each bacterial
concentration tested and the standard deviation between the normalized signals for a
particular concentration was determined. The limit of detection (LOD) for each
waveguide was determined by calculating the standard deviation of the backgrounds and
multiplying by three. This was done after three background readings were taken. In later
experiments the amount of backgrounds performed was increased to four and LODs were
calculated differently. The LOD was calculated by averaging the differences between
each consecutive background reading. Then the standard deviation of the mean was
calculated and multiplied by three. Those two values were added together and were
considered the LOD for each waveguide. Any signal over the LOD was considered a
positive.
The data for the indirect immunoassays for enterococci could not be expressed as
normalized signals because different waveguides were used to test various concentrations
of bacteria. The limit of detection for each waveguide was calculated in exactly the same
fashion as described above in later experiments when four background readings were
performed. A negative control was always tested along with test samples to assess the
extent of non-specific binding of the antigen specific antibody (anti-Strep group D
polyclonal antibody). A sample was considered positive only if the signal generated was
greater than the limit of detection and also greater than the signal generated by the
negative control.
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Seawater Sample Collection and Sample Preparations
Unspiked samples. Twenty liter volumes of seawater were collected using a sterile 20
liter carboy by the EPA Method 1600, American Public Health Standard Methods for the
Examination of Water and Wastewater, and the methods described by Simmons and
Francy (4, 88, 234, 263). Water was collected from Courtney Campbell Causeway
beach (Clearwater,FL). Samples were collected three feet from shore and at a depth of
approximately 6-12 inches below the water surface. Water samples were kept on ice for
30 minutes during transit to the laboratory. All samples were processed immediately
upon arrival or within 6 hours of collection. On Tuesdays when samples from this site
were also collected by the Pinellas County Department of Health, counts were obtained
from the Florida Department of Health, Tampa Branch Laboratory, which processed the
samples collected by Pinellas County officials. On all other days when samples were
collected, initial Enterococcus counts were obtained by using standard EPA methods
(263). Fifty and 100 ml samples were filtered through a 0.45 µm filter. After filtration,
the filter and the unit was rinsed with buffered water [1.25 ml stock phosphate solution
(34.0 g KH2PO4 in 500 ml reagent grade H2O) + 5.0 ml magnesium chloride solution
(81.1 g MgCl2 6H2O/L)/L]. The filter was then placed with sterile forceps on mEI media
and incubated at 41°C for 24 h. The following day, any colonies with blue halos
surrounding them indicating the presence of β-D-glucosidase positive enterococci and
were counted. Final concentrations were reported as CFU/100ml.
Spiked Samples. Twenty liter volumes of water were sterilized and used to fill a
sterile 20 liter carboy. Test organisms were grown on TSA for 12-24 h at 36°C. A
sample was taken from the culture plate and resuspended in PBS to approximately
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108 CFU/ml. A serial dilution of the starter tube was made and viable counts were
performed to determine the number of live bacteria in each tube. Spiked assay samples
were prepared by inoculating the carboy with 3 mls of a particular dilution of bacteria to
obtain the desired CFU/100ml. All assays performed in sterile water were also
performed in Instant Ocean (Aquarium Sytems Inc.; Mentor OH) (3.5% in DI water)
following the same procedure described above.
Concentration of Seawater with a Hollow Fiber Filter
Twenty liter samples of spiked sterile water and unspiked sea water samples were
concentrated by using an 80,000 molecular weight cutoff hollow fiber filter (Fresenius
USA; Lexington, ME) (88, 234). Initial experiments were carried out by the same
method but in 20 liters of sterile deionized water. The day before the assay was
performed, the filter was blocked with 0.1% Laureth-12 (PALL Corporation; East Hills,
NY) elution buffer (blocking buffer) made in 0.01 M PBS (pH 7.4). The filter was
incubated at 4°C for 18 h. Concentration was performed using a Masterflex 4S
motorized pump (Model # 77201-62, Cole Parmer Instrument Company; Barrington IL).
The filter was connected to the carboy using 36 gauge tygon tubing connected by plastic
adaptors and secured with metal clamps. The apparatus used to concentrate water is
illustrated in Figure 13.

81

Bacteria in

Clamp
Filter

Carboy

Pump
Orbital shaker

Pressure
Gauge

FIGURE 13. Concentration apparatus. Twenty liter volumes of spiked and unspiked
sterile water and seawater were concentrated using an 80 K MWCO hollow fiber filter.
Water was continuosly recirculated through the system releasing partial volumes as
permeate until the whole sample was filtered. Bacteria were eluted from the filter using
1% Laureth 12 solution.

Following concentration, the filtrate was eluted with 250 ml of 1% Laureth-12 elution
buffer made in PBS. The elution was performed for 1 minute with a visual reduction in
buffer volume. A sample from the elution was either plated directly or diluted and then
100 µl was plated on TSA, mEI and marine agar to obtain a viable count from the
concentrated sample and to calculate a percent recovery. This was also performed on the
three types of media listed above to observe any background flora which may also be
growing along with the enterococci. The eluted sample was then filtered through a
0.45 µm filter (Millipore). This filter was rinsed with buffered water and then cut out of
the filtration apparatus. Using sterile forceps, the filter was placed into a beaker
containing mE enrichment broth prewarmed to 36°C. One hundred microliters of this
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sample were also plated on TSA, mEI and marine agar. The beaker was then placed into
a 36°C shaking water bath to enrich for 8-24 hours. Figure 14 shows the procedure used
to process and enrich concentrated seawater samples. Following enrichment and
concentration, a sample was removed and directly assayed on the biosensor.

The filter is
cut out and
placed in 50
mls of mE

Eluted sample
is filtered
through a
0.45 µm filter

Eluted sample
250 ml

400 ml beaker

250 ml filtration unit

Enrichment
broth with filter
placed in 36°C
shaking water

400 ml beaker

Shaking water bath

Biosensor detection

FIGURE 14. Processing steps for concentrated seawater samples.
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Concentration, Enrichment and Biosensor Detection of Fecal Enterococci
Concentration with a hollow fiber filter was combined with biosensor detection to
create a sensitive and specific method to detect fecal enterococci in sea water.
Concentration was carried out as described above. During the enrichment period, a
100 µl sample was plated at strategic time periods, usually at the 8 h, 10 h, 12 h, 14 h and
24 h marks. Samples were plated on mEI, TSA, and marine agar to obtain a viable count
at that time period. An Enterococcus count of at least 106 CFU/ml was necessary to
obtain positive detection on the fiber optic biosensor. At those key time periods, a 1 ml
sample was removed and incubated with the polystyrene waveguide as described
previously. The glass capillary reaction chamber was filled with the enriched sample and
cells were allowed to adsorb to the waveguide at 36°C for a minimum of 30 minutes.
The biosensor assay was performed according to the protocol described for the indirect
immunoassay.
SDS PAGE and Western Blot Analysis
Enterococcus faecalis cells were grown on TSA agar for 18-24 h at 36°C. A sample
of the cell culture was taken with a sterile loop or swab and the sample was resuspended
in sterile H2O. Samples were prepared by combining 13 µl of sample (whole cell
samples of Ent. faecalis untreated or treated by sonication for 20 minutes) with 5 µl
NuPAGE LDS sample buffer (4x) (Invitrogen; Carlsbad,CA) and 2 µl H2O and heated at
95°C for 5 minutes. A 4-12% Bis-Tris polyaccrylamide gel (Invitrogen; Carlsbad, CA)
was loaded with 10 µl of the prepared sample. Running buffer used to run the gel was
1x SDS-MES running buffer (Invitrogen; Carlsbad,CA). The gel was run at 200 volts for
30 minutes. A protein color marker (Sigma; St. Louis, MO) with a molecular weight
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range between 6,500-205,000 was used to run the gels. The cells samples were
transferred to a nitrocellulose membrane (Sigma) in Tobin buffer (pH 8.3) for up to 48 h
at 20 volts. The following day, the membranes were removed from the transfer cell and
blocked with 40 ml of blocking solution (5% non-fat dry milk made in PBST) for 30
minutes with continuous agitation. The membrane was washed with 40 ml of PBST.
Target specific antibody (anti-Strep group D antibody) was added to the membrane at a
1:1000 dilution in PBS and incubated for 30 minutes with continuous agitation. The
membrane was rinsed with 40 ml of PBST three times. Anti-rabbit IgG conjugated to
alkaline phosphatase was diluted 1:5000 and was incubated on the membrane for 30
minutes with continuous agitation. The membrane was washed with 10mM EDTA for 30
seconds with agitation. The membrane was then washed with 40 ml of PBST three times.
Forty milliliters of substrate (50 ml borate buffer (pH 9.7) -13 mg o-dianisidine, 13 mg βnaphthyl acid phosphate) was added to the membrane and the membrane was allowed to
develop until bands appeared (59).
Immunodot Analysis
Nitrocellulose membrane was cut into a 4 inch square. Wells were embossed using a
96-well ELISA plate (Nunc, Fisher Scientific). Cells of Enterococcus faecalis were
grown on TSA at 36°C for 18-24 h. The cells were resuspended in PBS and a 10-fold
serial dilution was made and plated on TSA to obtain a viable count. On some occasions,
sonicated cells extracts (sonicated for 20-30 minutes) were analyzed. Ten microliters of
each dilution were dotted in the embossed wells and allowed to dry. The membrane was
incubated at 4°C for 10 minutes. The rest of the immunodot procedure was as described
above for Western blot analysis.
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Scanning Electron Microscopy Analysis
Waveguides were prepared as described above for the biosensor assays. After
cleaning, incubation with streptavidin and biotin-labeled anti Strep group D capture
antibody (ARP), the waveguides were incubated with 100 µl of an Ent. faecalis cell
suspension (3.8 x 108 CFU/ml in PBS). Two of the waveguides were incubated with
untreated cells and the other two were incubated with cells which were sonicated for
twenty minutes on setting number 2 using the Dismembrator 100 (Fisher Scientific). The
waveguides were washed with 2 ml of PBST and then the waveguides were taken to
Betty Loramm, USF Department of Biology, to prepare the waveguides for SEM
analysis. Waveguides were prepared according to her instructions. The waveguides were
fixed in Trump fixative (Electron Microscopy Sciences; Ft. Washington, Pennsylvania).
They were rinsed three times in 0.1M sodium cacodylate buffer (pH 7.4) for 10 minutes
each rinse. The waveguides were then placed into 2% osmium tetroxide in 0.1M sodium
cacodylate buffer (pH 7.4) for 1 h. Each waveguide was then rinsed three times again in
0.1M sodium cacodylate buffer (pH 7.4) for 1 h. The samples were then dehydrated
according to the following sequence:
30% ethyl alcohol-10 minutes
60% ethyl alcohol-10 minutes
90% ethyl alcohol-10 minutes
100% ethyl alcohol-15 minutes
100% ethyl alcohol-15 minutes
The waveguides were dried chemically with hexamethyldislazane (HMDS). The whole
procedure was repeated and then the waveguides were critical point dried with liquid
CO2. Double stick adhesive was used to mount dried waveguides onto SEM stubs
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Hitachi S800 (Ernest F. Fullam Inc., Latham, NY). The waveguides were then sputter
coated and mounted with Gold-paladium target using a Pelco Model 3 sputter coater.
Once sputter coated, the waveguides were ready for SEM analysis.
Growth Curve Experiments for Enterococci
Cells of Ent. faecalis were grown in TSB broth at 36°C for 18-24 h. A one percent
inoculation was performed in the enrichment broth being tested (mE broth or bile esculin
azide broth). One hundred microliters of the enrichment culture was plated on either
TSA or mEI or both every 30-60 minutes. Absorbance (OD 540 nm) readings were also
taken in growth curve experiments using a DU-64 spectrophotometer. The growth
experiments were performed over a 6 hour period.
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RESULTS
Development of Biosensor Sandwich Immunoassay for Enterococci
All initial experiments were performed on the Analyte 2000 biosensor using a
sandwich immunoassay format. Whole cells of Enterococcus faecalis were resuspended
in PBS and serially diluted by 10-fold dilutions. The samples were assayed from lowest
to highest cell concentration.
Antibody specificity. Several commercial and custom made antibodies were tested for
use in the development of a sensitive and specific assay for the detection of fecal
enterococci in seawater. Seawater of high quality contains a very low concentration of
enterococci in seawater (0.01 CFU/ml – 1 CFU/ml) and necessitates a method sensitive
enough to enumaerate such a low concentration. A high quality antibody was a very
important part in developing such an assay using the Analyte 2000 biosensor. Figure 15
shows the results of an ELISA screening of all the antibodies tested. Antibodies were
diluted to 10 µg/ml except the monoclonal antibodies tested which were diluted 1:10 in
PBS.
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FIGURE. 15. Enterococcus antibodies tested for biosensor assay optimization. All
antibodies were tested against Ent. faecalis cells at 10 µg/ml except the monoclonal
antibodies which were diluted 1:10 in PBS.
The commercial polyclonal antibodies from American Research Products (ARP), Lee
Laboratories, and the custom made Strategic Biosolutions (SBS) polyclonal antibodies
showed the greatest affinity for the Enteroccoccus faecalis cells. These antibodies were
tested to evaluate their efficiency at detecting low levels of Ent. faecalis on the biosensor.
Figure 16 shows the results of an ELISA used to determine the binding affinity of the
selected antibodies to low concentrations of enterococci. The custom made SBS
antibody and the commercial ARP gave the highest signals when tested against low
concentrations of Ent. faecalis.
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FIGURE 16. Comparison of high affinity Enterococcus antibodies for use in assay
development. Polyclonal antibodies from Lee Laboratories, American Research Products
(ARP) and Strategic Biosolutions (SBS) were tested against Ent. faecalis cells at 10
µg/ml. Both the ARP and the SBS had a higher affinity for Ent. faecalis than the
polyclonal antibodies from Lee Laboratories did.
ARP and SBS antibodies were assayed using Western blot analysis, as described in the
Materials and Methods, to see which antibody showed the greatest affinity for different
epitopes of Ent. faecalis cells. The cells were tested sonicated and unsonicated with
SDS-PAGE. Part of each sample was centrifuged to assay the pellet and supernatant
fluid to determine which fraction contained a greater amount of antigen to bind with the
ARP antibody. Subsequent Western blot analysis revealed that the SBS antibody showed
greater affinity for a low molecular weight molecule, but the ARP antibody showed a
higher affinity for more than one epitope on the Ent. faecalis cells (Figure 17) Also, it
was observed that after sonication, more soluble antigen was present in the supernatant
fluid than in the pellet fraction. The ARP antibody was chosen for further assay
development on the Analyte 2000 biosensor.
90

Strategic Biosolutions Antibody
2
3
4
5
6
7 8 9

1

10

205 kDa
116 kDa
66 kDa
45 kDa
29 kDa
20 kDa
14.2 kDa
6.5 kDa

1

American Research Products Antibody
2 3
4
5
6
7
8
9 10

205 kDa
116 kDa
66 kDa
45 kDa
29 kDa
20 kDa
14.2 kDa
6.5 kDa

Lane 1: Marker
Lane 2: Unsonicated Ent. faecalis ATCC 19433 cells
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Lane 4: Supernatant from sonicated cells after centrifugation
Lane 5: Pellet from sonicated cells after centrifugation
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Lane 10: 50 µg/ml lipoteichoic acid from Ent. faecalis (Sigma)

FIGURE 17. Western blot analysis of polyclonal ARP and SBS antibodies for
Enterococcus biosensor assay.
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Of note is the lack of a distinct bad for unsonicated cell preparations of Ent. faecalis.
This is probably due to the in accessible location of the group D antigen (LTA) of
enterococci. The LTA is located under the cell surface where antibodies do not have
binding access.
Crossreactivity assays. The ARP polyclonal antibody was assayed for specificity
against environmental isolates of enterococci and also other potentially cross-reactive
species. Positive samples were recorded as any fluorescence readings that gave a signal
to noise ratio of 2 or greater. Those microorganisms tested are listed in Table 11 along
with the signal to noise ratio that was obtained at the concentration required to give a
positive. Several bacteria were shown to crossreact with the ARP antibody at the same
concentrations as the enterococci tested. Those species included Lactobacillus
arabinosa, Leuconostoc, Pediococcous dextrinicus, Staphylococcus aureus.
TABLE 11. Specificity data for anti-Strep group D antibody (American Research
Products) generated by ELISA.
Microorganism

Signal to noise ratioa

Aerococcus viridans
(ATCC 700406)
Ent. casseliflavus (USF 691)
Ent. casseliflavus (USF 703)
Ent. casseliflavus (USF 707)
Ent. casseliflavus (USF 740)
E. coli (USF 640)
Ent. faecalis (ATCC 19433)
Ent. faecalis (USF 693)
Ent. faecalis (USF 696)
Ent. faecalis (USF 709)
Ent. faecalis (USF 710)
Ent. faecalis (USF 711)
Ent. faecalis (USF 713)
Ent. faecalis (USF 715)
Ent. faecalis (USF 719)

Concentration required for
positive signal (CFU/ml)

N/Ab

N/Ab

2.6
3.6
3.1
2.0
N/Ab
4.6
2.7
6.0
2.2
2.2
2.4
4.8
6.1
3.7

3.2 x 107
1.0 x 108
2.3 x 107
2.7 x 107
N/Ab
7.0 x 106
3.4 x 105
3.2 x 106
5.8 x 105
4.5 x 105
3.2 x 105
4.2 x 106
3.5 x 106
7.8 x 106
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Ent. faecalis (USF 720)
6.5
7.6 x 106
Ent. faecalis (USF 721)
2.0
1.0 x 106
Ent. faecalis (USF 723)
4.1
1.3 x 107
Ent. faecalis (USF 724)
2.1
1.3 x 106
Ent. faecalis (USF 726)
5.4
1.2 x 107
Ent. faecalis (USF 727)
4.9
7.9 x 106
Ent. faecalis (USF 734)
2.1
1.0 x 106
Ent. faecalis (USF 747)
3.2
1.4 x 106
Ent. faecalis (USF 751)
2.4
4.3 x 105
Ent. faecium (USF 692)
2.8
6.1 x 106
Ent. faecium (USF 725)
3.9
7.0 x 106
Ent. faecium (USF 730)
2.4
6.0 x 106
Ent. faecium (USF 753)
3.6
1.6 x 107
Ent. faecium (USF 754)
5.1
5.6 x 107
Ent. faecium (USF 759)
3.9
6.0 x 106
Ent. durans (USF 694)
2.4
1.8 x 106
Ent. durans (USF 732)
2.0
1.9 x 107
Ent. gallinarum (USF 767)
2.0
1.5 x 107
Group A Streptococcus
4.1
1.8 x 108
(8-R291 TGH)
N/Ab
Group B Streptococcus
N/Ab
(1215-RNSJ183V)
Lactobaccillus arabinosa
2.0
2.0 x 106
(USF 541)
Lactococcus lactis (USF 690)
N/Ab
N/Ab
Lactococcus lactis (USF 776)
3.0
6.2 x 107
Leuconostoc (USF 706)
2.6
8.3 x 106
Pediococcus dextrinicus
2.8
1.2 x 106
(ATCC 33087)
S. aureus (USF 645)
2.0
2.6 x 107
Streptococcus bovis
4.5
2.7 x 108
(ATCC15351)
Streptococcus bovis
2.2
8.7 x 108
(ATCC 49133)
Vibrio alginolyticus (USF 516)
2.5
8.4 x 108
Weissella confusa
3.2
2.9 x 107
(ATCC 14434)
a
A signal to noise ratio over 2.0 was required for a value to be considered positive.
b
N/A, no positives were observed
S. aureus consistently showed crossreactivity with the ARP antibody. While
Ent. faecalis and S. aureus both contain a lipoteichoic acid antigen, S. aureus has a
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ribitol teichoic acid and Ent. faecalis has a glycerol teichoic acid. The nature of this
crossreactivity, however, was found to be predominantly due to the protein A molecules
on the surface of S. aureus as this phenomenon has been reported in previous studies
(100). This characteristic was tested on ELISA by using an S. aureus strain mutated to
not produce protein A (Figure 18). This strain was tested against a Cowen I strain that
had abundant protein A molecules on its surface. In previous studies, it was found that
protein A bound the Fc portion of antibody molecules with great affinity. This was found
to be the case with the ARP antibody as well. There was still some degree of
crossreactivity, however, even with the non-protein A S. aureus.
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FIGURE 18. Crossreactivity between ARP antibody and S. aureus. Crossreactivity
was assessed through ELISA using ARP at 10 µg/ml. Non-protein A S. aureus ATCC
10832 and USF 613 Cowen I S. aureus were tested to see if ARP antibody specifically
bound epitopes on the cell surface of S. aureus or if crossreactivity was due to nonspecific binding of the Fc portion of the antibody to protein A on the cell surface.
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Affinity purification of ARP antibodies. The ARP antibody was affinity purified to
attempt to improve the sensitivity and specificity of the test assays. The antibody was
purified using an affinity column consisting of a gel bed that had oxidized teichoic acid
from Ent. faecalis cells attached to it. The column was made according to manufacturer’s
instructions and the antibody was purified also according to manufacturer’s instructions.
Figure 19 shows the mean signal to noise ratio obtained on ELISA at various
Ent. faecalis concentrations. Affinity purification did not improve the binding affinity of
the ARP antibody to Ent. faecalis cells.
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FIGURE 19. Affinity purification of ARP polyclonal antibody. An affinity column
kit from Pierce was used to create an affinity column conjugated with teichoic acid
extracted from Ent. faecalis cells. This column was used to affinity purify polyclonal
ARP antibody. A protein A column (Amersham Biosciences) was used to IgG purify the
ARP antibody as well.
Varying capture antibody concentration. Various conditions were tested to develop a
sensitive sandwich immunoassay on the Analyte 2000 biosensor. Two different ARP
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capture antibody concentrations of, 100 µg/ml and 200 µg/ml, were tested to determine
which concentration resulted in optimum capture on the polystyrene waveguides. The
mean LOD for the 200 µg/ml assay was 5.1. The mean LOD for the 100 µg/ml assay was
16.3. The mean fluorescence over background of those waveguides incubated with
200 µg/ml of capture antibody went up with increased cell concentrations; however, the
signals did not increase logarithmically as was expected in this type of immunoassay
(Figure 20). In fact, the signals were very low, even at 108 CFU/ml. There also was no

Mean fluorescence over background

discernible pattern when normalized signals were graphed (Figure 21).
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FIGURE 20. Various antibody capture concentrations for optimization of
Enterococcus sandwich immunoassay. Biotinylated ARP antibody was tested at 200
µg/ml and 100 µg/ml to optimize the sandwich immunoassay. The mean LODs were 5.1
and 16.3, respectively.
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FIGURE 21. Normalized values for the mean signals shown in Figure 20.
Results in Figures 20 and 21 are data obtained from two experiments.
Varying detection antibody concentration. Two different concentrations of ARP
detection antibody, 20 µg/ml and 40 µg/ml, were tested to try and optimize the biosensor
immunoassay as well. The 40 µg/ml detection antibody concentration showed improved
detection of Ent. faecalis, but only at 108 CFU/ml (Figures 22 and 23). This still, did not
improve the sandwich assay sufficiently to develop the assay in this format for screening
environmental sea water samples. The mean LOD of the assays tested with 20 ug/ml of
detection antibody was 26.1. The mean LOD for the assays tested with 40 ug/ml
detection antibody was 93.
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FIGURE 22. Determining optimal detection antibody concentration for biosensor
sandwich immunoassay. Two concentrations of ARP Cy5 labeled polyclonal antibody
were tested: 20 µg/ml and 40 µg/ml. Biotinylated capture antibody was used at 100
µg/ml. Mean fluorescence signals over the limit of detection for each concentration tested
are represented. The mean LODs were 26.1 and 93, respectively.
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FIGURE 23. Normalized values for the mean signals shown in Figure 22.
Figures 22 and 23 are summarized data from two different experiments.
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Comparison of broth media and plate media. Ent. faecalis cells were grown on plate
media or in broth media and assayed directly on the biosensor to see if the culture
medium would make a difference in the amount of antigen expressed by the cells that the
antibody could bind. The results suggested that the broth culture made a difference in the
binding of the antibodies to antigenic determinants on the cells, but not significantly
enough to improve the sensitivity of the sandwich immunoassay (Figure 24). The cell
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signals were very low. The mean LOD for the assay was 23.9.
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FIGURE 24. Comparison of biosensor signals when Ent. faecalis cells were grown
for 18 hours in trypticase soy broth (TSB) vs.trypticase soy agar (TSA). These results
were obtained from two replicate experiments. Mean fluorescence signals over the limit
of detection for each concentration tested are represented. This assay was performed
using a sandwich immunoassay and a polyclonal anti- Strep group D antibody (American
Research Products) to capture and detect cells of Enterococcus faecalis. The mean LOD
was 23.9.

Different antigen preparations tested for assay development. Various antigen preps
were attempted to try to optimize the immunoassay and obtain detection of Ent. faecalis
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within the limits required by the EPA for beach water quality. Antigen preparations
attempted included sonication, boiling and freeze-thawing. The methods for these
antigen preparations were described in the Materials and Methods. Boiling the cells was
the least efficient preparation for improving the immunoassay. This was most likely due
to the denaturation of some of the antigenic proteins by the heat (Figure 25). Freezethawing also showed an improvement, however, sonication showed a drastic
improvement in sensitivity when screened with ELISA. The ELISA, however, was not a
sandwich assay. The sandwich immunoassay format needed to be tested on the Analyte
2000 biosensor.
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FIGURE 25. Comparison of antigen preparations for immunoassay optimization. An
ELISA was performed to compare three different sample preparations: repeated freeze
thawing with dry ice and denatured ethanol; boiling for 20 minutes; and sonication for
10-30 minutes. Samples were tested in duplicate. Anti-Strep group D antibody (10
µg/ml) (American Research Products) was used to test the effect of each sample
preparation on assay sensitivity. Sonication of Ent. faecalis cells proved to be the most
efficient sample preparation.
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Sonication and boiling antigen preparation on biosensor sandwich immunoassay.
Viable and dead cells were assayed on the biosensor to verify results obtained by ELISA.
Cells were grown on TSA overnight as described in the Materials and Methods and
resuspended in PBS. After a 10-fold serial dilution was made, the cells were boiled and
allowed to cool and then assayed on the biosensor instrument. Mean signals and
normalized signals are shown in Figures 26 and 27. The mean LOD was 48.4. There
were minor increases in mean signals over background and the normalized signals, but
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not logarithmic as would be expected with the addition of higher cell concentrations.
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FIGURE 26. Comparison of boiled cells and viable cells for biosensor detection
using a sandwich immunoassay. Mean fluorescence signals over the limit of detection
for each concentration tested are represented. Biotinylated polyclonal anti-Strep group D
antibody (ARP) was used for capture (100 µg/ml) and Cy5 labeled ARP was used for
detection (20 µg/ml) of Ent. faecalis cells in PBS. The mean LOD was 48.4.
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FIGURE 27. Normalized values for the mean signals shown in Figure 26.
Figures 26 and 27 are summarized data from four different experiments.

Sonication of Ent. faecalis cells showed improvements in assay sensitivity on ELISA and
was tested on the biosensor using the sandwich immunoassay. Sonication showed a
marked increase in mean fluorescence over the previous signal (Figures 28 and 29). The
mean LOD was 15.1. The sensitivity of the sandwich immunoassay on the biosensor was
improved by one log concentrations to 107 CFU/ml. This sensitivity was still not low
enough for the development of an assay to comply with EPA water quality standards
using the biosensor alone. Figures 28 and 29 are summarized data from two different
experiments.
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FIGURE 28. Sonicated cell preparation used for optimization of biosensor sandwich
immunoassay. Mean fluorescence values over the limit of detection for each
concentration tested are represented. Biotinylated polyclonal anti-Strep group D
antibody (ARP) was used for capture (100 µg/ml) and Cy5 labeled ARP was used for
detection (20 µg/ml) of Ent. faecalis cells in PBS. The mean LOD was 15.1.
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FIGURE 29. Normalized values for the mean signals shown in Figure 28.
Figures 28 and 29 are summarized data from three different experiments.
Immunodot analysis of sonicated vs. unsonicated cells. An immunodot was
performed to verify results obtained from biosensor assays testing the efficacy of
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sonicating Ent. faecalis cells. The immunodot showed a distinct difference in antibody
binding to cells that were sonicated and not sonicated (Figure 30). The ARP antibody
binds with greater affinity to sonicated cells, suggesting that the antibody has better
access to those epitopes such as the group D antigen which is located beneath the cell
surface.
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Sonicated
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FIGURE 30. Immunodot analysis of sonicated and unsonicated preparations of
Ent. faecalis cells in PBS. Ent. faecalis cells were sonicated for 30 minutes at setting #2
on the Dismembrator (Fisher Scientific). Polyclonal ARP antibody was diluted 1:1000 in
PBS was used for detection.
SEM analysis. All SEM analysis was performed by Jay Bieber at the USF College of
Engineering. Waveguides were prepared as described in Materials and Methods. The
waveguides were prepared for SEM by Betty Loramm, USF Department of Biology as
described in Materials and Methods. The comparison of sonicated captured cells and
unsonicated captured cells is obvious. There are scattered debris and salt deposits on the
waveguide analyzed with cells that were unsonicated (Figures 31 and 32). This debris is
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more evident on the waveguide exposed to unsonicated cells, than on the other
waveguide analyzed. More efficient capture is obtained on the waveguide allowed to
react with sonicated cells and further explains the improved assay sensitivity when
sonication is used for sample preparation

FIGURE 31. Unsonicated Ent. faecalis cells captured on polystyrene waveguide.
Biotinylated ARP antibody was used to capture the cells.
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FIGURE 32. Sonicated Ent. faecalis cells captured on polystyrene waveguide.
Biotinylated ARP antibody was used to capture the cells.
Lectins as capture molecules. Lectins were tested as capture molecules for
enterococci on the fiber optic waveguide surface because of their known abilities to
agglutinate carbohydrate groups on the surface of gram positive cells. ConA and WGA
have been observed to agglutinate enterococci and group D streptococci so they were
chosen as test molecules. Initial screening with ELISA revealed that ConA cross-reacted
extensively with the polyclonal anti-strep group D antibody used as the detection
molecule in the assay. Antibodies are glycoproteins so this crossreactivity was not
surprising. WGA crossreacted to a lesser degree with the ARP antibody and so WGA
was pursued for use on the biosensor sandwich immunoassay. Because some cross
reactivity was also observed between WGA and the Enterococcus antibody, backgrounds
were performed by running negative samples (sterile PBS) and then the labeled detection
molecules. Cy5 labeled primary antibody did not directly detect captured Ent. faecalis
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cells, so an anti-IgG labeled with Cy5 was used to amplify the signal of antibodies bound
to cells. This antibody was diluted 1:1000 in 0.1M PBS. LODs were calculated as
described in Materials and Methods. Using WGA as a capture molecule was successful,
but not sensitive enough, to improve the efficiency of the sandwich assay. Sensitivity
was 2.1 x 108 CFU/ml. Figures 33 and 34 show the results of four experiments testing
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this WGA as an alternative capture in the sandwich assay. The mean LOD was 12.5.
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FIGURE 33. WGA as capture molecule for Enterococcus sandwich immunoassay.
Biotinylated WGA diluted 1:50 was used to capture Ent. faecalis cells. Mean LOD was
12.5.
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FIGURE 34. Normalized values for the mean signals shown in Figure 33.
Figures 33 and 34 are summarized data from four experiments.
Optimization of Biosensor Indirect Immunoassays for Enterococci
EPA standards for recreational water quality require a very sensitive assay for proper
water quality assessment. The sandwich immunoassay was optimized, but the sensitivity
was not adequate to be a feasible test for enumerating indicator organism density in beach
water. An indirect assay format (illustrated in Materials and Methods) was optimized as
an alternative to increase assay sensitivity. In preliminary experiments, Ent. faecalis cells
suspended in 0.1M carbonate-bicarbonate buffer (pH 9.3) were assayed to ascertain the
sensitivity of this type of assay (Figure 35). This format of immunoassay was used to
screen antibodies using ELISA and the sensitivity of the ARP antibody was found to be
106 CFU/ml. Using the same assay principles, this format was tested on a polystyrene
waveguide on the Analyte 2000 biosensor. Two polyclonal antibodies were used in the
assay, one specific to group D streptococci (ARP), and one used for determining
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background signals which was specific for V. cholerae O1 (Difco Laboratories). Antirabbit IgG labeled with Cy5 was used to generate a specific signal when excited at
635 nm. Figure 35 was generated with data from five experiments and the mean LOD
was 12.2. The sensitivity of this indirect immunoassay was 105-106 CFU/ml.
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FIGURE 35. Directly adsorbed Ent. faecalis cells in 0.1 M carbonate buffer (pH 9.3).
Polyclonal ARP antibody (10 µg/ml) was used to detect Ent. faecalis cells in carbonatebicarbonate buffer. Anti-IgG labeled with Cy5 was used to detect ARP antibody bound
to the target antigen. Mean LOD was 12.2.
Ent. faecalis cells were also tested in filter-sterilized seawater (Figure 36). A negative
control was tested to assure that there was no inherent or background fluorescence from
the seawater. Figure 36 is summarized data from three different experiments and the
mean LOD was 13.6. The sensitivity in seawater, detection of 106 CFU/ml, was
comparable to that in sterile carbonate-bicarbonate buffer (pH 9.3).
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FIGURE 36. Directly adsorbed Ent. faecalis cells in seawater. Polyclonal ARP
antibody (10 µg/ml) was used to detect Ent. faecalis cells in carbonate-bicarbonate
buffer. Anti-IgG labeled with Cy5 was used to detect ARP antibody bound to the target
antigen. Mean LOD was 13.6.
Table 12 shows the mean signals from five experiments where Ent. faecalis cells in
seawater were directly adsorbed to the waveguide. In four out of four experiments,
positives signals were seen when negative samples were assayed on the biosensor. This
was probably due to nonspecific binding of the detection antibody to the waveuide.
These false positives were very close to signals generated by the 105 concentrations
tested so positive signals were not significant until 106 CFU/ml.

110

TABLE 12. Comparison of mean signals from five biosensor experiments.

Avg. CFU/ml

0
3.1 x 105
3.1 x 106
3.0 x 107
4.7 x 108
a
Standard deviation

SDa

Mean signal
(pAmps)

56.6
23.8
162.4
395.2
7053.9

50.5
22.1
73.3
131.1
4121.4

Number of
positive
samples/
total number
of samples
4/4
0/5
2/2
2/2
5/5

Incubation times were also tested to try and shorten the time required for cells in
carbonate-bicarbonate buffer (pH 9.3) to adsorb to the polystyrene waveguides. Figure
37 shows summarized data obtained from four experiments and the mean LOD was 33.6.
High concentrations still gave strong positive signals with as short an incubation time as
30 minutes (Figure 37). Table 13 shows the mean signals from those 4 experiments.
False positive were seen in three out of four control samples and because the mean
signals at 105 were so close to the false positives, the sensitivity of this assay was 106
CFU/ml. This assay improved the overall sensitivity of the Enterococcus assay by one
log concentration, however, the assay was still not sensitive enough to detect enterococci
from the environment directly. The sensitivity, detection of 106 CFU/ml, in both matrices
was comparable to that on ELISA.
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FIGURE 37. Ent. faecalis cells directly adsorbed to a polystyrene waveguide after a
30 minute incubation at 36°C. Polyclonal ARP antibody (10 µg/ml) was used to detect
Ent. faecalis cells in carbonate-bicarbonate buffer. Anti-IgG labeled with Cy5 was used
to detect ARP antibody bound to the target antigen.
Table 13 shows the mean signals from four experiments where Ent. faecalis cells in
carbonate- bicarbonate buffer (pH 9.3) were incubated at 36°C for 30 minutes. The same
results were observed in these assays that were observed in the seawater assays. Signals
at 105 CFU/ml were very close to the false positives which were observed. Positive
detection was obtained at 106 CFU/ml.
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TABLE 13. Mean signals from four experiments where Ent. faecalis cells were
incubated at 36°C for 30 minutes.

Avg. CFU/ml

0
5.6 x 105
5.6 x 106
5.6 x 107
a
Standard deviation

SDa

Mean signal
(pAmps)
74.5
128.6
994.0
3695.7

59.5
75.7
358.6
2257.7

Number of positive
samples/ total
number of samples
3/4
4/4
4/4
4/4

Concentration of 20 Liter Volumes of Water
Twenty liter water samples were concentrated according to the method of Simmons
et al (234). Hollow fiber filter concentration was used to enhance the sensitivity of the
bioassay. Preliminary experiments were performed in 20 liter volumes of sterile water to
assess the recovery efficiency of the filter and also to see if samples could be
concentrated sufficiently to detect enterococci directly on the biosensor following
filtration (Table 14).
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TABLE 14. Recovery of Ent. faecalis cells when concentrated with hollow fiber
filter.
Concentration
in 20 L (CFU/ml)

Concentration
after filtration
(CFU/ml)

Eluted volume
(mls)

% Recovery

2.6 x 104
2.6 x 106
225
109
4
6
3.6 x 10
3.0 x 10
185
76.4
3.3 x 104
3.3 x 106
210
105
4
6
3.0 x 10
2.0 x 10
230
76.7
2.3 x 104
1.3 x 106
208
60
2.7 x 104
2.7 x 106
268
133
4
255
3.0 x 10
198
116
230
86.9
225
1.7 x 104
4
210
2.0 x 10
182
86.7
375
2.3 x 104
105
32
4
230
72.5
269
1.6 x 10
480
6.0 x 104
170
106
2.1
32
180
13
1.8
200
226
125
1
200
226
214
4.8
100
244
25
.08
10
138
86a
a. Experiment was performed with an environmental seawater sample. Counts were
obtained from the Florida Department of Health Tampa Branch Laboratory.
The mean recovery using the Fresensius hollow fiber filter was 89.6%. The lower the
cell concentration, the more erratic the recovery became. This was especially the case
when a concentration of ~ 1 CFU/ml was filtered. Overall, this process concentrated
water samples 100-fold. This improved assay sensitivity, but an enrichment step was
needed to further enhance assay sensitivity.
Growth Curve Experiments and Enrichment of Enterococci
To enhance the sensitivity of the biosensor assay, an enrichment step was added to
the method along with concentration. Initial experiments for enrichment of Ent. faecalis
were performed in bile esculin azide broth. This selective enrichment broth, however,
did not prove sufficiently selective for use with actual beach water samples. mE broth
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was used to perform the rest of the enrichment experiments. The mean generation time
of Ent. faecalis in mE broth was 40.5 minutes. The growth curve was performed as
described in the Materials and Methods and the results appear in Figure 38.
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FIGURE 38. Growth curve of Ent. faecalis in mE enrichment broth. Based on this
growth curve, the mean generation time for Ent. faecalis in mE broth was 40.5 minutes.

Concentration, Enrichment, and Biosensor Detection
Seawater samples were processed in 20 liter volumes on Tuesdays when the Pinellas
County Department of Health (DOH) also tested water from this same beach (Courtney
Campbell Causeway beach, Clearwater, FL). Initial counts were obtained from David
Wingfield at the Florida Department of Health Tampa Branch Laboratory. A guide was
developed similar to what is used in Pinellas County for gauging the quality of beach
water based on established EPA guidelines. The Pinellas county guidelines are listed in
Table 15.
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TABLE 15. Pinellas County Health Department/EPA water quality criteria.
Pinnellas County Water Quality Guidelines for Enterococcia
Good
0-34 CFU/100 ml
Moderate
35-104 CFU/100ml
Poor
> 105 CFU / 100 ml
a
These criteria were derived from standard set by the U.S. Environmental Protection
Agency.
A similar guideline to that described above was created to gauge water quality based on
enrichment times and biosensor detection. Seawater samples were processed as
described in the Materials and Methods. Following concentration with a hollow fiber
filter, samples were enriched in 50 ml of mE broth. Samples were taken at key time
intervals for detection on the biosensor and also to perform a viable count. Based on
these data a guide was developed to determine the water quality of unspiked samples.
The guide consisted of three parts, Good quality water, Moderate quality water, and Poor
quality water, similar to the Pinellas County method. These categories were established
based on the time it took for a sample to enrich to 106 CFU/ml (the limit of detection for
the indirect immunoassay on the biosensor) where there should also be positive detection
on the biosensor. That general guideline is listed in Table 16 for this integrated method
for determining water quality.
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TABLE 16. Biosensor/ enrichment criteria for determining water quality.
Category

Viable counts

Enrichment time needed
for positive biosensor detection

Good
106 CFU/ml
over 14 hoursa
Moderate
106 CFU/ml
12-14 hoursb
6
Poor
10 CFU/ml
8-10 hoursc
a
In two out of three experiments, positive detection was observed after 14 h of
enrichment in mE broth. In one of the replicate experiments, detection was
observed at 14 h.
b
In two out of three experiments, positive detection was observed between 12-14 h of
enrichment in mE broth. One of the replicate experiments, detection was not
observed until14 h of enrichment.
c
In three out of three experiments, positive detection was observed between 8-10 h
of enrichment in mE broth.
All experiments to create these guidelines were performed in triplicate in sterile water
and in simulated sea water (Instant Ocean, 3.5% in DI H2O). Results were the same in
both matrices.
Experiments for determining criteria for Good quality water samples. Sterile water
was spiked with a concentration of Ent. faecalis cells that would give an approximate
count equal to what the Pinellas County Health Department considers good quality water
(0-34 CFU/100 ml of enterococci). The process was performed as described in Materials
and Methods. Three experiments were performed and the results of those experiments
are listed in Table 17.
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TABLE 17. Experiments for the development of criteria to measure Good quality
water.
Experiment

Time point
(hrs)

Viable count
LODa
(CFU/ml)
(pAmps)

Biosensor signal
(pAmps)

8
10
12
14
72

2.3 x 103
7.8 x 103
2.4 x 104
2.0 x 105
1.6 x 108
Neg. controlc

N/Ab
12.6
N/Ab
16.4
21.4
53.1

N/Ab
8.0
N/Ab
68.3
3579.9
179.3d

2
(3 CFU/
100 ml)

10
12
14
24

2.8 x 103
5.0 x 103
6.1 x 104
1.7 x 107
Neg. Controlc

4.2
N/Ab
18.7
13.6
5.5

24.7
N/Ab
23.2
573.3
48.7 d

3
(3 CFU/
100 ml)

10
12
14
24

7.2 x 104
1.6 x 106
9.6 x 106
2.6 x 109
Neg. controlc

12.4
N/Ab
14.3
32.8
44.9

35.8
N/Ab
379.4
5512.8
139.1 d

1
(5 CFU/
100 ml)

a

Limit of Detection
N/A= samples were not assayed on the biosensor.
c
Negative control consisted of uninoculated mE broth which was allowed to react
with the polystyrene waveguides at 36°C for the same amount of time as the samples.
d
False positives were seen for negative controls. Positives had to be higher than the
LOD and higher than the negative control.
b

Time points were judged based on viable counts and if positive detection was observed
when counts reached the biosensor’s limit of detection (106 CFU/ml). Those points are
boldfaced in the Table 17. To be considered a positive result, not only did the signal
have to be higher than the LOD, but it also had to be higher than the false positive
observed for the negative control. The mean LOD was 20.8 + 15.2. The mean recovery
was 72%. Two times out of three, it required over 14 hours to enrich a concentration this
low (~0.01 CFU/ml) to obtain the minimum CFU/ml (106 CFU/ml) required for positive
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detection on the Analyte 2000 biosensor. The growth rate for Ent. faecalis was
calculated to observe any discrepancies in growth due to differences in initial inoculum
between the three categories. The mean growth rate for these experiments was calculated
to be 43.6 + 2.6 minutes. All of these data were used to establish criteria for the Good
category of water quality developed in this method.
Experiments for determining criteria for Moderate quality water samples. Sterile
water was spiked with a concentration of Ent. faecalis cells that would give an
approximate count equal to what Pinellas County Health Department considers moderate
quality water (35-104 CFU/100 ml of enterococci). The process was performed as
described in Materials and Methods. Three experiments were performed and the results
of those experiments are listed in Table 18.
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TABLE 18. Experiments for the development of criteria to measure Moderate quality
water.
Experiment

Time point
(hrs)

Viable count
LODa
(CFU/ml)
(pAmps)

Biosensor signal
(pAmps)

1
(71 CFU/
100 ml)

10
12
14
24

5.1 x 105
2.9 x 106
1.6 x 107
2.5 x 109
Neg. controlb

9.8
42.5
24.9
31.2
50.2

33.9
308.6
781.9
5280.2
135.9c

2
(48 CFU/
100 ml)

10
12
14
36

1.1 x 105
4.9 x 105
4.4 x 106
2.0 x 107
Neg. controlb

8.9
N/Ad
7.0
34.6
47.3

24.9
N/Ad
167.5
5595.2
136.2c

3
(32 CFU/
100 ml)e

10
12
14
36

2.0 x 103
6.4 x 104
1.1 x 105
1.7 x 108
Neg. controlb

13.0
N/Ad
33.9
52.2
46.1

11.5
N/Ad
32.1
3950.9
158.7 c

a

Limit of Detection
Negative control consisted of uninoculated mE broth which was allowed to react
with the polystyrene waveguides at 36°C for the same amount of time as the samples.
c
False positives were seen for negative controls. Positives had to be higher than the
LOD and higher than the negative control.
d
N/A= samples were not assayed on the biosensor.
e
Results fit into Good category, but this experiment was done as part of moderate
quality experiments.
b

When an initial inoculum of ~0.1 CFU /ml was tested, two out of three experiments
showed that 12-14 hours of enrichment was required to obtain the minimum
concentration of Ent. faecalis (106 CFU/ml) to get positive detection on the Analyte 2000
biosensor. Those time points are boldfaced in Table 18. Again, to be considered a
positive result, the signal had to be higher than the LOD and higher than the false positive
observed for the negative control. The mean LOD was 30.9 + 16.6. The mean recovery
was over 100%. The mean growth rate of Ent. faecalis in this set of three experiments
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was calculated as 46.9 + 3.2 minutes. This data was used to establish criteria for samples
of moderate quality using concentration, enrichment and biosensor detection.
Experiments for determining criteria for Poor quality water samples. Sterile water
was spiked with a concentration of Ent. faecalis cells that would give an approximate
count equal to what Pinellas County Health Department considers poor quality water
(>105 CFU/100 ml of enterococci). The process was performed as described in Materials
and Methods. Three experiments were performed and the results of those experiments
are listed in Table 19.
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TABLE 19. Experiments for the development of criteria to measure Poor quality
water.
Experiment

Time point
(hrs)

Viable count
(CFU/ml)

LODa
(pAmps)

Biosensor signal
(pAmps)

1
(180 CFU/
100 ml)

5
6
7
8
9
10
24

1.4 x 104
4.5 x 104
1.1 x 105
3.7 x 105
6.1 x 105
1.7 x 106
3.9 x 108
Neg. control c

N/Ab
N/Ab
N/Ab
N/Ab
N/Ab
14.1
39.3
36.3

N/Ab
N/Ab
N/Ab
N/Ab
N/Ab
268.1
4185.5
107.4 d

2
(600 CFU/
100 ml)

8
10
24

2.2 x 106
2.6 x 107
1.1 x 109
Neg. control c

41.6
40.8
46.3
20.3

318.8
2993.8
4923.3
104.6 d

3
(330 CFU/
100 ml)

8
10
36

1.0 x 106
5.4 x 106
3.0 x 107
Neg. control c

13.1
11.2
74.6
50.1

66.7
191.6
4698
97.9 d

a
b
c

d

Limit of Detection
N/A= samples were not assayed on the biosensor.
Negative control consisted of uninoculated mE broth which was allowed to react
with the polystyrene waveguides at 36°C for the same amount of time as the
samples.
False positives were seen for negative controls. Positives had to be higher than the
LOD and higher than the negative control.

When an initial inoculum of ~1 CFU/ml was tested, three out of three experiments
showed that 8-10 hours of enrichment was required to obtain the minimum concentration
of Ent. faecalis (106 CFU/ml) to get positive detection on the Analyte 2000 biosensor.
Those time points are boldfaced in Table 19. To be considered a positive result, the
signal had to be higher than the LOD and higher than the false positive observed for the
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negative control. The mean recovery was 148% and the mean LOD was 35.3 + 19.3. The
mean growth rate of Ent. faecalis in this set of three experiments was calculated as
43.3 + 8.4 minutes. These data were used to establish criteria for samples of poor quality
using concentration, enrichment and biosensor detection. In all the experiments
performed, the growth rates were similar. Of note is the false positives seen with the
negative control waveguides. The backgrounds were taken using a primary antibody
other than the anti-Strep group D polyclonal antibody. A Difco anti-V. cholerae O1
polyclonal antibody was used to ascertain all background noise which the Cy5 labeled
anti-IgG would give due to non-specific binding. While the anti-V. cholerae antibody did
not seem to show affinity to any of the media components or non-specifically adhere to
the polystyrene waveguide, the anti-Strep group D antibody did show some nonspecific
activity leading to higher background signals and false positive when allowed to react
with the secondary antibody.
While this water quality guide is only semi-quantitative, it definitively distinguishes
between Good and Poor quality of water very well. A draw back to the method is that the
geometric mean, which is routinely calculated by the Pinellas County Department of
Health, cannot be calculated based solely on this method because it is semi-quantitative.
Initial counts for all these experiments were obtained from viable counts on TSA before
spiking 20 L of sterile water in a carboy, but in blind samples, the water would just be
processed to observe in what category the water would fall into (23). This category as
explained previously would be an estimate of the counts that are truly present in the
water. Criteria for closing a beach not only rely on the three categories mentioned
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previously, but also on the calculated geometric mean which takes into account specific
counts from the previous five sampling weeks. If the geometric mean exceeds
35 CFU/100 ml, than the beach is posted and warnings are sent out to the news media and
posted on the county website and at the beach. This method would be a very good
preliminary screening tool and results would be obtained faster than the standard methods
which can require biochemical confirmation to assert the presence of fecal enterococci.
Unspiked 20 liter volumes of seawater. Samples of unspiked seawater were assayed
as described in Materials and Methods. Table 20 shows the results of three
environmental seawater samples which were processed using the integrated
biosensor/concentration/enrichment method.
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TABLE 20. Results from environmental samples tested using integrated biosensor
method.
Experiment

Time point
(hrs)

Viable count
(CFU/ml)

LODa
(pAmps)

Biosensor signal
(pAmps)

1e
(6 CFU/
100 ml)h
(9 CFU/
100 ml)i

8
10
12
14
16
24

N/Ab
6.0 x 103
3.0 x 104
4.8 x 105
2.3 x 106
6.1 x 108

N/Ab
N/Ab
35.0
35.4
N/A
58.0

N/Ab
N/Ab
-2.2
-3.3
N/A
777.5

2f
(4 CFU/
100 ml)h
(69 CFU/
100 ml)i

8
10
12
14
16

N/Ab
2.4 x 105
1.2 x 106
1.0 x 107
2.6 x 108
Neg. controlc

N/Ab
N/Ab
75.0
218.9
-39.1
13.7

N/Ab
N/Ab
37.7
403.3
4028
104 d

3g
(60 CFU/
100 ml)h
(43 CFU/
100 ml)i

10
12
14
16
18

2.6 x 105
6.4 x 106
7.0 x 106
3.9 x 197
1.4 x 108
Neg. control c

-26.5
422.9
79.0
N/Ab
N/Ab
15.5

-28.7
282.2
138.5
N/Ab
N/Ab
29.7 d

a

Limit of Detection
N/A= samples were not assayed on the biosensor.
c
Negative control consisted of uninoculated mE broth which was allowed to react
with the polystyrene waveguides at 36°C for the same amount of time as the
samples.
d
False positives were seen for negative controls. Positives had to be higher than the
LOD and higher than the negative control.
e
Water sample falls into good category according to counts and biosensor
detection. Also matches good category in Pinellas county guidelines.
f
Water sample falls into good category according to Pinellas county guidelines.
According to counts and biosensor data, it falls into the moderate water quality
category.
g
Water sample falls in moderate category for both Pinellas county guidelines and
biosensor detection.
h
Counts obtained from the Department of Health
i
Filtration counts on mEI performed in the lab.
b
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Two out of three times, the method correctly correlated the growth of fecal enterococci in
mE enrichment broth to the actual density of the organisms in beach water. The mean
recovery was 71.5% and the mean LOD was 80.7 + 132.5. The mean growth rate was
46.3 + 1.1. The increased growth rate is expected as the cells from environmental
samples are stressed and then undergo further stress through filtration with the hollow
fiber filter. In all unspiked samples, representative colonies with blue halos on mEI were
confirmed by inoculating into brain heart infusion broth with 6.5% NaCl and streaking
onto bile esculin azide agar. These isolates were identified using API Strep and a
biochemical key that was put together by Manero (171). The predominating species
identified were Ent. faecium and Ent. faecalis. The yellow bacterium Ent. casseliflavus
was found only occasionally. Two red colonies which resulted on mEI in one of the
experiments were not able to be identified through API Strep and these results remained
inconclusive. In one of the experiments, one red colony was found to grow which had no
blue halo on mEI. This isolate was identified as Aerococcus viridans. In experiment 3,
Vibrio alginolyticus thrived in the mE enrichment broth along with the enterococci. This
was only found to happen in this experiment. V. alginolyticus was assayed on the
biosensor and with ELISA to check for crossreactivity with the anti-Strep group D
antibody. This organism was not found to crossreact significantly. The fact that this
organism grew in the mE broth which contained nalidixic acid was surprising considering
that this organism is very susceptible to this antibiotic. An experiment performed on
isolates of V. alginolyticus isolated from marine water from Indonesia showed that 1.3 %
of the strains recovered were resistant to nalidixic acid (183). The high pH (9.3) of the
medium did not present an obstacle as vibrios are known to thrive in alkaline
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environments. The recovery from the filtration of the water sample was erratic between
experiments including those used to create this water quality guideline. While unusual,
preliminary experiments where low concentrations of enterococci were concentrated also
showed these fluctuations. At higher concentrations, the loss is less evident and may
account for the greater and more consistent recovery. This unusual recovery was seen in
all concentrations with a low starting bacterial concentration.
Isolation of E. coli O157:H7 in seawater.
Seawater samples were analyzed and enriched for E. coli O157:H7 as described in
Materials and Methods. Samples were analyzed from two beaches and no isolates were
found to be E. coli O157:H7. Any suspect isolates of E. coli O157:H7 which were
sucrose negative on CT-SMAC were identified through API. These isolates were found
to be either non- O157:H7 E. coli or Klebsiella spp.
Biosensor Immunoassays for the Detection of E. coli O157:H7 in Seawater.
Previous work by DeMarco and Lim showed that the KPL affinity purified polyclonal
antibody against E. coli O157:H7 was only mildly crossreactive with one other organism,
Escherichia hermanii (63, 64). Assays were performed as described in Materials and
Methods using the sandwich immunoassay. The data in Figures 39 and 40 are results
from seven different experiments. The mean LOD was 69.5. Detection in seawater was
comparable to detection in 0.01M PBS (pH 7.4). Sensitivity in PBS and seawater was
3.6 x 105 CFU/100 ml.
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FIGURE 39. Detection of E. coli O157:H7 in PBS vs. seawater. A sandwich
immunoassay format was used to detect E. coli O157:H7 in seawater. Biotinylated KPL
polyclonal antibody (100 µg/ml) was used to capture. Cy5 labeled KPL (10 µg/ml).
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FIGURE 40. Normalized values for the mean signals shown in Figure 39.
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Isolation of V.cholerae from Seawater
A total of 128 isolates were recovered from seawater by isolation on TCBS agar as
described in Materials and Methods. Any organisms that were yellow and 2-3 mm in
diameter on TCBS agar were restreaked onto TSA and further analyzed. After gram stain
and oxidase test, the organisms were examined using the two test method developed by
Chopun et al. (46). The organisms were inoculated into iron esculin medium and
arginine dihydrolase broth. One drawback to the two test method was the difficulty in
interpreting the iron esculin hydrolysis test as described by Chopun et al. The black
precipitate which formed from esculin hydrolysis could also be the result of melanin
production. This was sidetstepped by checking for fluorescence of esculin under UV
light which resulted from hydrolysis. While this made interpretation easier, it was still
difficult to interpret tubes which were completely black. Negative results in both of these
test lead to further identification through the API test. Table 21 compares the three
methods used to identify V. cholerae in this study.
TABLE 21. Comparison of three methods for the identification of V. cholerae
isolates.
Two-test method a
API ID b
PCR c
______________________________________________________________________
Number of
Number other/
Number
Number other/
Number of
V. cholerae /
total number
V. cholerae/
total number
V. cholerae/
total number of isolates
number of
of isolates
number of
of isolates
total isolates
total isolates
121/127
a

6/127

87/127

40/127

67/127

Using the 2-test method, 121 out of 127 isolates obtained from environmental samples
were identified as V. cholerae.
b
87 out of 127 isolates obtained from environmental samples were identified as V.
cholerae through API.
c
67 out of 127 isolates obtained from environmental samples were identified as V.
cholera.
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Some of the isolates identified which were sucrose negative included V. vulnificus and V.
parahaemolytcus. These isolates were included in the final count of isolates and were
API identified, but were not assayed through PCR or the two-test method. All sucrose
positive isolates were identified through API even if the two-test method results
suggested a microorganism other than V. cholerae. Many of the isolates which may have
been considered V. cholerae from using just the two-method test were, in fact, identified
as Vibrio alginolyticus when assayed using an API test strip. V. alginolyticus is sucrose
positive and also negative for arginine dihydrolase and iron esculin hydrolysis. Another
sucrose positive organism isolated was identified as Aeromonas hydrophila through API.
This isolate, however, gave the expected results for arginine dihydrolase (+) and iron
esculin hydrolysis (+) in the two test method. In some instances the API results
suggested A. hydrophila Group II and V. alginolyticus as alternatives if the isolate
assayed was not V. cholerae. In these cases, the isolate was identified through PCR along
with other isolates which were identified as V. cholerae at greater confidence levels (95%
and greater) through API. When assayed through PCR by amplifying the ITS region of
the 16S-23S rRNA sequence of V. cholerae, a total of 67 isolates from the 127 isolated
from the two beaches tested resulted as being V. cholerae (Table 21). This result was
confirmed by the presence of the 300 bp fragment upon gel electrophoresis. Figure 41
shows the typical results of five isolates assayed by PCR and gel electrophoresis. Four
out of the five isolates assayed were confirmed as V. cholerae. All other isolates were
assayed the same way. All confirmed V. cholerae isolates were non-O1 strains of V.
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cholerae as confirmed through slide agglutination with Difco polyclonal anti-V. cholerae
O1 polyclonal serum.
1

2

3

4

5

6

7

8

1 Kb
750 bp
500 bp
300 bp

300 bp

150 bp
50 bp

Lane 1- 1 Kb Marker (Bench Top PCR marker)
Lane 2 - Negative control, sterile H2O
Lane 3 – Positive V. cholerae O1 (CDC E5906-1018)
Lane 4 – Isolate USF 877 from N. Shore beach
Lane 5 – Isolate USF 878 from N. Shore beach
Lane 6 – Isolate USF 879 from N. Shore beach
Lane 7 – Isolate USF 880 from N. Shore beach
Lane 8 – Isolate USF 883 from Courtney Campbell beach

FIGURE 41. Summary of PCR results for the identification of V. cholerae
environmental isolates obtained from two Tampa Bay beaches.

Specificity Studies for V.cholerae Detection
Five different antibodies were tested for purposes of biosensor assay development.
One monoclonal and four polyclonal were tested against V. cholerae O1 whole cells
(Figure 42). The Austral Biologicals monoclonal and the Difco polyclonal outperformed
all the other antibodies tested. The Difco polyclonal was chosen for use on the biosensor
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due to its higher affinity for lower concentrations of V. cholerae O1 cells and the lower
cost.
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Denka Seiken polyclonal
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'10^6
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V. cholerae O1 concentration (CFU/ml)

FIGURE 42. Comparison of commercial polyclonal antibodies for V. cholerae
detection on ELISA. All antibodies were assayed as whole serum diluted 1:500 in PBS.
A signal to noise ratio above 2.0 was necessary for a value to be considered positive.
Several organisms were assayed for specificity against the Difco polyclonal antibody
against V. cholerae O1 using ELISA (Table 22).
TABLE 22. Organisms tested for crossreactivity with Difco polyclonal V. cholerae
antibody through ELISA.

Microorganism

Signal to noise ratioa

Concentration needed
for (+) signal
(CFU/ml)

Aeromonas hydrophila (USF 530)
2.0
2.2 x 107
E.coli ATCC 29417
2.8
2.6 x 108
Salmonella typhimurium (USF 515)
4.8
4.3 x 108
V. cholerae O1 (CDC E5906-1018)
2.0
2.2 x 105
Pseudomonas aeruginosa (USF 620)
N/A
N/A
Vibrio alginolyticus (USF 516)
3.5
8.4 x 106
V. cholerae O139 (CDC 2412-93)
3.3
3.7 x 109
a
A signal to noise ratio above 2.0 was required for the ELISA to be considered positive.
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Several of the organisms tested did crossreact with the Difco polyclonal. The majority of
the organisms only crossreacted at high concentrations. Vibrio alginolyticus crossreacted
to a greater degree. This crossreactivity could be problematic considering how prevalent
V. alginolyticus is in marine waters.
Different Sample Preparations for V. cholerae Immunoassay Optimization
Different sample preparations were also tested for assay optimization. Cells of
V.cholerae were tested untreated, boiled for 20 minutes, or sonicated for 10-20 minutes.
Boiled cells suspensions were compared to untreated cell suspensions using ELISA
(Figure 43).
4.5

Signal to noise ratio

4
3.5
3

Untreated V.
cholerae O1 cells
Boiled V.
cholerae O1 cells

2.5
2
1.5
1
0.5
0
10^9

10^8

10^7

10^6

10^5

V. cholerae O1 concentration (CFU/ml)

FIGURE 43. Detection of viable V. cholerae cells and boiled V. cholerae cells. Cells
were boiled for 20 minutes and allowed to cool before assaying through ELISA. Difco
polyclonal anti-V. cholerae O1 antibody (10 µg/ml) was used to test the different cell
preparations.
Boiled cells showed much stronger fluorescence readings than untreated cells.
Sonication was compared to boiling on the biosensor to see if sensitivity could further be
enhanced (Figure 44 and 45). These data are results from 3 experiments. Boiling still
appeared to be the best sample preparation method for V. cholerae O1 assay
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development. The mean LOD was 30.8. The assay sensitivity for this assay was 1.6 x 109
CFU/ml.
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FIGURE 44. Detection of boiled and sonicated V. cholerae cells. A sandwich
immunoassay format was used to detect V. cholerae O1 cells on the biosensor. Mean
fluorescence over the limit of detection for each concentration tested is represented.
Biotinylated Difco polyclonal antibody (100 µg/ml) was used to capture cells. Cy5
labeled Difco polyclonal antibody (10 µg/ml) was used to detect the captured cells. Mean
LOD was 30.8.
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FIGURE 45. Normalized values for the mean signals shown in figure 44.
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Isolation of S. aureus from Seawater
Samples of seawater from North Shore beach and Courtney Campbell Causeway
beach were collected, filtered and enriched for the presence of S. aureus as described in
Materials and Methods. Briefly, 100 ml samples (diluted and undiluted) were filtered
through a 0.45 µm filter and the filter was placed onto Baird Parker agar. Any black
colonies were gram stained and then further tests were performed to identify any
potential S. aureus isolates. Only 12 isolates were identified as S. aureus and stored in
glycerol and TSB at -80 °C.
Specificity Assays for S. aureus Detection
Two antibodies were tested for purposes of assay development. A polyclonal rabbitanti-S. aureus antibody from Maine Biotechnology Services Inc and a monoclonal
antibody against peptidoglycan from Chemicon International, Temecula CA were tested
against viable and dead cells of S. aureus (Figure 46). These tests were performed by Dr.
Marianne Kramer, University of South Florida, Tampa, FL. The monoclonal antibody
did not show good affinity for S. aureus. Based on these results, further specificity
studies were performed using the Maine Biotechnology polyclonal antibody.
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FIGURE 46. Screening of S. aureus commercial antibodies. Cells were boiled for 20
minutes and allowed to cool before assaying with ELISA. All antibodies were assayed at
10 µg/ml.
The Maine Biotechnology polyclonal antibody was tested for crossreactivity with other
species of Staphylocococcus (Figure 47) using ELISA. A signal to noise ratio over 2 was
considered a positive result. All the organisms tested were crossreactive with this
polyclonal antibody; however, S. aureus gave much stronger signals. This antibody was
used to develop the biosensor assay for S. aureus.
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FIGURE 47. Crossreactivity studies with other Staphylococcus species. The Maine
Biotechnology polyclonal aantibody was tested at 10 µg/ml on ELISA. A signal to noise
ratio over 2.0 was required for a value to be considered positive.

Biosensor Sandwich Immunoassays for S. aureus.
Waveguides were prepared as described in Materials and Methods. The Maine
Biotechnology polyclonal antibody used in the biosensor assay for S. aureus failed to
detect S. aureus to any degree. Figure 48 and 49 is data from three different experiments.
The mean signals did not increase in proportion to the increase in cell concentrations
assayed and no detection of S. aureus was observed at any concentration (Figure 48).
The mean LOD was 68.2. Normalized signals failed to show any distinctive pattern of
detection either (Figure 49). This assay was not pursued any further due to the lack of a
high affinity antibody.
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FIGURE 48. Detection of S. aureus using biosensor sandwich immunoassay. Mean
fluorescence (pAmps) over the limit of detection for each concentration tested are
represented.
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FIGURE 49. Normalized values for the mean signals shown in figure 48.
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DISCUSSION
The U.S. Environmental Protection Agency has set forth strict guidelines with respect
to recreational water quality and the degree of contamination which is permissible. Fecal
indicator bacteria provide an estimation of the amount of feces in the water, and
indirectly, the presence and quantity of fecal pathogens in the water. Enterococci have
been recommended as one of the most accurate indicators of seawater quality. In
accordance with EPA regulations, a single sample containing >105 CFU/100ml
(~1 CFU/ml) of enterococci is indicative of a high degree of fecal contamination and,
therefore, could pose a dangerous threat to the health of the swimming public (261). This
danger is not due to the presence of enterococci, which can be pathogenic themselves, but
more so because the presence of this particular bacterium indicates the possibility that
other, more pathogenic bacteria and viruses of fecal origin could be present in the water
as well.
Indicator organisms, particularly E. coli, have been assayed for over a century to
assess water quality because these organisms are consistently found in the feces of
warmblooded animals. In the infancy of the science of waterborne diseases, a test for
specific pathogens such as V. cholerae did not exist. Since Escherich’s discovery of the
abundance of E. coli in fecal matter, contaminated water has been analyzed by assessing
concentrations of fecal indicator bacteria (79). Presently, assays for indicator organisms
are routinely performed and preferred to assays for pathogenic microorganisms because
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they are easy, inexpensive, do not require skilled personnel and depending on the
indicator, and indicator bacteria densities have been found to correlate with the incidence
of bather illness. There are several emerging and reemerging waterborne pathogens that
are becoming of increasing public health concern. Many of those bacteria, viruses, and
protozoans were listed in Table 4. While assays for indicator organisms are convenient
and easy, they are a preventative measure and tests for pathogenic microorganisms are
also necessary, especially when a waterborne disease outbreak occurs. Such was the case
in New Orleans during recent Hurricane Katrina where cases of Vibrio vulnificus
infections were reported to the CDC (34).
Conventional methods for the detection and enumeration of enterococci and other
pathogenic bacteria have largely been culture based. Methods for detecting enterococci
include membrane filtration and enrichment on mEI agar and the Enterolert most
probable number system. As explained previously, these methods are simple, user
friendly, do not require highly skilled personnel and give results within 24-48 hours.
However, colonies obtained from the membrane filtration technique are routinely
confirmed through biochemical tests which add an extra day or longer for final results.
The Enterolert system is unable to detect very low levels of enterococci since all samples
need to be diluted 10-fold before testing (71). Special equipment is also needed to run
this test. In spite of the advantages and disadvantages of culture methods, bacteria have
evolved in such a way that culture based methods may not accurately depict the extent of
contamination by these bacteria in the environment. Research is now revealing that any
method developed for the detection of bacteria in the environment needs to be designed
to take into account conditions in the environment and how these conditions affect the
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organism. The viable but non-culturable (VBNC) phenomenon, for example, has been
observed in many bacteria including the enterococci, E. coli O157:H7, and Vibrio
cholerae (37, 106, 233). The VBNC phenomenon results from a drastic change in
environmental conditions such as changes in temperature or nutrients which stresses the
bacteria and renders them unculturable. Conventional culture techniques cannot account
for these VBNC bacteria. Furthermore, these bacteria while unculturable still can be
capable of causing disease if they find the right host.
Due to the limitations of culture methods, molecular and immunological methods are
being increasingly researched. Immunomagnetic separation (IMS) has been used to
rapidly detect low levels of E. coli O157:H7 and Salmonella typhimurium in food, water
and feces (15, 40, 257, 282). This method is simple and requires little expertise. Rapid
immunodiagnostic test kits using monoclonal antibodies to V. cholerae O1 such as the
Cholera-Screen coagglutination test (52) and Cholera SMART from New Horizons
Diagnostics, a colloidal gold based colorimetric test (109), have proved highly specific
and sensitive when compared to culture methods. A direct fluorescent antibody
technique using monoclonal antibodies labeled with fluorescein isothiocyanate is able to
detect 1.5 x 102 CFU/ml of V. cholerae O139 in water when combined with filtration
(108).
Molecular methods such as PCR have been used to detect V. cholerae and
Enterococcus faecalis in seawater and simulated seawater (111, 169, 220). PCR has been
used to detect V. cholerae cells and toxin genes in raw oysters and in synthetic seawater
with much success (6 to 8 CFU per gram in oysters and 10 CFU per gram in seawater)
(169, 211). Some studies have even shown the ability to detect 10 CFU per gram of
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oyster homogenate (139). PCR has obvious advantages such as sensitivity, specificity
and rapidity of results however, there are limitations to the technique. The presence of
inhibitors in the environment, which can interfere with the assay, is a large problem when
rapid results from a dirty sample are desired. Additional steps to clean up and purify a
sample add extra time to the assay. More importantly, the fact that PCR cannot
distinguish between live and dead cells is one of the biggest disadvantages of this
technique. Nonpathogenic dead cells would be detected along with viable cells and could
lead to an inaccurate assessment of a particular sample. If those bacteria are nonviable
cells from a previous contamination event, results could lead to unsubstantiated beach
closings. Other nucleic acid techniques are finding a place in the field of rapid detection.
Fluorescent in situ hybridization (FISH) is a method used to identify bacteria with a high
degree of specificity. FISH uses fluorophore-labeled nucleic acid probes complementary
to a specific rRNA sequence in a particular bacterium to visibly identify the organism.
This method has been used in combination with membrane filtration in a technique called
microcolony filter hybridization to more rapidly identify indicator bacteria such as E.
coli, S. aureus and enterococci (156, 177, 178, 198). In this method, a volume of water is
filtered through a 0.45 µm filter and pre-enriched on selective media. Cells are then fixed
with formaldehyde and nucleic acid probes are introduced to hybridize with a target
sequence. The membranes are then visualized using a fluorescent microscope. An
advantage to using probes targeted to rRNA sequences is the flexibility of probe
specificity. By targeting regions of greater or lesser conservation, probes can be designed
to be specific at a kingdom, genus, or species specific level (156). While novel, this
technique differs in efficiency between gram positive and gram negative cells. Due to the
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thicker cell wall of gram positive bacteria, added steps are required to allow the probe to
enter the cell in these organisms. This adds time to the overall procedure. The sensitivity
of this assay is high and 102-105 cells/membrane are usually necessary (245). FISH using
peptide nucleic acid probes has been used to detect 104 CFU of E. coli with high
specificity (245). This technique also offers the added benefit that if multiple probes are
used with different conjugated fluorophores, multiplexing can be achieved (198). While
molecular and immunological methods have proven to be comparable in sensitivity and
specificity to culture methods, they often require preenrichment of up to 24 hours for
positive detection. The method developed in this study was no exception.
Very low levels of enterococci in water can be indicative of larger amounts of fecal
contamination in beachwater. With the many epidemiological studies and reviews which
have been published correlating the incidence of disease in bathers to the levels of
enterococci in seawater, the development of rapid and specific methods to detect low
levels of enterococci in environmental samples has become more important and
necessary (25, 72, 95, 259, 265). Few if any immunoassays have been described for the
detection of enterococci in seawater. The primary goal of this study was to detect the low
levels of enterococci required by EPA guidelines using an immunoassay format and an
evanescent wave fiber optice biosensor. This could not be achieved using the biosensor
alone and, therefore, sample concentration and enrichment were required.
An evanescent wave fiber optic biosensor, the Analyte 2000, was used to detect
enterococci in unspiked samples of seawater. The limit of detection of the sandwich
assay was 1.5 x 107 CFU/ml when Enterococcus cells were sonicated for a minimum of
10 minutes. An indirect assay format was developed where by Enterococcus cells were
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adsorbed directly onto the polystyrene waveguide and detected using a specific antibody
and a Cy5 labeled anti-IgG. Using this method, 1 x 106 CFU/ ml of enterococci could be
consistently detected in PBS (pH 7.4) and in environmental seawater samples. Neither
method alone was successful in detecting the low levels of enterococci required by the
U.S. Environmental Protection Agency. Sample concentration methods and enrichment
were used to improve the assay sensitivity.
A guideline was developed to assess environmental samples for water quality based
on enrichment times in mE broth and biosensor detection. In accordance with this
guideline, environmental water samples were assayed through concentration, enrichment
and biosensor detection. Environmental water samples were collected in 20 liter volumes
from two Gulf Coast beaches known to consistently yield samples of poor quality. When
concentrated with a hollow fiber filter and subsequent enriched in mE broth, water
samples containing as few as 6 CFU/100ml of enterococci could be detected with the
Analyte 2000 biosensor in 16-24 hours and determined to be water of good quality. This
result was found to correlate with the criteria set forth in the guideline developed in
simulated water quality experiments. The biosensor assay alone, excluding enrichment
and sample preparation, took only 10 minutes total. The anti-Strep group D antibody
(American Research Products) was found to crossreact significantly with only S. aureus
cells. The nature of this crossreactivity was attributed mainly to nonspecific binding of
the primary antibody used to the protein A molecules found on the surface of S. aureus.
This crossreativity has been noted in other immunoassays developed to specifically detect
S. aureus (100). Crossreactivity could be eliminated to an extent by blocking the protein
A binding sites on S. aureus cells with another species of IgG. In this study, horse serum
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was used as a blocking agent. Crossreactivity could not be completely eliminated using
this method.
Studies were also conducted to test the efficiency of the hollow fiber filtration step of
the assay. This process consistently concentrated water 100-fold and recovery was found
to vary between 13% and greater than 100% depending on the concentration of the initial
inoculum. Lower recoveries were observed for lower concentrations of cells where the
loss was more evident due precisely to the fact that lower cells are present and loss is
more evident in this realm. Only one non-target bacterium, Vibrio alginolyticus, was
found to enrich along with the enterococci in mE enrichment broth. This organism was
assayed on ELISA with the anti-Strep group D antibody to check for cross-reactivity and
no significant cross reaction was found.
While this integrated method was successful at detecting low levels of enterococci
directly from seawater, this method could not be used alone without confirmatory
biochemical tests. This is because of the cross-reactivity that was found to exist between
the anti-Strep group D antibody and other organisms such as S. aureus. Five percent of
the colonies obtained from viable counts on mEI agar were inoculated on bile esculin
agar and into Brain Heart Infusion broth with 6.5 % Nacl to confirm that they were
enterococci. This type of confirmation must be done in all immunoassays not just the one
developed in this study because of antibody crossreactivity.
A secondary goal of this project was to analyze water samples collected from two of
the most highly contaminated beaches around Tampa Bay for the presence of Vibrio
cholerae, E. coli O157:H7, and Staphylococcus aureus. Furthermore, biosensor assays
were developed to detect these pathogens which could be potentially shed in the water
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simultaneously with enterococci. Standard assay methods for total coliforms in seawater
could not be used to isolate E. coli O157:H7 from seawater as the common temperature
to isolate these organisms is 44.5°C. This temperature was too high for the growth of
E. coli O157:H7. Maximum growth temperature for E. coli O157:H7 is 41.5- 42.5 °C
(96, 208). Ultimately, methods were modified to optimize chances of isolating E. coli
O157:H7. Immunomagnetic separation has been used to recover E. coli O157:H7 with
great success from food, fecal samples, and water, so this method was employed to try
and recover the organism from seawater (15, 40, 257, 282). No isolates of E. coli
O157:H7 were found in the waters from Courtney Campbell Causeway beach and North
Shore Beach.
The Analyte 2000, evanescent wave fiber optic biosensor was used to detect the
pathogenic E. coli O157:H7, Vibrio cholerae O1 and S. aureus in PBS and seawater. A
sandwich immunoassay format was used to detect E. coli O157:H7 in seawater and was
able to detect the organism at 105 CFU/ml. The zero tolerance policy of the FDA for
E. coli O157:H7 in food matrices necessitates the improvement of assay sensitivity for
rapid detection in food. Similar low detection limits are required for water contaminated
with E. coli O157:H7 because the infectious dose of E. coli O157:H7 is thought to be
very low (50 CFU>) (254).
Isolates of V. cholerae and S. aureus were obtained from environmental water
samples taken from Courtney Campbell Causeway beach in Clearwater, FL and North
Port beach in St. Petersburg FL. Sixty seven isolates were confirmed as V. cholerae
through PCR. None of the isolates were V. cholerae O1 strains as determined by slide
aggluntination with V. cholerae O1 antiserum. Twelve isolates of
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S. aureus were also recovered from the two Gulf beaches using culture methods. A
suggested direction for this part of the project would be to further characterize the
presence or absence of toxin genes in the 67 Vibrio cholerae isolates and to test the
S. aureus isolates for methicillin resistance. The presence of these pathogens in marine
waters further substantiated the development of rapid assays for the detection and
monitoring of these organisms in seawater. The sensitivity of the biosensor sandwich
immunoassay for V. cholerae O1 was 1.6 x 109 CFU/ml.

The evanescent wave fiber

optic biosensor was evaluated for detection of S. aureus in seawater as well. This attempt
was not successful in PBS and was not pursued further because a high quality antibody
was not available.
Many limitations to the developed biosensor assays were observed in this study. For
instance, inherent variability exists between polystyrene waveguides made by the
manufacturer for the Analyte 2000 biosensor. This however, was not the root of the
sensitivity issues for the biosensor assay for enterococci and the other organisms tested.
One factor was the evanescent wave biosensor itself. Any assay based on evanescent
wave principles is limited by the distance of that evanescent wave. The evanescent wave
of the Analyte 2000 biosensor extended ~100 nm from the surface of the waveguide so
anything outside of that evanescent wave was not detected. Bacteria are large in size
(enterococci are approximately 1.5 µm in length) and any antibodies attached to the cells
that are outside the evanescent wave could not be detected (216). In an assay format
where capture and detection antibodies already compete for epitopes on the target
antigen, the potential area for antibody binding is reduced greatly by the limitations of the
evanescent wave. This handicap was overcome to some extent by using the indirect assay
147

format with signal amplification to detect enterococci. Signal amplification could bypass
the effects of the evanescent wave phenomenon by increasing the signal of those
antibodies which are bound to the target within the evanescent wave. This was done in
this study by using a fluorophore labeled anti-IgG.
The biggest limiting factor in the Enterococcus, Vibrio cholerae O1, and S. aureus
assays was the lack of high quality antibodies. As with all immunoassays, the test is only
as good as the antibody and antigen. If either one is less than optimal, than the success of
the assay is compromised. The antibody used in assays for V. cholerae O1 was found to
be very crossreactive with several other organisms, especially Vibrio alginolyticus, and,
in previous studies, it has been found that the KPL polyclonal anti-E. coli O157:H7
antibody minimally crossreacted with E. hermanii (63). A high quality antibody to
S. aureus cells could not be found and, therefore, the assay was unsuccessful.
Compounding this problem is that any antibody used in an immunoassay for S.aureus
would be problematic due to non-specific binding of the Fc portion of the antibody to
protein A on the surface of S. aureus cells. Specificity in any immunoassay for S. aureus
would be compromised and methods to overcome this would need to be developed. This
would include finding a way to block those protein A binding sites.
As for the enterococci, two antibodies were commissioned for use in optimizing the
biosensor assay for enterococci. They were made by immunizing mice and rabbits with
boiled cell preparations of Ent. faecalis and Ent. faecium. The first antibody created was
a monoclonal antibody made by the Hybridoma Core Laboratory at the University of
Florida, Gainesville, FL. This process failed to yield a high affinity IgG for use on the
biosensor assay. IgM produced from this process was tested on the biosensor using the
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sandwich immunoassay format and detection was not improved. The other antibody was
a polyclonal antibody made by a commercial source (Strategic Biosolutions) which
showed high affinity for cells of Ent. faecalis when screened through ELISA. On further
analysis through Western blot, it was found that this antibody was specific for one
primary target on the Ent. faecalis cells. When compared to the American Research
Products (ARP), polyclonal anti-Strep group D antibody, the custom-made antibody was
found to be inferior. The ARP antibody showed high affinity for several targets on the
Enterococcus cells. In theory, this antibody would allow for the maximum capture of
cells and would minimize competition between capture and detection antibodies for the
same epitopes (Figure 13). One future direction for this part of the Enterococcus project
would be to further research and characterize all the epitopes for which the ARP
antibodies showed highest affinity. Those proteins or carbohydrates could then be
isolated and used to create several monoclonal antibodies to be combined later on to
make a custom prepared polyclonal antibody. The success of this procedure could yield a
more specific and higher affinity antibody which could improve the sensitivity of the
Enterococcus assay.
Within the past decade, research has revealed many new characteristics about the
enterococci. First, the enterococci have been found to subsist embedded in sediments and
sand which would make counts obtained from water underestimates of the actual counts
that are in the environment (92). Second, enterococci have been known to enter a viable
but non culturable state and attach to copepods much like V. cholerae does to enhance
their survival under nutrient limiting conditions (164, 173, 231-233) These findings drive
the need to move away from or at least add to culture based methods of detection which
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probably underestimate Enterococcus concentrations in the water. This of course is a
double edged sword with detection of indicators. While it is desirable to be able to
completely enumerate enterococci in seawater at any given time, if VBNC enterococci
are present in the environment, their detection could compromise risk assessment. The
inability to distinguish the presence of enterococi due to current contamination event
from those presnt from a previous contamination event could lead to unnecessary beach
closings. These are all factors which must be considered when developing methods for
the detection of indicators of fecal pollution.
Viable but nonculturable cells present a unique problem for the biosensor and any
immunoassay geared toward the detection of bacteria. Antibodies for these assays are
made to specific epitopes and antigens on the surface of a bacterial cell. Many bacteria
undergo physiological changes when in the viable but non culturable state which can lead
to changes in antigenicity and cell surface structure. However, an immunoassay format
for detection of enterococci in seawater is feasible even when cells are in a VBNC state.
The group D antigen is consistently produced by Enterococcus cells, even when the cells
go VBNC. In fact, it has been observed that teichoic acid production in these cells
increases when they are in the VBNC state (86, 233). This would certainly work to the
benefit of an immunoassay as antibodies could bind cells even in times of stress. E. coli
O157:H7, has been found to undergo structural changes that could interfere with an
immunoassay. The antibody used in assay development is directed against the O antigen
of the cells. This antigen has been found to be shed and not produced when these cells
are in the VBNC state, however, verotoxin can still be produced (106). This structural
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change presents a problem because the immunoassay would not be able to detect the cells
that are still virulent.
VBNC V. cholerae is less of a concern in immunoassay development. As described
previously, this state has been shown to affect the production of O antigen in E. coli
O157:H7 affecting the ability of an antibody to bind to the target cell. The antiserum
used in this study was created against the O antigen of V. cholerae, calling into question
whether these VBNC cells may not be detected when assayed by immunological
methods. Research has shown that the loss of O antigen is not a problem with V.cholerae
in the VBNC state as these cells do not lose O antigenicity when they are under these
stressed conditions (37). However, a limitation of the biosensor assay for V. cholerae
would be the inability to detect nonagglutinable V. cholerae which does not react with O1
antiserum. While these vibrios are not as highly pathogenic as O1 V. cholerae, they have
been found to cause disease. This is a limitation for any immunoassay for V. cholerae,
not just the biosensor assay. Other supplemental methods such as culture or molecular
methods would be needed to detect these vibrios.
There are several ways that the fiber optic biosensor assay could be improved in
order to make this method more feasible for field use. The most important factor would
be to improve the sensitivity of the assays by several log concentrations. One way to
address this problem would be to search for alternative capture and detection molecules
besides antibodies. One such alternative would be to model the fluorescent in situ
hybridization technique (FISH) described above and use DNA or PNA probes specific for
the 16S rRNA region of the enterococci labeled with a fluorescent molecule (120, 177,
178, 255). Advandx Inc. (Woburn, MA) has developed such a system for detecting
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Ent. faecalis using a fluorescein isothiocyanate (FITC) labeled PNA probe. The system
is intended for use in blood culture however, it could be tested for use in other matrices.
Although this system has been developed for use on a microscope slide, it could be
adapted for use in cell suspension and ultimately, for use on the biosensor. Aptamers
which are unique antibody-like nucleic acids are also promising nucleic acid alternatives
which could be used to improve biosensor assays.
Several molecules could be suggested as specific alternative capture and detection
molecules for enterococci. For example, enterococci have been found in clinical studies
to bind biological molecules (extracellular matrix proteins) found in the human body such
as collagen, fibronectin, fibrinogen, and vitronectin (186, 217, 278). Bacterial surface
adhesions called MSCRAMMs (microbial surface components recognizing adhesive
matrix molecules) have been found in isolates of Ent. faecalis and Ent. faecium. One
such molecule, Ace, in Ent. faecalis binds collagen (206). One of these molecules could
potentially be used as a capture molecule much like lectins were used in this study. A
specific antibody could then be used for the detection step. Also, human mannose
binding protein has been found to bind the liptoeichoic acid of gram positive bacteria
including enterococci, so this molecule is also an alternative for capture and detection of
enterococci (205). Lectins could also be tested as alternative capture molecules in the
assays for V. cholerae, E. coli O157:H7 and S. aureus since they were not done so in this
study.
Another way to improve assay sensitivity would be to add the sensitivity of PCR to
the immunoassay. One way to accomplish this would be to employ the use of a more
novel technique, immuno polymerase chain reaction (immuno-PCR). This method
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developed by Sano et al. combines the specificity of both nucleic acids and antibodies
into a versatile ELISA (219). In immuno-PCR, antibodies are linked to specific nucleic
acid sequences. Using a standard sandwich immunoassay format, target antigen is
captured by an antibody. An antibody tagged with a specific nucleic acid sequence is
used to detect the captured target. Then nucleotides, primer, and polymerase are added to
the mix and the specific DNA sequence attached to the detection antibody is amplified
and used to generate a fluorescent signal using a real time PCR machine. Immuno-PCR
has been used to detect protein A of S. aureus with much success (113). This
methodology could be applied to the biosensor assay described in this study as a
confirmatory method and a method of signal amplification. It has been shown in our
laboratory by Dr. Joyce Simpson, a postdoctoral fellow, that PCR can be performed on
captured cells on the waveguide when the waveguide is cut into pieces (235). This
method could be used to try immuno-PCR on captured cells as well.
Novel methods are being studied and developed everyday for the detection and
recovery of enterococci in water and these methods could potentially be adapted for
biosensor detection. Chemiluminescence has been discovered in enterococci when the
bacteria are grown in the presence of a fermentable sugar and this property is now being
developed as a method to try and detect fecal contamination in water (7).
Chemiluminescence is based on the detection of photon emission produced by a chemical
such a luminol in response to oxygen metabolites. In the case of the enterococci, it was
found that when the respiratory chain is impaired, extracellular superoxide is generated
and can react with luminol to generate a chemiluminescent signal (7). This property
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could be used in an array type biosensor format using a camera which could detect the
chemiluminescent signal.
Emerging biosensor technologies offer the opportunity to further expand detection
assays. DNA microarrays have been developed as a way to detect multiple targets at
once. The principle behind microarray technology is that DNA probes can be
synthesized and patterned onto a glass slide for the detection of a specific cDNA
sequence. The patterned slide is exposed to the test sample labeled with either a
radioactive label or a fluorescent tag and a signal is generated or not based on the
hybridization event. This technique has been used for years to monitor and record gene
expression in different types of clinical research and now is being applied to pathogen
detection in environmental samples (28, 197). This technology has already been used to
detect disease agents, but instead of DNA, antibodies were patterned onto a slide (216,
249). Multiplex methods such as a microarray would allow for the simultaneous
monitoring of all suggested indicator organisms not just enterococci, and specific agents
of waterborne disease such as V. cholerae O1, E. coli O157:H7, and S. aureus. It has
already been done to detect Staphylococcus enterotoxin B, ricin, Francisella tularensis,
and Bacillus globigii using a portable version of the biosensor used in this study, the
RAPTOR (5). An approach like this would also be very helpful for epidemiological
studies because they are always being conducted to try and correlate the incidence of
disease caused by specific pathogens to the densities of indicator organisms in water.
There are many future directions for this project. The first would be to attempt a
study to determine the origin of fecal contamination at the Courtney Campbell beach in
Clearwater. Scott etal. recently reported the use of a host associated molecular marker
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(esp; enterococcal surface protein) in Ent. faecium which could be used as an index of
human fecal pollution (222). This could be a way in which to ascertain if indicator
bacteria are present in the water due to human fecal contamination. Another recent study
of Pensacola beach, addressed not only source-tracking of contamination at the beach, but
also the survival of enterococci in the swash zone interstitial waters (92). The swash
zone is described as the area on shore where the waves continuously wash up on the sand.
This swash zone is known to harbor generally higher densities of organisms than the
actual water (85, 122, 227). This becomes a problem because people spend more time on
the beach rather than in the actual water. Analyzing the swash zone for higher densities
of enterococci at Courtney Campbell beach would be a worthy direction to pursue, as this
beach is lacking in restrooms and pets are allowed on the beach at all times. While it has
been shown in this study that V. cholerae and S. aureus can be isolated from the seawater
in Tampa Bay, these data should be followed up with a study to track the abundance of
these organisms in the water.
A rapid assay for the detection of S. aureus and E. coli O157:H7 in seawater is both
desirable and necessary for the prevention of illness. The swimming public is exposed to
numerous potential health hazards that could end up in serious infection unless a rapid
method is developed to preempt the danger. S. aureus has been frequently isolated from
recreational waters using culture based methods (4). The need for rapid methods of
detection of S. aureus is necessary, especially now with the emergence of methicillin
resistant Staphylcoccocus aureus (MRSA) and their isolation from marine waters (39).
There is a real need not only to develop methods to rapidly detect low levels of S. aureus
but also to assess the prevalence of S. aureus in seawater. A study addressing the
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abundance of S. aureus in Tampa Bay seawater could add to research that this organism
is and indicator of contamination that should be routinely monitored for in seawater
(281).
The majority of water related outbreaks of E. coli O157:H7 have been due to
contaminated freshwater and drinking water. At least one study in the past has suggested
that toxigenic E. coli is not a health risk associated with coastal waters (148). While not
a prevalent health risk, enterotoxigenic E. coli has caused beachwater related illness in at
least two instances. The first beach water outbreak of E. coli O157:H7 took place in the
United Kingdom in 1999 (107). Since then, there has also been an outbreak reported at a
beach in Montreal in 2001 (22). These outbreaks necessitate the need for a rapid assay
for E. coli O157:H7 in seawater especially in those instances of disease outbreak.
Currently, outbreaks of cholera are ongoing in West Africa and are constantly being
reported to the World Health Organization (WHO). Some of those African countries
include Benin, Mauritania, and Mali. In Guinea alone, 1956 cases were reported from
mid-July to September of this year. Of those cases, 72 resulted in death (276). Kaper
et al. found in 1982 that there was a resident toxigenic strain of V. cholerae in the Gulf
coast (128). It is for this reason that there is a need for screening and detection methods
to monitor this bacterium in seawater. There is a requirement for rapid, specific, and
sensitive methods for detecting V. cholerae in shellfish as well as in water, particularly in
the third world. Methods such as these are especially necessary for the complete
assessment of seawater due to the presence of VBNC cells. The infectious dose of Vibrio
cholerae in food is between 104 and 107 CFU, but in seawater the infectious dose is 1010
CFU because of the absence of food which can absorb stomach acid and improve the
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chances of survival of the cells in the body (33). The biosensor immunoassay could be
used as a screening tool for consistent monitoring of beach water so that when
temperatures started to increase and optimum conditions for the proliferation of V.
cholerae in the environment arose, this shift could be detected and illness could be
prevented. The biosensor has the potential to specifically detect low levels of V. cholerae
in seawater and seafood as well if a high quality antibody can be found.
Biosensors are currently being used in marine science to detect various pollutants
including algal toxins (brevetoxins, saxitoxin) (31), pesticides (264), phosphates (78),
pathogens (150), and trace metals (lead, zinc, cadmium) (118, 166, 214) directly from sea
water which can many times be a very complex matrix. Biosensor immunoassays are
ideal for the detection of small molecules like toxins or pesticides; however, detection
sensitivity can be affected with large target analytes such as bacteria. This problem can
be resolved to some extent through signal amplification techniques and the use of novel
capture and detection molecules; however, the task of detecting very low concentrations
of microorganisms in a complex matrix without the use of selective enrichment will
remain difficult. The low numbers of enterococci required by the EPA to designate a
beach uncontaminated or minimally contaminated necessitates a sensitive method for
detection. In the method developed in this study, such low levels of detection could be
obtained using the Analyte 2000 biosensor in combination with sample concentration and
selective enrichment in mE broth for 8-24 hours. The biosensor assay alone took only 10
minutes after the samples was attached to the waveguide and results could be obtained in
24 hours or less. This method could serve as an efficient preliminary screening tool for
the assessment of recreational water quality.
157

REFERENCES
1.

Aarestrup, F., P. Butaye, and W. Witte. 2002. Nonhuman reservoirs of
enterococci, p. 55-99. In M. S. Gilmore (ed.), The Enterococci: Pathogenesis,
Molecular Biology, and Antibiotic Resistance. ASM Press, Washington, D.C.

2.

Aarestrup, F. M., F. Bager, and J.S. Andersen. 2000. Association between the
use of avilamycin for growth promotion and the occurrence of resistance among
Enterococcus faecium from broilers: epidemiological study and changes over
time. Microb. Drug. Resis. 6: 71-75.

3.

Aldova, E., K. Laznickova, E. Stepankova, and J. Lietava. 1968. Isolation of
nonagglutinable Vibrios from an enteritis outbreak in Czechoslovakia. J. Infect.
Dis. 118: 25-31.

4.

Amercan Public Health Association. 1995. Standard methods for the
examination of water and wastewater, 19 ed. American Public Health
Association, Washington D.C.

5.

Anderson, G. P., K.D. King, K.L. Gafney, and L.H. Johnson. 2000. Multianalyte interrogation using the fiber optic biosensor. Biosens. Bioelectron. 14:
771-777.

6.

Anderson, K. L., J.E. Whitlock, and V.J. Harwood. 2005. Persistence and
diffferential survival of fecal indicator bacteria in subtropical waters and
sediments. Appl. Environ. Microbiol. 71: 3041-3048.

7.

Andre, P., C. Metzger, S. Petey, D. Muller, and D.J-M. Vidon. 2005.
Chemiluminescence of enterococci isolates from freshwater. FEMS Microbiol.
Lett. 245: 123-129.

8.

Andreotti, P. E., G.V. Ludwig, A.H. Peruski, J.J. Tuite, S.S. Morse, and L.F.
Peruski Jr. 2003. Immunoassay of infectious agents. Biotech. 35: 850-859.

9.

Andrewes, F. W., and T.J. Horder. 1906. A study of the streptococci pathogenic
for man. Lancet 2: 708-713.

10.

Archibald, A. R., and H. E. Coapes. 1971. The interaction of Concanavalin A
with teichoic acids and bacterial walls. J. Biochem. 123: 665-667.
158

11.

Aslan, K., J.R. Lakowicz, and C.D. Geddes. 2004. Nanogold-plasmonresonance-based glucose sensing. Anal. Biochem. 330: 145-155.

12.

Baddiley, J., and A. L. Davison. 1961. The occurrence and location of teichoic
acids in Lactobacilli. J. Gen. Microbiol. 24: 295-299.

13.

Bager, F., M. Madsen, J. Christensen, and F.M. Aarestrup. 1997. Avoparcin
used as a growth promoter is associated with the occurrence of vancomycinresistant Enterococcus faecium on Danish poultry and pig farms. Prev. Vet. Med.
31: 95-112.

14.

Barua, D. 1992. History of cholera, p. 1-36. In D Barua and W.B. Greenough III
(ed.), Cholera. Plenum Medical Book Co., New York.

15.

Bennett, A. R., S. MacPhee, and R.P. Betts. 1996. The isolation and detection
of Escherichia coli O157:H7 by use of immunomagnetic separation and
immunoassay. Lett. Appl. Microbiol. 22: 237-243.

16.

Bennish, M. L. 1994. Cholera: pathophysiology, clinical features, and treatment,
p. 229-255. In P. A. Blake, I.K. Wachsmuth, and O. Olsvik (ed.), Vibrio cholerae
and Cholera: Molecular to Global Perspectives. ASM Press, Washington D.C.

17.

Blake, P. A. 1994. Endemic cholera in Australia and the United States, p. 309319. In I.K. Wachsmuth, P.A. Blake, and O. Olsvik (ed.), Vibrio cholerae and
Cholera: Molecular to Global Perspectives ASM Press, Washington, D.C.

18.

Boutelle, M. G., H. Allen, O. Hill, M. Berners, R. John, P.D. Dobson, and P.
Leigh 1996. New technologies for amperometric biosensors. J. Mol. Recognit. 9:
664-71.

19.

Bradley, D. 1977. Health aspects of water supplies in tropical countries. p. 3-17.
Water, Wastes, and Health in Hot Countries. John, Wiley, and Sons Ltd., London.

20.

Brandt, O., J. Feldner, A. Stephan, M. Schroder, M. Schnolzer, H. F.
Arlinghaus, J.D. Hoheisel, and A. Jacob. 2003. PNA microarrays for
hybridisation of unlabelled DNA samples. Nucleic Acids Research. 31: 1-9.

21.

Brandt, O., and J. D. Hoheisel. 2004. Peptide nucleic acids on microarrays and
other biosensors. Trends in Biotechnology 22: 617-622.

22.

Bruneau, A. 2004. Outbreak of E. coli O157:H7 associated with bathing at a
public beach in the Montreal-Centre region. Can. Commun. Dis. Rep. 30: 133136.

159

23.

Buchanan, R. L., and M. P. Doyle. 1997. Foodborne disease significance of
Escherichia coli O157:H7 and other enterohemorrhagic E.coli. Foodtechnol. 51:
69-76.

24.

Budnick, G. E., R.T. Howard, and D.R. Mayo. 1996. Evaluation of Enterolert
for enumeration of enterococci in recreational waters. Appl. Environ. Microbiol.
62: 3881-3884.

25.

Cabelli, V. J. 1983. Health effects criteria for marine recreational waters. U.S.
Environmental Protection Agency publication no. EPA-600/1-80-031. Office of
Research and Development, U.S. Environmental Protection Agency, Washington,
D.C.

26.

Cabelli, V. J., A.P. Dufour, L.J. McCabe, and M.A. Levin. 1982. Swimmingassociated gastroenteritis and water quality. Am. J. Epidemiol. 115: 606-616.

27.

Calamita, H., B.P. Thuan, M. Kemper, G. Buck, A.M. Calderon de la Barca,
and R.J. Doyle. 2000. Drift in lectin reactivity of group D Streptococci between
the years 1983 and 1998 In D. Rogers (ed.), Lectins, Biology, Biochemistry,
Clinical Biochemistry, vol. 14, Hellerup.

28.

Call D.R., M. K. Borucki., and F.J. Loge. 2003. Detection of bacterial
pathogens in environmental samples using DNA microarrays. J. Microbiol. Met.
53: 235-243.

29.

Carmon, K. S., R.E. Baltus, and L.A. Luck. 2005. A biosensor for estrogenic
substances using the quartz crystal microbalance. Anal. Biochem. 345: 277-283.

30.

Carrillo, C. 1991. Difference between toxigenic Vibrio cholerae O1 from South
America and U.S. gulf coast. The Lancet 337: 1097-1098.

31.

Carter, R. M. 1993. Immunoelectrochemical biosensors for detection of
saxitoxin and brevetoxin. Immunometh. 3: 128-133.

32.

Carter, R. M., M.B. Jacobs, and G.J.Lubrano 1995. Piezoelectric detection of
ricin and affinity purified goat anti-ricin antibody. Anal. Lett. 28: 1379-1386.

33.

Cash, R. A., S.I. Music, J.P. Libonati, M.J. Snyder, R.P. Wenzel, and R.B.
Hornick. 1974. Response of man to infection with Vibrio cholerae. I. Clinical
serologic, and bacteriologic responses to a known inoculum. J. Infect. Dis. 129:
45-52.

34.

Centers for Disease Control and Prevention. 2005. Vibrio illnesses after
hurricane Katrina-multiple states, August-September 2005. Morbid. Mortal.
Weekly Rep. 54: 1-4.
160

35.

Centers for Disease Control and Prevention. 1991. Cholera-Peru. Morbid.
Mortal. Weekly Rep. 40: 108-109.

36.

Centers for Disease Control and Prevention. 1999. Laboratory methods for the
diagnosis of epidemic dysentery and cholera. p. 41-54. Division of Bacterial and
Mycotic Diseases, Atlanta.

37.

Chaiyanan, S., A. Huq, T. Maugel, and R.R. Colwell 2001. Viability of the
nonculturable Vibrio cholerae O1 and O139. Syst. Appl. Microbiol. 24: 331-341.

38.

Chalmers, R. M., H. Aird, and F.J. Bolton. 2000. Waterborne Escherichia coli
O157:H7. J. Appl. Microbiol. 88: 124-132.

39.

Chambers, H. F. 2001. The changing epidemiology of Staphylococcus aureus?
Emerg. Infec. Dis. 7: 178-182.

40.

Chapman, P. A., A.T. Cerdan Malo, C.A. Siddons, and M. Harkin 1997. Use
of commercial enzyme immunoassays and immunomagnetic separation systems
for detecting Escherichia coli O157 in bovine fecal samples. Appl. Environ.
Microbiol. 63: 2549-2553.

41.

Charles, K., N. Ashbolt, C. Ferguson, D. Roser, R. McGuinness, and D.
Deere. 2003. Centralised versus decentralised sewage systems: a comparison of
pathogen and nutrient loads released into Sydney's drinking water catchments.
Water. Sci. Technol. 48: 53-60.

42.

Charych, D. 1999. Biochromic polydiacetylene synthetic membranes, p. 1-24. In
V. C. Yang (ed.), Biosensors and Their Applications. Kluwer Academic/Plenum
Publishers, New York.

43.

Charych D.H., J. O. Nagy, W. Spevak, and M.D. Bednarski. 1993. Direct
colorimetric detection of a receptor-ligand interaction by a polymerized bilayer
assembly. Science. 261: 585-588.

44.

Chen, D., Y. Cao, B. Liu, and J. Kong. 2002. A BOD biosensor based on a
microorganism immobilized on an Al203 sol-gel matrix. Anal. Bioanal. Chem.
372: 737-739.

45.

Cheung, W. H. S., K.C.K. Chang, and R.P.S. Hung. 1989. Health effects of
beach water pollution in Hong Kong. Epidemiol. Infect. 105: 139-162.

46.

Choopun, N., V. Louis, A. Huq, and R.R. Colwell. 2002. Simple procedure for
rapid identification of Vibrio cholerae from the aquatic environment. Appl.
Environ. Microbiol. 68: 995-998.
161

47.

Chun, J., A. Huq, and R.R. Colwell. 1999. Analysis of 16S-23S rRNA
intergenic spacer regions of Vibrio cholerae and Vibrio mimicus. Appl. Environ.
Microbiol. 65: 2202-2208.

48.

Clark, L. C., and C. Lyons. 1962. Electrode systems for continuous monitoring
in vascular surgery. Ann. NY Acad. Sci. 102: 29-45.

49.

Clarke, S. H., and R. Rudikoff. 1984. Evidence for gene conversion among
immunoglobulin heavy chain variable region genes. J. Exp. Med. 159: 773-782.

50.

Cole, H. B., J.W. Ezzell, K.F. Keller, and R.J. Doyle. 1984. Differentiation of
Bacillus anthracis and other Bacillus species by lectins. J. Clin. Microbiol. 19:
48-53.

51.

Colwell, R. R. 2004. Infectious disease and environment: cholera as a paradigm
for waterborne disease. International Microbiol. 7: 285-289.

52.

Colwell, R. R., J.A.K. Hasan, A. Huq, L. Loomis, R.J. Siebeling, M. Torres,
S. Galvez, S. Islam, M. Tamplin, and D. Bernstein. 1992. Development and
evaluation of a rapid, simple, sensitive, monoclonal antibody-based
coagglutination test for direct detection of Vibrio cholerae O1. FEMS Microbiol.
Lett. 97: 215-220.

53.

Corbett, S. J., G.L. Rubin, G.K. Curry, and D.G, Kleinbaum. 1993. The
health effects of swimming at Sydney beaches. Am. J. Pub. Health 83: 17011706.

54.

Cowburn, J. K., T. Goodall, E.J. Fricker, K.S.Walter, and C.R. Fricker.
1994. A preliminary study of the use of colilert for water quality monitoring. Lett.
Appl. Microbiol. 19: 50-52.

55.

Coyette, J., and L.E. Hancock. 2002. Enterococcal cell wall, p. 177-218. In M.
S. Gilmore (ed.), The Enterococci: Pathogenesis, Molecular Biology, and
Antibiotic Resistance. ASM Press, Washington, D.C.

56.

Dakin, W. P. H., D.J. Howell, R.G.A. Sutton, M.F. O'Keefe, and P. Thomas.
1974. Gastroenteritis due to non-agglutinable (non-cholera) Vibrios. Med. J. Aust.
2: 487-490.

57.

Danbing, K., F.J. Picard, F. Martineau, C. Menard, P.H. Roy, M. Ouellette,
and M. G. Bergeron. . 1999. Development of a PCR assay for the rapid detection
of enterococci. J. Clin. Microbiol. 37: 3497-3503.

162

58.

Daniels, L., R.S. Hanson, and J.A. Phillips. 1994. Chemical analysis, p. 518519. In R. G. E. Murray, W.A. Wood, and N.R. Krieg (ed.), Methods for general
and molecular bacteriology. ASM Press, Washington D.C.

59.

Dao, M. 1985. An improved method of antigen detection on nitrocellulose: in situ
staining of alkaline phosphatase conjugated antibody. J Immunol Methods 82:
225-231.

60.

De, S., I.G. Macara, and D.A. Lannigan. 2005. Novel biosensors for the
detection of estrogen receptor ligands. The J. Ster. Biochem. and Mol. Biol. 96:
235-244.

61.

De Vaux, A., G. Laguerre, C. Divies, and H. Prevost. 1998. Enterococcus
assini sp. nov. isolated from the caecum of donkeys. Int. J. Syst. Bacteriol 48:
383-387.

62.

Deibel, R. H. 1964. The group D Streptococci. Bacteriol. Rev. 3: 330-366.

63.

DeMarco, D. R., and. D. V. Lim. 2002. Detection of Escherichia coli O157:H7
in 10- and 25- gram ground beef samples with an evanescent wave biosensor with
silica and polystyrene waveguides. J. Food. Prot. 65: 596-602.

64.

DeMarco, D. R., and D. V. Lim. 2001. Direct detection of Escherichia coli
O157:H7 in unpasteurized apple juice with an evanescent wave biosensor. J Rap.
Meth. Auto. Microbiol. 9: 241-257.

65.

DePaola, A. 1992. Isolation of Latin American epidemic strain of Vibrio cholerae
O1 from the U.S. Gulf Coast. Lancet 339: 624-625.

66.

Devriese, L. A., B. Pot, and M.D. Collins. 1995. Phenotypic identification of the
genus Enterococcus and differentiation of phylogenetically distinct enterococcal
species groups. J. Appl. Bacteriol. 75: 399-408.

67.

Devriese, L. A., K. Ceyssens, U.M. Rodrigues, and M.D. Collins. 1990.
Enterococcus columbae, a species from pigeon intestines. FEMS Microbiol. Lett.
71: 247-252.

68.

Dible, H. 1921. The Enterococcus and the faecal streptococci: their properties and
relations. J. of Pathol. Bacteriol. 24: 3-12.

69.

Donaldson, K. A., M.F. Kramer, and D.V. Lim. 2004. A rapid detection
method for Vaccinia virus, the surrogate for smallpox virus. Biosens. Bioelectron.
20: 322-327.

163

70.

Doyle, R. J., and M. Slifkin. 1989. Applications of lectins in microbiology. ASM
News 55: 655-658.

71.

Eckner, K. F. 1998. Comparison of membrane filtration and multiple tube
fermentation by the Colilert and Enterolert methods for the detection of
waterborne coliform bacteria, Escherichia coli, and enterococci used in drinking
and bathing water quality monitoring in southern Sweden. Appl. Environ.
Microbiol. 64: 3079-3083.

72.

Efstratiou, M. A., A. Mavridou, S.C. Richardson, and J.A. Papadakis. 1998.
Correlation of bacterial indicator organisms with Salmonella spp., Staphylococcus
aureus and Candida albicans in sea water. Lett. Appl. Microbiol. 26: 342-346.

73.

Elliot, E. L., C. A. Kaysner, L. Jackson, and M.L. Tamplin. 1995.
Bacteriological analytical manual , 8th ed. AOAC International. Gaithersburg,
MD.

74.

Elliot, S. D. 1959. Group and type specific polysaccharides of group D
Streptococci. Nature 184: 1342.

75.

Elliot, S. D. 1962. Teichoic acid and the group antigen of group D streptococci.
Nature. 193: 1105-1106.

76.

Elliot, S. D. 1960. Type and group polysaccharides of group D Streptococci. J.
Exp. Med. 111: 621.

77.

Emanuel, P. A., J. Dang, J.S. Gebhardt, J. Aldrich, E.A. Garber, H. Kulaga,
P. Stopa, J.J. Valdes, and A. Dion-Schultz. 2000. Recombinant antibodies: a
new reagent for biological agent detection. Biosens. and Bioelectron. 14: 751759.

78.

Engblom, S. O. 1998. The phosphate sensor. Biosens. Bioelectron. 13: 981-994.

79.

Escherich, T. 1887. Ueber darmbakterien im allgemeinen and diejenige der
sauglings im besonderen, sowie der beziehungen der letzteren zur aetiologiebder
darmerkrankungen. Centralblatt. fur. Bakteriologie. 1: 705-713.

80.

Exall, K., J. Marsalek, and K. Schaefer 2004. A review of water reuse and
recycling, with reference to Canadian practice and potential: 1. incentives and
implementation. Water. Qual. Res. J. Can. 39: 1-12.

81.

Facklam, R. R., M. da Gloria, S. Carvalho, and L.M. Teixeira. 2002. History,
taxonomy, biochemical characteristics, and antibiotic susceptibility testing of
enterococci, p. 1-54. In M. S. Gilmore (ed.), The Enterococci; Pathogenesis,
Molecular Biology, and Antibiotic Resistance ASM Press, Washington, D.C.
164

82.

Faruque, S. M., and G.B. Nair. 2002. Molecular ecology of toxigenic Vibrio
cholerae. Microbiol. Immunol. 46: 59-66.

83.

Fattal, B., E. Peleg-Olvesky, T. Agurshy, and H.I. Suval. 1987. The association
between sea water pollution as measured by bacterial indicators and morbidity of
bathers at Mediterranean beaches in Israel. Chemosphere 16: 565-570.

84.

Feng, P., and P. A. Hartman. 1982. Fluoregenic assays for immediate
confirmation of Escherichia coli. Appl. Environ. Microbiol. 43: 1320-1329.

85.

Ferguson, D. M., D.F. Moore, M.A. Getrich, and M.H. Zhowandi. 2005.
Enumeration and speciation of enterococci found in marine and intertidal
sediments and coastal water in southern California. J. Appl. Microbiol. 99: 598608.

86.

Fischer, W. 1988. Physiology of lipoteichoic acids in bacteria. Adv. Microbial
Phys. 29: 233-296.

87.

Florida Department of Environmental Protection, Bureau of Watershed
Management. 2004. Integrated water quality assessment for Florida: 2004 305
(b) Report and 303 (d) list update. Tallahassee, FL.

88.

Francy, D. S., O.D. Simmons III, M.W. Ware, E.J. Granger, M.D. Sobsey,
and F.W. Schaefer III. 2004. Effects of seeding procedures and water quality on
recovery of Cryptosporidium oocysts from stream water by using U.S.
environmental protection agency method 1623. Appl. Environ. Microbiol. 70:
4118-4128.

89.

Fujioka, R., B. Roll, and M. Byappanahalli. 1997. Appropriate recreational
water quality standards for Hawaii and other tropical regions based on
concentrations of Clostridium perfringens. In Proceedings of WEF-TEC 97, 70th
Annual Conference and Exposition, Water Environment Federation, Alexandria,
VA 4: 405-411.

90.

Fujioka, R. S. 2002. Microbial indicators of marine recreational water quality, p.
234-243. In R. L. Crawford, C.J. Hurst, G.R. Knudsen, M.J. McInerney, and L.D.
Stetzenbach (ed.), Manual of Environmental Microbiology, 2nd ed. ASM Press,
Wasington, D.C.

91.

Geng, T., M.T. Morgan, and A.K. Bhunia. 2004. Detection of low levels of
Listeria monocytogenes cells by using a fiber-optic immunosensor. Appl.
Environ. Microbiol. 70: 6138-6146.

165

92.

Genthner, F. J., J.B. James, D.F. Yates, and S. D. Friedman. 2005. Use of
composite data sets for source-tracking enterococci in the water column and
shoreline intersitial waters on Pensacola Beach, FL. Marine Poll. Bull. 50: 724732.

93.

Gessel, P. D., N.C. Hanson, S.M. Goyal, L.J. Johnston, and J. Webb. 2004
Persistence of zoonotic pathogens in surface soil treated with different rates of
liquid pig manure. Appl. Soil. Ecol. 25: 237-243.

94.

Glaser, R. W. 1999. Surface plasmon resonance biosensors, p. 195-212. In V. C.
Yang (ed.), Biosensors and Their Applications. Kluwer Academic/ Plenum
Publishers, New York.

95.

Godfree, A. F., D. Kay, and M.D. Wyer. 1997. Faecal streptococci as indicators
of faecal contamination in water. J. Appl. Microbiol. 83: 110-119.

96.

Gonthier, A., Guerin-Faublee, B. Tilly, and M.L Delignette-Muller. 2001.
Optimal growth temperature of O157 and non-O157 Escherichia coli strains. Lett.
Appl. Microbiol. 33: 352-356.

97.

Goodgame R.W., and. W. B. Greenough III. 1975. Cholera in Africa: a
message from the west. Ann. Intern. Med. 82: 101-106.

98.

Gordon, A. M. 1970. Cholera in the new world. J. Ky. Med. Assoc. 68: 657.

99.

Graham, K., K. Keller, J. Ezzell, and R. Doyle 1984. Enzyme-linked
lectinosorbent assay (ELLA) for detecting Bacillus anthracis. Eur. J. Clin.
Microbiol. 3: 210-212.

100.

Guidry, A. J., K.E. Squiggins, W.F. Vann, and D.C. Westhoff. 1991.
Prevention of nonspecific binding of immunoglobulin to Staphylococcus aureus
protein A in ELISA assays. J. Immunol. Meth. 143: 159-165.

101.

Guilbault, G. G. 1983. Determination of formaldehyde with an enzyme coated
piezoelectric crystal. Anal. Chem 55: 1682-1684.

102.

Halamek, J., J. Pribyl, A. Makower, P. Skladal, and F.W. Scheller. 2005.
Sensitive detection of organophosphates in river water by means of a piezoelectric
biosensor. Anal. Bioanal. Chem. 382: 1904-1911.

103.

Halverson, K., R.G. Panchal, T.L. Nguyen, R. Gussio, S.F. Little, M.
Misakian, S. Bavari, and J.J. Kasianowicz. 2005. Anthrax biosensor, protective
antigen ion channel asymmetric blockade. J. Biol. Chem. 280: 34056-34062.

166

104.

Hammonds, S. J., T.J. Easterbrook, and M.B. McIllmurray. 1991.
Differentiation of enterococci from other group D streptococci by means of a
specific monoclonal antibody. FEMS Microbiol. Lett. 82: 91-94.

105.

Hancock, L. E., and M. S. Gilmore. 2000. Pathogenicity of enterococci, p. 251258. In V. A. Fischetti (ed.), Gram Positive Pathogens. ASM Press, Washington
D.C.

106.

Hara-Kudo, Y., M. Miyahara, and S. Kumagai. 2000. Loss of O157 O
antigenicity of verotoxin-producing Escherichia coli O157:H7 surviving under
starvation conditions. Appl. Environ. Microbiol. 66: 5540-5543.

107.

Harrison, S., and S. Kinra. 2004. Outbreak of Escherichia coli O157 associated
with a busy bathing beach. Commun. Dis. Pub. Health 7: 47-50.

108.

Hasan, J. A. K., A. Huq, B. Nair, S. Garg, A.K. Mukhopadhyay, L. Loomis,
D. Bernstein, and R. R. Colwell. 1995. Development and testing of monoclonals
antibody-based rapid immunodiagnostic test kits for direct detection of Vibrio
cholerae O139 synonym Bengal. J. Clin. Microbiol. 33: 2935-2939.

109.

Hasan, J. A. K., A. Huq, M.L. Tamplin, R.J. Siebeling, and R. R. Colwell.
1994. A novel kit for rapid detection of Vibrio cholerae O1. J Clin. Microbiol. 32:
249-252.

110.

Haugland, R. A., S.C., Siefring, L.J. Wymer, K.P. Brenner, and A. P. Dufour.
2005. Comparison of Enterococcus measurements in freshwater at two
recreational beaches by quantitative polymerase chain reaction and membrane
filter culture analysis. Water Res. 39: 559-568.

111.

He, J. W., and S. Jiang. 2005. Quantification of enterococci and human
adenoviruses in environmental samples by real-time PCR. Appl. Environ.
Microbiol. 71: 2250-2255.

112.

Hitchins, A. D., P.Feng, W.D. Watkins, S.R. Rippey, and L.A. Chandler.
1995. Escherichia coli and the coliform bacteria. AOAC. Bacteriological
analytical manual, 8th ed. Gaithersburg, MD.

113.

Huang, S. H., and T. C. Chang. 2004. Detection of Staphylocococcus aureus by
a sensitive immuno-PCR assay. Clin. Chem. 50: 1673-1674.

114.

Huber, M., U. Vor Dem Esche, R. Grunow, and W.G. Bessler. 2005.
Generation of mouse polyclonal and human monoclonal antibodies against
Bacillus anthracis toxin. Drugs Exp. Clin. Res. 31: 35-43.

167

115.

Huq, A., E.B. Small, P.A. West, M.I. Huq, R. Rahman, and R.R. Colwell.
1983. Ecological relationships between Vibrio cholerae and planktonic crustacean
copepods. Appl. Environ. Microbiol. 45: 275-283.

116.

Ikebukuro K., A. Miyata, S.J. Cho, Y. Nomura, S.M. Chang, Y. Yamauchi,
Y. Hasebe, S. Uchiyama, and I. Karube. 1996. Microbial cyanide sensor for
monitoring river water. J. Biotechnol. 48: 73-80.

117.

Isobe, K. O., M. Tarao, N. H. Chiem, L.Y. Minh, and H. Takada. 2004. Effect
of environmental factors on the relationship between concentrations of
coprostanol and fecal indicator bacteria in tropical (Mekong Delta) and temperate
(Tokyo) freshwaters. Appl. Environ. Microbiol. 70: 814-821.

118.

Ivask, A. 2002. Construction and use of specific luminescent recombinant
bacterial sensors for the assessment of bioavailable fraction of cadmium zinc,
mercury, and chromium in soil. Soil. Biol. Biochem. 34: 1439-1447.

119.

Jackson, D. E., W. Wong, M.T. Largen, and G.D. Shockman. 1984.
Monoclonal antibodies to immunodeterminants of lipoteichoic acids. Infec.
Immun. 43: 800-803.

120.

Jansen, G.J., M. Mooibroek, J. Idema, H.J. M., Harmsen, G.W. Welling, and
J.E. Degener. 2000. Rapid identification of bacteria in blood cultures by using
fluorescently labeled oligonucleotide probes. J. Clin. Microbiol. 38: 814-817.

121.

Jiang, S.C., and W. Fu. 2001. Seasonal abundance and distribution of Vibrio
cholerae in coastal waters quantified by a 16S-23S intergenic spacer probe.
Microb. Ecol. 42: 540-548.

122.

Jin, G., A.J. Englande, H. Bradford, and H.W. Jeng. 2004. Comparison of
E.coli,enterococci, and fecal coliform as indicators for brackish water quality
assessment. Water Environ. Res. 76: 245-255.

123.

Johnson, W. M., H. Lior, and G.S. Bezanson. 1983. Cytotoxic Escherichia coli
O157: H7 associated with haemorrhagic colitis in Canada. Lancet i:76.

124.

Jolivet-Reynaud C., A. A., S. Michel, G. Deleage, G. Paranhos-Baccala, V.
Gonin, N. Battail-Poirot, X. Lacoux , and D. Rolland. 2004. Characterization
of mimotopes mimicking an immunodominant conformational epitope on the
hepatitis C virus NS3 helicase. J. Med. Virol. 72: 385-395.

125.

Jones, D. and P. M. Shattock. 1960. The location of the group D antigen of
Streptococcus. J. Gen. Microbiol. 23: 335-343.

168

126.

Joseph, R., and G. D. Shockman. 1975. Cellular localization of lipoteichoic acid
in Streptococcus faecalis. J. Bacteriol. 122: 1375-1386.

127.

Josephson, S. L., M.W. Stinson, S.J. Millar, and R.E. Cohen. 1986.
Purification of lipoteichoic acid by chromatography in water-organic solvent
systems. Infec. Immun. 51: 378-384.

128.

Kaper, J. B., H.B. Bradford, N.C. Roberts, and S. Falkow. 1982. Molecular
epidemiology of Vibrio cholerae in the U.S. Gulf Coast. J. Clin. Microbiol. 16:
129-134.

129.

Kaper, J. B., J.P. Nataro, N.C. Roberts, R.J. Siebeling, and H.B. Bradford.
1986. Molecular epidemiology of non-O1 Vibrio cholerae and Vibrio mimicus in
the U.S. Gulf coast region. J. Clin. Microbiol. 23: 652-654.

130.

Karch, H., C. Janetzki-Mittman, A. Aleksic, and M. Datz. 1996. Isolation of
enterohemorrhagic Escherichia coli O157:H7 strains from patients with hemolytic
uremic syndrome by using immunmagnetic separation, DNA-based methods, and
direct culture. J. Clin. Microbiol. 34: 516-519.

131.

Kay, B. A., C.A. Bopp, and J.G. Wells. 1994. Isolation and identification of
Vibrio cholerae O1 from fecal specimens, p. 3-25. In P. A. Blake, I.K.
Wachsmuth, O. Olsvik (ed.), Vibrio cholerae and cholera: Molecular to Global
Perspectives. ASM Press, Washington, D.C.

132.

Kaysner, C. A., and A. DePaola Jr. 2004. V. cholerae, V. parahaemolyticus, V.
vulnificus, and other Vibrio spp. AOAC. Bacteriological analytical manual, 8th ed.
Gaithersburg, MD.

133.

Kaysner, C. A., and W.E. Hill. 1994. Toxigenic Vibrio cholerae O1 in food and
water, p. 27-39. In P. A. Blake, I.K. Wachsmuth, and O. Olsvik (ed.), Vibrio
cholerae and Cholera: Molecular to Global Perspectives. ASM Press, Washington
D.C.

134.

Kirby, R., E.J. Cho, B. Gehrke, T. Bayer, Y.S. Park, D.P. Neikirk, J.T.
McDevitt and A.D. Ellington. 2004. Aptamer-based sensor arrays for the
detection and quantitation of proteins. Anal. Chem 76: 4066-4075.

135.

Kissinger, P. T. 2005. Biosensor-a perspective. Biosens. Bioelectron. 20: 25122516.

136.

Klapes, N. A. 1983. Comparison of Vogel-Johnson and Baird-Parker Media for
membrane filtration recovery of Staphylococci in swimming pool water. Appl.
Environ. Microbiol. 46: 1318-1322.
169

137.

Klein, E., and A.C. Houston. 1899. Twenty-eighth annual report of the local
government board containing the report of the medical officer. Her majesty's
stationary office.

138.

Knox, K. W., and A. J. Wicken. 1973. Immunological properties of teichoic acid
Bacteriol. Rev. 37: 215-257.

139.

Koch, W. H., W. L. Payne, B. A. Wentz, and T.A. Cebula. 1993. Rapid
polymerase chain reaction method for detection of Vibrio cholerae in foods. Appl.
Environ. Microbiol. 59: 556-560.

140.

Kohler, G., and C. Milstein. 1975. Continuous cultures of fused cells secreting
antibody of predefined specificity. Nature 256: 495-497.

141.

Konig, B., and M. Gratzel. 1994. A novel immunosensor for herpes viruses.
Anal. Chem. 66: 341-344.

142.

Kramer, M. F., and D.V. Lim. 2004. A rapid and automated fiber optic based
biosensor assay for the detection of Salmonella in spent irrigation water used
inthe sprouting of sprout seeds. J. Food. Prot. 67: 46-52.

143.

Kronick, M. N., and W. A. Little. 1975. New immunoassay based on
fluorescence excitation by internal reflection spectroscopy. J. Immunol. Meth. 8:
235-240.

144.

Kubitschko, S., J. Spinke, T. Bruckner, S. Pohl, and N. Oranth. 1997.
Sensitivity enhancement of optical immunosensors with nanoparticles. Anal.
Biochem. 253: 112-122.

145.

Kubo, I., M. Inagawa, T. Sugawara, Y. Arikawa, and I. Karube. 1991.
Phosphate sensor composed from immobilized pyruvate oxidase and an oxygen
electrode. Anal. Lett. 24: 1711-1727.

146.

Lancefield, R. C. 1940. Specific relationship of cell composition to biological
activity of hemolytic streptococci. Harvey Lect. 36: 251.

147.

Lee, J. H., R.J. Mitchell, B.C. Kim, D.C. Cullen, and M.B. Gu. 2005. A cell
array biosensor for environmental toxicity analysis. Biosens. Bioelectron. 21:
500-507.

148.

Lee Lang, A., Y. Tsai, C.L. Mayer, K.C. Patton, and C.J. Palmer. 1994.
Multiplex PCR for detection of the heat-labile toxin gene and shiga-like toxin I
and II genes in Escherichia coli isolated from natural waters. Appl. Environ.
Microbiol. 60: 3145-3149.
170

149.

LeJeune, J. T., T.E. Besser, D.H. Rice, and D.D. Hancock. 2001. Methods for
the isolation of water-borne Escherichia coli. Lett. Appl. Microbiol. 32: 316-320.

150.

Leonard, P. 2003. Advances in biosensors for detection of pathogens in food and
water. Enzyme Microb. Technol. 32: 3-13.

151.

Leriche, V. P. S., and B. Carpentier 2000. Use of enzyme-linked lectinsorbent
assay to monitor the shift in polysacharide composition in bacterial biofilms.
Appl. Environ. Microbiol. 66: 1851-1856.

152.

Leslie, R. G. Q., and S. Cohen. 1970. Chemical properties of guinea-pig
immunoglobulins G1, G2, and M. Biochem. J. 120: 787-795.

153.

Levin, M. A., J.R. Fischer, and V.J. Cabelli. 1975. Membrane filter technique
for enumeration of enterococci in marine water. Appl. Microbiol. 30: 66-71.

154.

Levin, M. M., J.P. Kaper, D. Herrington, J. Ketley, G. Losonsky, C.O.
Tacket, B. Tall, and S. Cryz. 1983. New knowledge on pathogenesis of bacterial
enteric infections as applied to vaccine development. Microbiol. Rev. 47: 510550.

155.

Levine, W. C., and P. M. Griffin. 1993. Vibrio infections on the Gulf Coast:
results of first year of regional surveillance. J. Infect. Dis. 167: 479-483.

156.

Lewis, G. D., S. A. Anderson, and S.J. Turner. 2002. Detection of Enterococci
in freshwater and seawater (16S and 23S rRNA Enterococcus oligonucleotide
probes). Methods in Mol. Biol. 179: 159-169.

157.

Lim, D. V. 2003. Detection of microorganisms and toxins with evanescent wave
fiber-optic biosensors. Proceedings of the IEEE 91: 902-907.

158.

Lim, D. V., J.M. Simpson, E.A. Kearns, and M.F. Kramer. 2005. Current and
developing technologies for monitoring agents of bioterrorism and biowarfare.
Clin. Microbiol. Rev. 18: 583-607.

159.

Lin, H. C., and W. C. Tsai. 2003. Piezoelectric crystal immunosensor for the
detection of staphylococcal enterotoxin B. Biosens. Bioelectron. 18: 1479-1483.

160.

Lipp, E. K., A. Huq, and R.R. Colwell. 2002. Effects of global climate on
infectious disease: the cholera model. Clin. Microbiol. Rev. 15: 757-770.

161.

Lipp, E. K., I.N.G., Rivera, A.I. Gil, E.M., Espeland, N. Choopun, V.R.
Louis, E. Russek-Cohen, A. Huq, and R.R. Colwell. 2003. Direct detection of
Vibrio cholerae and ctx A in Peruvian coastal water and plankton by PCR. Appl.
Environ. Microbiol. 69: 3676-3680.
171

162.

Liu, J., and Y. Lu. 2004. Colorimetric biosensors based on DNAzyme-assembled
gold nanoparticles. J. Fluoresc. 14: 343-354.

163.

Liu, Y., and Y. Li. 2002. Detection of Escherichia coli O157:H7 using
immunomagnetic separation and absorbance measurement. J. Microbiol. Met. 51:
369-377.

164.

Lleo, M. M., B. Bonato, M.C. Tafi, C. Signoretto, M. Boaretti, and P.
Canepari. 2001. Resuscitation rate in different enterococcal species in the viable
but non-culturable state. J. Appl. Microbiol. 91: 1095-1102.

165.

Lobitz, B., L. Beck, A. Huq, B. Wood, G.Fuchs, A.S.G. Faruque, and R.
Colwell. 2000. Climate and infectious disease: use of remote sensing for detection
of V. cholerae by indirect measurement. PNAS 97: 1438-1443.

166.

Lu, Y. 2003. New highly sensitive and selective catalytic catalytic DNA
biosensors for metal ions. Biosens. Bioelectron. 18: 529-540.

167.

Lucht, A., R. Grunow, C. Otterbein, P. Moller, H. Feldmann, and A. Becker.
2004. Production of monoclonal antibodies and development of an antigen
capture ELISA directed against the envelope glycoprotein GP of Ebola virus.
Med. Microbiol. Immunol. 193: 181-187.

168.

Luque de Castro, M. D., and M.C. Herrera. 2003. Enzyme Inhibition based
biosensors and biosensing systems: questionable devices. Biosens. Bioelectron.
18: 279-294.

169.

Lyon, W. J. 2001. TaqMan PCR for detection of Vibrio cholerae O1, O139, NonO1, and Non-O139 in pure cultures, raw oysters, and synthetic seawater. Appl.
Environ. Microbiol. 67: 4685-4693.

170.

Maekawa, S. M., M. Yoshioka, and Y. Kumamoto. 1992. Proposal of a new
scheme for the serological typing of Enterococcu faecalis strains. Microbiol.
Immunol. 36: 671-681.

171.

Manero, A., and A. R. Blanch. 1999. Identification of Enterococcus spp. with a
biochemical key. Appl. Environ. Microbiol. 65: 4425-4430.

172.

Masarova, J., E.S. Dey, and B. Danielsson. 2004. Optical lectin based biosensor
as tool for bacteria identification. Pol. J. Microbiol. 53: 23-27.

173.

Maugeri, T. L., M. Carbone, M.T. Fera, G.P. Irrera, and C. Gugliandolo.
2004. Distribution of potentially pathogenic bacteria as free living and plankton
associated in a marine coastal zone. J. Appl. Microbiol. 97: 354-361.
172

174.

McCafferty, J., A. D. Griffiths, G. Winter, and D.J. Chiswell. 1990. Phage
antibodies: filamentous phage displaying antibody variable domains. Nature. 348:
552-554.

175.

McFadden, P. 2002. Broadband biodetection: holmes on a chip. Science. 297:
2075-2076.

176.

Mcgowan, K., E. Wickersham, and N.A., Strockbine. 1989. Escherichia coli
O157:H7 from water. The Lancet 1: 967-968.

177.

Meier, H. 1998. Detection and identification of indicator bacteria using rRNA
targeted probes. Presented at the OECD Workshop Molecular Methods for Safe
Drinking.

178.

Meier, H., C. Koob, W. Ludwig, R. Amann, E. Frahm, S. Hoffman, U. Obst,
and K.H. Schleifer. 1997. Detection of enterococci with rRNA targeted DNA
probes and their use for hygienic drinking water control. Wat. Sci. Tech 35: 437444.

179.

Messer, J. W., and A. P. Dufour. 1998. A rapid, specific membrane filtration
procedure for enumeration of enterococci in recreational water. Appl. Environ.
Microbiol. 64: 678-680.

180.

Mintz, E. D., T. Popovic, and P.A. Blake. 1994. Transmission of Vibrio
cholerae O1, p. 345-356. In P. A. Blake, I.K. Wachsmuth, and O. Olsvik (ed.),
Vibrio cholerae and Cholera: Molecular to Global Perspectives. ASM Press,
Washington, D.C.

181.

Minunni, M. G. G. Guilbault., and B. Hock. 1995. The quartz crystal
microbalance as a biosensor. Anal. Lett. 28: 411-419.

182.

Miyagi, K., K. Omura, A. Ogawa, M. Hanafusa, Y. Nakano, S. Morimatsu,
and K. Sano. 2001. Survival of Shiga-toxin producing Escherichia coli O157:H7
in marine water and frequent detection of the shiga toxin gene in marine water
samples from an estuary port. Epidemiol. Infect. 126: 129-133.

183.

Molitoris, E., S.W., Joseph, M.I., Krichevsky, W. Sindhuhardja, and R.R.
Colwell. 1985. Characterization and Distribution of Vibrio alginolyticus and
Vibrio parahaemolyticus isolated in Indonesia. Appl. Environ. Microbiol. 50:
1388-1394.

184.

Morris, G. J., and R.E. Black. 1985. Non-O group 1 Vibrio cholerae: a look at
the epidemiology of an occasional pathogen. Epidemiol. Rev. 12: 179-191.

173

185.

Nakamura, H., and I. Karube. 2003. Current research activity in biosensors.
Anal. Bioanal. Chem. 377: 446-468.

186.

Nallapareddy, S. R., G.M. Weinstock, and B.E.Murray. 2003. Clinical isolates
of Enterococcus faecium exhibit strain-specific collagen binding mediated by
Acm, a new member of the MSCRAMM family. Mol. Microbiol. 47: 1733-1747.

187.

Nataro, J. P., and J. B. Kaper. 1998. Diarrheagenic Escherichia coli. Clin.
Microbiol. Rev. 11: 142-201.

188.

National Research Council of the National Academies. 2004. Indicators for
waterborne pathogens. The National Academies Press, Washington D.C.

189.

Nielsen, P. E., M. Egholm, R.H. Berg, and O. Buchardt 1991. Sequenceselective recognition of DNA by strand displacement with a thymine-substituted
polyamide. Science 254: 1497-1500.

190.

Noble, R. T., D.F. Morre, M.K. Leecaster, C.D. McGee, and S.B. Weisberg.
2003. Comparison of total coliform, fecal coliform, and enterococcus bacterial
indicator response for ocean recreational water quality testing. Water Res. 37:
1637-1643.

191.

Noble, R. T., M.K. Leecaster, C.D. McGee, S.B. Weisberg, and K. Ritter.
2004. Comparison of bacterial indicator analysis methods in stormwater affected
coastal waters. Water Res. 38: 1183-1188.

192.

Noble, R. T., S.B. Weisberg, M.K. Leecaster, C.D. Mcgee, K. Ritter, K.O.
Walker, and P.M. Vainik. 2003. Comparison of beach bacterial water quality
indicator measurement methods. Environ. Mon. Assess. 81: 301-312.

193.

O'Sullivan, C. K., and G.G. Guilbault. 1999. Piezoelectric immunosensors:
theory and applications, p. 159-173. In V. C. Yang (ed.), Biosensors and Their
Applications. Kluwer Academic/Plenum Publishers, New York.

194.

Ogert, R. A., J.E. Brown, B.R. Singh, L.C. Shriver-Lake, and F.S. Ligler.
1992. Detection of Clostridium botulinum toxin A using a fiber optic based
biosensor. Anal. Biochem. 205: 306-312.

195.

Orla-Jensen, S. 1919. The lactic acid bacteria. Mem. Acad. Roy. Sci. Danemark.
Sec. Sci. Ser. 5: 81-197.
Paitan, Y., D. Biran, I. Biran, N. Shechter, R. Babai, J. Rishpon, and E.Z.
Ron. 2003. On-line and in-situ biosensors for monitoring environmental
pollution. Biotech. Adv. 22: 27-33.

196.

174

197.

Pancrazio, J. J., J.P. Whelan, D.A. Borkholder, W. Ma, and D. A. Stenger.
1999. Development and application of cell-based biosensors. Ann.Biomed. Eng.
27: 697-711.

198.

Perry-O'Keefe, H., S. Rigby, K. Oliveira, D. Sorensen, H. Stender, J. Coull,
and J.J. Hyldig-Nielsen. 2001. Identification of indicator microorganisms using
a standardized PNA FISH method. J. Microbiol. Methods 47: 281-292.

199.

Peterson, K. M., and J.J. Mekalanos. 1988. Characterization of the Vibrio
cholerae Tox R regulon: identification of novel genes involved in intestinal
colonization. Infec. Immun. 56: 2822-2829.

200.

Peterson, M. E., B.J. Yokel, and D.V. Lim. 1984. Recovery of Selected
Pathogens from Naples Bay, Florida, and Associated Waterways. Estuaries 7:
133-138.

201.

Pfeffer, C., and J. D. Oliver. 2003. A comparison of thiosilphate-citrate-bile
salts-sucrose (TCBS) agar and thiosulphate-chloride-iodide (TCI) agar for the
isolation of Vibrio species from estuarine environements. Lett. Appl. Microbiol.
36: 150-151.

202.

Pini, A., and L. Bracci. 2000. Phage display of antibody fragments. Curr.
Protein. Pept. Sci. 1:155-169.

203.

Pless, D. D., E.R. Torres, E.K. Reinke, S. Bavari. 2001. High-affinity,
protective antibodies to the binding domain of botulinum neurotoxin type A.
Infec. Immun. 69: 570-574.

204.

Pollitzer, R. 1959. Cholera, Monograph no. 43. World Health Organization.

205.

Polotsky, V. Y., W. Fischer, R. Alan, B. Ezekowitz, and K.A. Joiner. 1996.
Interactions of human mannose-binding protein with lipoteichoic acid. Infec.
Immun. 64: 380-383.

206.

Ponnuraj, K., Y. Xu, D. Moore, C.S.Champion, L. Boque, M. Hook, S. V.L.
Narayana. 2002. Crystallization and preliminary X-ray crystallographic analysis
of Ace: a collagen binding MSCRAMM from Enterococcus faecalis. Biochimica.
Biophysica. Acta. 1596: 173-176.

207.

Rabbani, G. H., and W.B. Greenough. 1999. Food as a vehicle of transmission
of cholera. J. Diarrhoeal Dis. Res 17:1-9.

208.

Raghubeer, E. V., and J. R. Matches. 1990. Temperature range for growth of
Escherichia coli serotype O157:H7 and selected coliforms in E.coli medium. J.
Clin. Microbiol. 28: 803-805.
175

209.

Ramamurthy, T., S. Garg, R. Sharma, S.K. Bhattacharya, G.B. Nair, T.
Shimada, T. Takeda, T. Karasawa, H. Kurazano, A. Pal, and Y. Takeda.
1993. Emergence of novel strain of Vibrio cholerae with epidemic potential in
southern and eastern India. Lancet 341: 703-704.

210.

Reidl, J., and K. E. Klose. 2002. Vibrio cholerae and cholera:out of the water
and into the host. FEMS Microbiol Rev 26: 125-139.

211.

Ren, S., Y. Qin, X. Zhang, D. Lin, B. Yan, and W. Wang. 1996. Rapid
detection of cholera toxin gene of Vibrio cholerae O1 by polymerase chain
reaction. Chin. Med. J. 109: 494-496.

212.

Riley, L. W., R.S. Helgerson, S.D. McGee, H.B. Wells, J.G. Davis, B.R.
Hebert, R.J. Olcott, H.M., Johnson, L.M. Hargrett, N.T. BLake, and P.A.
Cohen 1983. Hemorrhagic colitis associated with a rare Escherichia coli
serotype. N. Engl. J. Med. 308: 681-685.

213.

Rivera, S. C., T.C. Hazen, and G.A. Toranzos. 1988. Isoaltion of fecal
coliforms from pristine sites in a tropical rainforest. Appl. Environ. Microbiol. 54:
513-517.

214.

Rodriguez, B. B. 2004. Development of urease and glutamic dehydrogenase
amperometric assay for heavy metals and screening in polluted samples. Biosens.
Bioelectron. 19: 1157-1167.

215.

Roitt, I., J. Brostoff, and D.Male. 2001. Immunology. Harcourt Publishers,
London.

216.

Rowe Taitt, C., G.P. Anderson, and F.S. Ligler. 2005. Evanescent wave
fluorescence biosensors. Biosens. and Bioelectron. 20: 2470-2487.

217.

Rozdzinski, E., R. Marre, M. Susa, R. Wirth, and A. Muscholl-Silberhorn.
2001. Aggregation substance-mediated adherence of Enterococcus faecalis to
immobilized extracellular matrix proteins. Microbial. Patho. 30: 211-220.

218.

Sakazaki, R., and K. Tamura. 1971. Somatic antigen variation in Vibrio
cholerae. Jpn. J. Med. Sci. Biol 24: 93-100.

219.

Sano, T. 1992. Immuno-PCR: very sensitive antigen detection by means of
specific antibody-DNA conjugates. Science. 258: 120-122.

220.

Santo Domingo, J. W., S.C. Siefring, and R.A. Haugland. 2003. Real-time
PCR method to detect Enterococcus faecalis in water. Biotech. Lett 25: 261-265.
176

221.

Sasaki, S., K. Yokoyama, E. Tamiya, I. Karube, C. Hayashi, Y. Arikawa, and
M. Numata. 1997. Sulfate sensor using Thiobacillus ferrooxidans. Anal. Chim.
Acta. 347: 275-280.

222.

Scott, T. M., T.M. Jenkins, J. Lukasik, and J.B. Rose. 2005. Potential use of a
host associated molecular marker in Enterococcus faecium as an index of human
fecal pollution. Environ. Sci. Technol. 39: 283-287.

223.

Scott, W. J. 1932. Survey of Connecticut's shore bathing waters. Public Health
Eng. 19: 316.

224.

Sghir, A., G. Gramet, A. Suau, V. Rochet, P. Pochart, and J.Dore. 2000.
Quantification of bacterial groups within human fecal flora by oligonucleotide
probe hybridization. Appl. Environ. Microbiol. 66: 2263-2266.

225.

Sharma, S., P. Sachdeva, and J.S. Virdi. 2003. Emerging water-borne
pathogens. Appl. Microbiol. Biotechnol. 61: 424-428.

226.

Sherman, J. M. 1937. The streptococci. Bacteriol. Rev. 1: 3-97.

227.

Shibata, T., H.M. Solo-Gabriele, L.E. Fleming, and S. Elmir. 2004.
Monitoring marine recreational water quality using multiple microbial indicators
in an urban tropical environment. Water Res. 38: 3119-3131.

228.

Shmuel, A., and B. Sasson. 1979. Immunoglobulin differentiation is dictated by
repeated recombination sequences within the V region prototype gene: A
hypothesis. Proc. Natl. Acad. Sci. USA 76: 4598-4602.

229.

Shons, A. F. D., and J. Najarian. 1972. Piezoelectric quartz immunosensor. J.
Biomed. Mater. Res. 6: 565-575.

230.

Shriver-Lake, L. C., G.P.Anderson, J.P. Golden, R.A.Ogert, D. Wijesuria,
L.Cao, J.M. Mauro, and F. Ligler. 1994. Fiber-optic sensor detection of
biological agents. Director’s Series on Proliferation 4: 47-54.

231.

Signoretto, C., G. Bulacchini, C. Pruzzo, and P. Canepari. 2005. Persistance
of Enterococcus faecalis in aquatic environments via surface interaction with
copepods. Appl. Environ. Microbiol. 71: 2756-2761.

232.

Signoretto, C., G. Bulacchini, M. del Mar Lleo, C. Pruzzo, M. Zampini, L.
Pane, G. Franzini, and P. Canepari. 2004. Adehsion of Enterococcus faecalis
in the nonculturable state to plankton is the main mechanism responsible for
persistance of this bacterium in both lake and seawater. Appl. Environ. Microbiol.
70: 6892-6896.
177

233.

Signoretto, C., del Mar, L., Tafi, M.C., and P. Canepari. 2000. Cell wall
chemical composition of Enterococcus faecalis in the viable but nonculturable
state. Appl. Environ. Microbiol. 66: 1953-1959.

234.

Simmons, O. D., M.D. Sobsey, C.D. Heaney, F.W. Schaefer, and D.S. Francy.
2001. Concentration and detection of Cryptosporidium oocysts in surface water
samples by method 1622 using ultrafiltration and capsule filtration. Appl.
Environ. Microbiol. 67: 1123-1127.

235.

Simpson, J. M., and D.V. Lim. 2005. Rapid PCR confirmation of E.coli
O157:H7 after evanescent wave fiber optic biosensor detection. Biosens.
Bioelectron. 21: 881-887.

236.

Singh, B. R., S.H. Harrison, and J.S. Schoeniger. 2000. Gangliosides as
receptors for biological toxins: development of sensitive fluoroimmunoassays
using ganglioside-bearing liposomes. Anal. Chem. 72: 6019-6024.

237.

Singh, B. R., and M. A. Silvia. 1996. Detection of botulinum neurotoxins using
optical fiber-based biosensor. Adv. Exp. Med. Biol. 391: 499-508.

238.

Singh, D. V., M.H. Matte, G.R. Matte, S. Jiang, F. Sabeena, B.N. Shukla, S.C.
Sanyal, A. Huq, and R.R. Colwell. 2001. Molecular analysis of V. cholerae O1,
O139, non-O1, and non-O139 strains: clonal relationships between clinical and
environmental isolates. Appl. Environ. Microbiol. 67: 910-921.

239.

Singh, K. V., T.M. Coque, G.M. Weinstock, and B.E. Murray. 1998. In vivo
testing of an Enterococcus faecalis efaA mutant and use of efaA homologs for
species identification. FEMS Immunol. Med. Microbiol. 21: 323-331.

240.

Skladal, P., C. dos Santos Riccardi, H. Yamanaka, and P.I. da Costa. 2004.
Piezoelectric biosensors for real-time monitoring of hybridization and detection of
hepatitis C virus. J. Virol. Methods 117: 145-151.

241.

Skretas, G., and D. W. Wood. 2005. A bacterial biosensor of endocrine
modulators. J. Mol. Biol 349: 464-474.

242.

Smith, T. 1891. A new method for determining quantitatively the pollution of
water by fecal bacteria. 13th Annual Report of the New York State Board of
Health. Albany, NY.

243.

Snow, J. 1954. On cholera, L. Clendening, ed. ed. Paul B, Hoeber, Inc., New
York.
Sood, S., B.K. Das, A. Kapil, and A. Rattan. 1996. TCBS for the isolation of
Vibrio cholerae. Trop. Gastroenterol. 17:177.

244.

178

245.

Stender, H., K. Oliveira, S. Rigby, F. Bargoot, and J. Coull. 2001. Rapid
detection, identification, and enumeration of Escherichia coli by fluorescence in
situ hybridization using an array scanner. J. Microbiol. Methods 45: 31-39.

246.

Stender, H., M. Fiandaca, J.J.Hylig-Nielsen, and J. Coull. 2002. PNA for rapid
microbiology. J. Microbiol. Met. 48: 1-17.

247.

Straub, T., and D. P. Chandler. 2003. Towards a unified system for detecting
waterborne pathogens. J. Microbiol. Met. 53: 185-197.

248.

Su, X. L., and Y. Li. 2004. A self-assembled monolayer-based piezoelectric
immunosensor for rapid detection of Escherichia coli O157:H7. Biosens.
Bioelectron. 15: 563-574.

249.

Taitt, C. R., J.P. Golden, Y.S. Shubin, L.C. Shriver-Lake, K.E. Sapsford, A.
Rasooly, and F.S. Ligler. 2004. A portable array biosensor for detecting multiple
analytes in complex samples. Microb. Ecol. 47:175-185.

250.

Taylor, R. K., V.L.Miller, D.B. Furlong, and J.J. Mekalanos. 1987. Use of
phoA gene fusionsto identify a pilus colonization factor coordinately regulated
with cholera toxin. Proc. Natl. Acad. Sci. USA 84: 2833-2837.

251.

Tempelman, L. A., K.D. King, G.P. Anderson, and F.S.Ligler. 1996.
Quantitating staphylococcal enterotoxin B in diverse media using a portable fiberoptic biosensor. Anal. Biochem. 233: 50-57.

252.

Theron, J., and T.E. Cloete. 2002. Emerging water borne infections:
contributing factors, agents, and detection tools. Crit. Rev. Microbiol 28: 1-26.

253.

Thiercelin, M. E., and L. Johaud. 1903. Reproduction de l'enterocoque;taches
sentrales; graduations periferiques et microblastes. CRS Soc. Biol. Fil. 55: 686688.

254.

Tilden, J. J., W. Young, A.M. McNamara, C. Custer, B. Boesel, M.A.
Lambert-Fair, J. Majkowski, D. Vugia, S.B. Werner, J. Hollingsworth, and
J.G. Morris Jr. 1996. A new route of transmission for Escherichia coli: infection
from dry fermented salami. Am. J. Public Health 86: 1142-1145.

255.

Timm, E. A., and C. Stewart. 1992. Fluorecent in situ hybridization en
suspension (FISHES) using digoxigenin-labeled probes and flow cytometry.
Bio.Techniques 12: 362-367.

256.

Tims, T. B., and D. V. Lim. 2004. Rapid detection of Bacillus anthracis spores
directly from powders with an evanescent wave fiber optic biosensor. J.
Microbiol. Meth. 59: 127-130.
179

257.
258.

Tomoyasu, T. 1998. Improvement of the immunomagnetic separation method
selective for Escherichia coli O157:H7 strains. Appl. Environ. Microbiol. 64:
376-382.
Toranzos, G. A., G.A. McFeters, and J.J. Borrego. 2002. Detection of
microorganisms in environmental freshwaters and drinking waters, p. 205-219. In
R. L. C. C.J. Hurst, G.R. Knudsen, M.J. McInerney, L.D. Stetzenbach (ed.),
Manual of Environmental Microbiology. ASM Press, Washington, D.C.

259.

Turbow, D. J., N.D. Osgood, and S.C. Jiang. 2003. Evaluation of recreational
health risk in coastal waters based on enterococcus densities and bathing patterns.
Environ. Med. 111: 598-603.

260.

Turner, A. P. F. 2000. Biosensors---- sense and sensitivity. Science. 290: 13151317.

261.

U.S. Environmental Protection Agency. 1986. Ambient water qualtiy criteria
for bacteria--1986. U.S. Environmental Protection Agency publication no. EPA
440-5-84-002. Office of Research and Development, U.S. EPA. Washington,
D.C.

262.

U.S. Environmental Protection Agency. 1999. EPA action plan for beaches and
recreational waters. U.S. Environmental Protection Agency publication no.
EPA/600/R-998/079. Office of Research and Development, U.S. EPA.
Washington, D.C.

263.

U.S. Environmental Protection Agency. 2005. Method 1600: Membrane filter
test method for enterococci in water. U.S. Environmental Protection Agency,
Washington D.C.

264.

Vedrine, C. 2003. Optical whole-cell biosensor using Chlorella vulgaris designed
for monitoring herbicides. Biosens. Bioelectron. 18: 457-463.

265.

Wade, T. J., N. Pai, J.N.S. Eisenberg, and J.M. Colford. 2003. Do U.S.
Environmental Protection Agency water quality guidelines for recreational waters
prevent gastrointestinal illnes? Environ. Health. Persp. 111: 1102-1109.

266.

Wadkins, R. M., J.P. Golden, and F.S. Ligler. 1995. Calibration of biosensor
response using simultaneous evanescent wave excitation of cyanine-labeled
capture antibodies and antigens. Anal. Biochem. 232: 73-78.

267.

Wai, S. N., Y. Mizunoe, and S. Yoshida. 1999. How Vibrio cholerae survive
during starvation. FEMS Microbiol. Lett. 180: 123-131.

268.

Wang, J. 1999. Electroanalysis and biosensors. Anal. Chem 71: 329-332.
180

269.

Watanabe, A., K. Yano, K. Ikebukuro, and I. Karube. 1998. Investigation of
the potential active site of a cyanide dihydratase using site-directed mutagenesis.
Bichim. Biophys. Acta. 1382:1-4.

270.

Watson, B. K., R. C. Moelleing, and L.J. Kunz. 1976. Effects of penicillin and
lysozymes on the immunofluorescent and precipitin reactivity of group D
streptococci. Am. J. Clin. Pathol. 66: 73-79.

271.

Weissman, J. B., W.E. DeWitt, J. Thompson, C.N. Muchnick, B.L. Portnoy,
J.C. Feeley, and E.J. Gangarosa. 1975. A case of cholera in Texas, 1973. Am. J.
Epidemiol. 100: 487-498.

272.

Wicken, A. J., S.D. Elliott, and J. Baddiley. 1963. The identity of Streptococcal
group D antigen with teichoic acid. J. Gen. Microbiol. 31: 231-239.
Wicken, A. J., and K. W. Knox. 1975. Lipoteichoic acids: A new class of
bacterial antigen. Science 187: 1161-1167.

273.
274.

Willats, W. G. T. 2002. Phage display: practicalities and prospects. Plant Mol.
Biol. 50: 837-854.

275.

Wilson, A. 1971. The spread of cholera to and within Nigeria 1970-71. J Clin
Pathol 24: 768.

276.

World Health Organization. 2005. Cholera in West Africa. Wkly Epidemiol
Rec. 80: 297-298.

277.

Wu, A. M., J.H. Wu, W.M. Watkins, C.P. Chen, S.C. Song, and Y.Y. Chen.
1998. Differential binding of human blood group Sd (a+) abd Sd (a-) TammHorsfall glycoproteins with Dolichos biflorus and Vicia villosa-B4 agglutinins.
FEBS Lett. 429: 323-326.

278.

Xiao, J., M. Hook, G.M. Weinstock, B.E. Murray. 1998. Conditional adherence
of Enterococcus faecalis to extracellular matrix proteins. FEMS Immunol. Med.
Microbiol. 21: 287-295.

279.

Yalow, R., and S. A. Berson. 1959. Assay of plasma insulin in human subjects
by immunological methods. Nature 184: 1684-1649.

280.

Yang, V. C., and T. T. Ngo. 2000. p. ix-x. In V. C. Yang (ed.), Biosensors and
Their Applications. Kluwer Academic/Plenum Publishers, New York.

281.

Yoshpe-Purer, Y., and S. Golderman. 1987. Occurrence of Staphylococcus
aureus and Pseudomonas aeruginosa in Israeli coastal water. Appl. Environ.
Microbiol. 53:1138-1141.
181

282.

Yu, H., and J. G. Bruno. 1996. Immunomagnetic electrochemiluminescent
detection of Escherichia coli O157:H7 and Salmonella typhimurium in foods and
environmental water samples. Appl. Environ. Microbiol. 62: 587-592.

283.

Zmirou, D. 2003. Risks assoicated with the microbiological quality of bodies of
fresh and marine water used for recreational purposes: summary estimates based
on published epidemiological studies. Arch. Environ. Health 58: 703-711.

182

ABOUT THE AUTHOR
Theresa Trindade received a Bachelor’s Degree in Biology with a minor in Chemistry
from Florida Southern College in 1999. She entered the Ph.D. program in Biology at the
University of South Florida in 2000. While in the Ph.D. program at the University of
South Florida, Ms. Trindade was active in the American Society for Microbiology
(ASM). She made several poster and oral presentations at various regional and national
ASM meetings and was awarded travel grants to attend two of those meetings.

